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Histone H3 lysine 27 dimethylation 
lysine36 dimethylation,  
H3K27me3 
Histone H3 lysine 27 trimethylation,  
H3K27me3K36me1 
Histone H3 lysine 27 trimethylation 
lysine 36 monomethylation,  
H3K4me3 
Histone 3 Lysine 4 Trimethylation,  
H3K9me2 
Histone H3 lysine 9 dimethylation,  
H3K9me2K14ac 
Histone H3 lysine 9 dimethylation 
Lysine 14 acetylation),  
H3K9me3 
Histone H3 lysine 9 trimethylation,  
H3K9me3K14ac 
Histone H3 lysine 9 trimethylation, 
lysine 14 acetylation,  
H3K9MeS10PhosK14Ac 
Histone 3 lysine 9 methylation serine 
10 phosphorylation and lysine 14 
acetylation,  
H3S10 
Hinstone H3 serine 10,  
H3S10phos 
Histone H3 Serire 10 
phosphorylation,  
H4K16ac 
Histone 4 lysine 16 acetylation,  
H4K20me1 
Histon H4 lysine 20 monomethyl,  
H4K20me2 
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Histone H4 lysine 20 dimethylation,  
HDAC 
Histone deacetylase,  
HDACi 
Histone Deacetylase Inhibitor,  
HDHD5 
Haloacid dehalogenase like 
hydrolase domain containing 5,  
HFBA 
heptafluorobutyric acid,  
HGH1 
Human growth hormone 1 homolog,  
HPLC 
high performance liquid 
chromatography,  
hsp 
Heat shock protein,  
IAA 
Iodoacetic acid,  
IFN- 
Interferon gamma,  
IGV 
Integrated genomics viewer,  
IL-1 
interleukin 1 beta,  
IL-18 
Interleukin 18,  
IL-6 
Interleukin 6,  
InlB 
internalin B, 34 
IPD 
Invasive Pneumococcal Disease,  
K 
Lysine,  
KAT6A 
Lysine acetyltransferase 6A,  
KCl 
potassium chloride,  
Kdm1b 
lysine demethylase 1B, 
Kdm3a 
lysine demethylase 3a,  
Kdm3b 
lysine demethylase 3b,  
KEGG 
Kyoto Encyclopaedia of Genes and 
Genomes,  
KEGG 
Kyoto encyclopaedia of genes and 
genomes,  
KMT 
Lysine methyltransferase,  
LC-MS/MS 
Liquid chromatography and tandem 
mass spectrometry,  
LFQ 
Label Free Quantification,  
LINC01667 
Long non-protein coding RNA 1667,  
Lowess 
locally weighted scatterplot 
smoothing,  
LPS 
Lipopolysaccharide,  
LSD1 
Lysine specific demethylase 1,  
LSD2 
lysine-specific histone demethylase 2,  
m/z 
Mass to charge ratio,  
MACS 
Model-based Analysis of ChIP-Seq,  
MAPK 
Mitogen activated protein kinase,  
MDM 
Monocyte Derived Macrophages,  
MgCl 
Magnesium Chloride,  
mgf 
Mascot Generic Format,  
MI 
Mock infected,  
MIP-1 
Macrophage inflammatory protein 1 ,  
MIP-1/LD78 
macrophage inflammatory protein,  
miR155 
micro RNA 155 host gene,  
mRNA 
Messenger ribonucleic acid,  
MS 
Mass spectrometry,  
MS/MS 
Tandem mass spectrometry,  
MS2 
Tandem mass spectrometry spectra,  
MUC3A 
mucin 3A,  
NaCl 
Sodium Chloride,  
NCE 
Normalised Collision Energy,  
NGS 
Next Generation Sequencing,  
NLRP3 
nod like receptor pyrin domain 
containing 3,  
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NLS 
N-Laurosyl-sarcosine,  
NO 
Nitrogen oxide,  
NOD 
Nucleotide binding oligomerization 
domain-containing protein,  
NP40 
Nonidet P-40,  
NPAS3 
Neuronal Per-Arnt-Sim domain 3,  
NQO1 
NAD(P)H dehydrogenase quinone 1,  
NR4A1 
Nuclear receptor subfamily 4 group A 
member 1,  
NR4A2 
Nuclear receptor subfamily 4 group A 
member 2,  
NRF2 
Nuclear erythroid factor 2,  
NSC 
Normalised strand coeficient,  
OD 
Optical Density,  
PBS 
Phosphate buffered saline,  
PCR2 
Ploycomb repressive complex 2,  
PGC 
Porous Graphitic Column,  
PHF8 
PHD finger protein 8,  
PI 
Protease Inhibitor,  
PLY 
Pneumolysin,  
ppm 
Parts per million,  
PRM 
Parallel reaction monitoring,  
PSM 
Peptide sequence match,  
PTM 
Post-translational modification,  
PTX3 
Pentraxin 3, 
PVDF 
Polyvinylidene fluoride membrane, 
QE 
Orbitrap Q-Exactive HF,  
QE 
QExactive HF Orbitrap,  
qPCR 
quantitative polymerase chain 
reaction,  
Rag1 
recombination activating gene 1,  
rcf 
Relative Centrifugal Force,  
RIPK2 
Receptor-interacting 
Serine/threonine-protein kinase 2,  
RLE 
Relative log expression,  
RNA45SN1 
45S Pre-Ribosomal N1,  
RNASeq 
RNA Sequencing, 
ROCK1P1 
Rho associated coiled-coil containing 
protein kinase 1 pseudogene 1,  
ROS 
Reactive oxygen species,  
RSC 
Relative strand correlation,  
S. pneumoniae 
Streptococcus pneumoniae,  
SCC 
Side scatter,  
SCID 
Severe combined immunodeficiency,  
SD 
Standard deviation,  
SDS 
Sodium dodecyl sulphate,  
SEM 
standard error of the mean,  
Sirt1 
Sirtuin 1,  
Sirt2 
Sirtuin2,  
SLIT2 
Slit homolog 2 protein,  
SMARCA 
SW/SNF related, matrix associated, 
actin dependent regulator of 
chromatin, subfamily A, member 2, 
SRM 
Selective reaction monitoring,  
STAB1 
stabilin 1,  
Suv39h 
SET domain of the human homolog of 
Drosophila Su(var)3-9,  
SWI/SNF 
SWitch/Sucrose non-fermentable,  
TBS/tween 
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Solution of Tris-HCL, sodium 
Chloride, and tween-20,  
TCA 
Trichloroacetic acid,  
TCEP 
Tris(2-carboxyethyl)phosphine 
hydrochloride,  
TEAB 
Triethylammonium bicarbonate,  
TEMED 
Tetramethylethylenediamine,  
TFA 
Trifluoroacetic acid,  
TLR 
Toll-like receptor,  
TLR4 
Toll like receptor 4,  
TNF 
Tumour Necrosis factor,  
TNF- 
Tumour necrosis factor alpha,  
ToF 
Time of flight,  
TRIM24 
tripartite motif containing 24,  
TRXR1 
Thioredoxin reductase,  
TSS 
Transcription start site,  
TTTY23 
testis specific transcript Y linked 23,  
UBTD1 
Ubiquitin domain-containing protein1,  
UCK1 
Uridine-cytidine kinase 1,  
UV 
ultraviolet,  
VPS13C 
vacuolar protein sorting 13C,  
XIC 
Extracted ion Chromatogram,  
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Thesis abstract: 
 
Streptococcus pneumoniae is the leading cause of community acquired 
pneumonia. The pathogenesis of pneumococcal disease is not fully understood. 
Nasopharyngeal colonisation precedes pneumococcal disease and is influenced by the 
effectiveness of innate immune responses. As the macrophage is a key component in the 
innate immune response, the interaction between S. pneumoniae and the macrophage 
will be crucial in controlling susceptibility to pneumococcal disease. It is increasingly 
recognised that epigenetic mechanisms play key roles in the host pathogen interaction. 
Mass spectrometry has emerged as a powerful tool for the study of global changes in 
histone post-translational modifications (PTM) one of the key epigenetic mechanisms. 
 
I hypothesised that S. pneumoniae induces immediate changes in the host’s 
epigenome by altering histone post-translational modifications, in turn regulating the 
innate immune responses by modulating gene expression and may explain some of the 
variation observed in the susceptibility to invasive pneumococcal disease. 
 
I established a proteomic approach to determine the extent and nature of PTMs 
in primary human macrophages following challenge with S. pneumoniae and the 
contribution of pneumolysin, a key virulence factor, to changes in histone PTMs 
following bacterial challenge of MDMs. This illustrated that the relative abundance of 
several histone PTMs is modified in response to challenge with S. pneumoniae. 
 
I demonstrated that the bacterial virulence factor pneumolysin causes significant 
changes in both gene expression (503 differentially expressed genes) and protein 
expression in primary MDMs.  
 
Finally, I used RNA-Seq and ChIP-Seq, to attempt to determine the relationship 
between gene expression levels and PTMs of the associated histones. These analyses 
demonstrated a number of innate immune response genes to be differentially enriched, 
demonstrating the role of epigenetic regulation of gene expression associated with the 
innate immune response upon challenge with S. pneumoniae. 
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Chapter 1: Introduction  
 
1.1 Streptococcus pneumoniae: 
1.1.1 The public health burden of Streptococcus pneumoniae: 
 Streptococcus pneumoniae (S. pneumoniae) is a Gram-positive bacterium that 
remains a major cause of invasive disease in humans despite the availability of 
polysaccharide and protein conjugate vaccines (Ladhani et al., 2013). It causes 
approximately 5000 cases of invasive disease a year in England and Wales (“ 
GOV.UK,”2018.). Invasive pneumococcal disease (IPD) is defined as the isolation of S. 
pneumoniae from otherwise sterile sites such as blood or cerebral spinal fluid. S. 
pneumoniae is the leading cause of community-acquired pneumonia (Holter et al., 
2015). Invasive pneumococcal disease accounts for at least 2 million deaths globally 
(O’Brien et al., 2009) and represents therefore a major burden on health services. The 
presence of S. pneumoniae in the nasopharynx, without causing disease, is termed 
colonisation. This has been shown to precede invasive disease (Kadioglu et al., 2008a; 
Ramos-Sevillano et al., 2011). Although there is a role for the adaptive immune 
response, as vaccination with pneumococcal conjugate vaccine has been shown to 
reduce IPD through antibody and T cell responses (Bryant et al., 2010; Ladhani et al., 
2013), the likelihood of severe disease or of IPD is thought to be governed by the 
interaction between the innate immune response and S. pneumoniae. It is not fully 
understood how S. pneumoniae evades the host’s innate immune defences, nor how 
aberrant host responses contribute to disease severity. Microorganisms have evolved a 
variety of mechanisms to evade host defences. These include inhibition of phagocytosis 
through the action of polysaccharide capsule (Hyams et al., 2010), subversion of 
bacterial killing, inhibition of inflammation, modulation of cell trafficking and survival 
(Baxt et al., 2013; Fernie-King et al., 2002). Several of these mechanisms rely on the 
modulation of host gene expression (Jenner and Young, 2005; Nau et al., 2002). 
 
1.1.2 The role of pneumolysin as a virulence factor: 
 S. pneumoniae has a number of different virulence factors (Kadioglu et al., 
2008a). Among these one of the most important is pneumolysin (PLY), a cholesterol-
dependent cytolysin (Marriott et al., 2008). It is produced by almost all invasive clinical 
isolates of S. pneumoniae and has been implicated in migration from lung tissue to 
blood (Hu et al., 2015), in host immune subversion and as a trigger of inflammatory 
responses. In human cells PLY is a potent activator of gene transcription and potentially 
interacts with several pattern recognition receptors to mediate innate immune responses. 
These include toll-like receptor 4 (TLR4) and nod-like receptor pyrin domain 
containing 3 (NLRP3) and potentially other NLRs, which help coordinate the host 
response to pneumococcal infection (McNeela et al., 2010; Srivastava et al., 2005; 
Witzenrath et al., 2011). Although the exact role played by TLR4 in pneumolysin 
remains controversial. S. pneumoniae mutants lacking PLY in murine models display 
attenuated virulence but cause chronic bacteraemia rather than overwhelming sepsis and 
death (Benton et al., 1995). This underlines the importance of PLY in activating the host 
response, which leads to bacterial clearance. It therefore appears that although PLY is 
required to activate a successful innate immune response, PLY achieves this at the 
expense of generating a vigorous inflammatory response, which in some individuals is 
excessive and contributes to disease pathogenesis. 
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 Furthermore, PLY is responsible for the differential expression of 142 genes in 
an undifferentiated THP-1 cell model of infection. Importantly a number of these genes 
are involved in host immune responses, thereby reinforcing the role of PLY as a key 
virulence factor (Rogers et al., 2003). 
 
1.2 The innate immune system: 
 Invasive disease has been shown to be preceded by colonisation (Bogaert et al., 
2004; Gray et al., 1980). The host’s innate immune response contributes to the 
clearance of colonising bacteria and those that reach the lower airway, thereby playing a 
key role in determining whether S. pneumoniae colonisation progresses to pneumonia or 
IPD. The mammalian immune system has traditionally been described as comprising 
two different types of immune responses. First, the innate immune response, a general 
response to pathogens which was initially thought to occur with identical intensity on 
repeated exposure and is composed chiefly of phagocytic cells, cells that release 
cytokines and chemokines and natural killer cells. The second, the adaptive immune 
response, is a more specialised response that develops in response to each new pathogen 
it encounters, gives rise to a stronger response on repeated exposure and is composed of 
proliferating B and T Lymphocytes allowing it to develop a memory of antecedent 
events with great specificity. The innate immune system is responsible for detection and 
recognition of pathogens, phagocytosis of cellular debris and pathogens, cytokine 
release and regulation of the inflammatory response. These different processes are 
achieved by specialised cells involved primarily in phagocytic clearance (neutrophils, 
macrophages and monocytes), or cells not primarily involved in phagocytic clearance 
but that can activate host responses following exposure to pathogens (dendritic cells, 
basophils, mast cells, eosinophils) or destruction of malignant cells (natural killer cells). 
However, in practice, there is overlap between roles, and the distinction is less clear 
(Delves and Roitt, 2000). In addition, the innate immune system primes the adaptive 
response by way of antigen presenting cells and release of cytokines during infections. 
Therefore, the two systems can be viewed as being complementary to each other. 
 
1.2.1 Macrophages: 
 Macrophages can arise from bone marrow-derived precursor cells known as 
monocytes. However, it has been shown in mice, that the ontology of tissue-resident 
macrophages varies (Ginhoux and Jung, 2014). Some tissue-resident macrophages, such 
as intestinal, dermal and cardiac macrophages, are continually renewed from circulating 
monocytes. Others, such as alveolar macrophages, arise prior to birth from primarily 
foetal liver derived stem cells and monocyte derived cells only contribute to renewal 
when resident cells are depleted to an extent that replication of resident cells cannot 
replenish numbers. Microglial cells, conversely, arise primarily from embryonic yolk 
sac derived precursors. Finally, Langerhans cells rise from a combination of both. These 
tissue resident macrophages can then be maintained within that tissue during normal 
homeostatic conditions (Yona et al., 2013). Furthermore, during tissue injury these 
resident cells release signals that stimulate circulating monocytes to migrate into tissues, 
where they then differentiate into either dendritic cells or tissue-specific macrophages. 
Moreover, different macrophage populations vary in their functional activity according 
to the environmental stimuli they encounter. This has led to the terms M1 and M2 
polarisation being used to describe these different roles in mice. The current M1/M2 
paradigm is likely to be an oversimplification and describes the extremes of the 
continuum, as it relies on descriptions of in vitro murine models with distinct stimuli 
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which don't occur in isolation in nature. Furthermore, it does not take into account the 
context of the stimulation nor the stage of maturation of the macrophages as it has been 
shown that stimulation of monocytes gives rise to different phenotypes to mature 
macrophages being stimulated (Martinez and Gordon 2014).. Finally, it is likely that the 
different lineages of macrophages such as tissue resident macrophages versus monocyte 
derived macrophages may have distinct responses. The M1 polarised macrophage is 
better suited to some aspects of bacterial killing, whereas the M2 macrophage is better 
suited to tissue repair (Martinez et al., 2008). However, there is overlap between 
functional states, as M2 macrophages are better suited to anti helminthic responses and 
some bacteria will cause a mixed response (Benoit et al., 2008). As macrophages are the 
resident tissue phagocyte, they are key in controlling infection They also have an 
important role in escalating the inflammatory response by releasing cytokines, and 
provide linkage to the adaptive immune response by recruiting T lymphocytes and 
dendritic cells, making them the cornerstone of the innate immune response. 
 
1.3 Epigenetics: 
1.3.1 Chromatin remodelling: 
 Cell function is governed by the dynamic translation of the genetic code into 
proteins in response to a diverse range of external and endogenous signals. The 
deoxyribonucleic acid (DNA) contained within the cell’s nucleus encodes a series of 
genes, and it is by varying their expression that the cell is able to adapt to its 
environment and fulfil its role. The term epigenetics was initially used to describe 
heritable changes in the transcriptional phenotype of cells without altering DNA 
sequence (Berger et al., 2009). More recently it is also used to include transient changes 
in chromatin state that result in gene expression changes (Natoli, 2010). The epigenome 
is the net result of the interaction between the host genome and its environment. It is 
recognised as making a critical contribution to the control of gene expression in cells. 
Epigenetic changes, such as DNA methylation, histones post-translational modifications 
and miRNA interactions, regulate gene transcription through alterations other than 
changes in the DNA sequence (Jenuwein and Allis, 2001). 
 DNA is coiled around a histone octamer (composed of pairs of H2A, H2B, H3 
and H4 histones) to form a nucleosome (Kornberg, 1974). In turn, chains of 
nucleosomes along with linker DNA and Histone H1 form chromatin (Figure 1.1, 
adapted from (Cole et al., 2014)). These histones are highly conserved throughout 
eukaryotic cells. The manner in which DNA is wound around histones and the 
modelling of the chromatin that results, dictates the availability of DNA sequences to 
the various transcriptional elements which regulate gene transcription. The traditional 
view, which is probably an oversimplification, states that chromatin can be densely 
packed, in which case it is termed heterochromatin. In this state, the DNA sequence is 
so tightly coiled that gene transcription is not possible. Conversely, in euchromatin, the 
bound DNA is loosely coiled and the coding sequence of genes is available for 
transcription. Evidence exists in drosophila of 5 distinct chromatin states based on 
different protein interactions and transcriptional states of the bound DNA sequence 
(Filion et al., 2010). Therefore, the control over chromatin density and the proteins 
bound to it, including the post-translational modifications of histones (PTM), are, in 
part, responsible for the regulation of gene transcription. 
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Figure 1.1: Schematic representation of histone post-translational 
modifications and their influence on chromatin remodelling. The figure shows a 
nucleosome composed of an octamer of histones with a schematic representation of the post-translational 
modifications (PTM) on the histone tails. Following an external stimulus the levels of trimethylation on 
the 4th lysine of Histone H3 (H3K4me3) are modified and along with other PTMs (not represented) this 
leads to a change in the conformation of the chromatin and subsequently the RNA polymerase is no 
longer able to bind the DNA. (adapted from (Cole et al., 2014)). 
 
1.3.2 DNA methylation: 
 DNA methylation refers to the chemical addition of a methyl group to the 
cytosine base. This process is regulated by DNA methyltransferase (DNMT) 1 for 
maintenance and DNMT3A and DNMT3B for de novo methylation in embryonic 
tissues. The methylation of cytosine bases occurs principally at the CpG dinucleotides. 
Studies have shown that between 50 to 90% of these are methylated in mammalian 
tissues (Ehrlich et al., 1982). DNA methylation associated with the promoter region of 
genes leads to reduced gene expression, as the promoter region is not available to 
initiate transcription. Importantly DNA methylation appears to be conserved over time 
and is heritable (Smith and Meissner, 2013). 
 
1.3.3 Histone post-translational modifications: 
 Modifications of the N-terminal tails of histones influence the availability of the 
bound DNA sequence by altering chromatin conformation or interacting with 
transcription factors (Berger, 2007; Jenuwein and Allis, 2001). These changes in the N-
terminal domain of the histone tail, termed PTMs, are caused by chemical alterations, 
such as phosphorylation, methylation, acetylation, ubiquitination, propionylation and 
sumoylation. These chemical modifications cause adjoining histone tails to be either 
attracted to each other or repulsed (Rhee et al., 2014). The PTMs not only regulate the 
density of the chromatin binding but can also block the binding of transcription factors 
and RNA polymerase (Gerber and Shilatifard, 2003). There are a number of different 
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enzymatic processes involved in the control of these PTMs (Jenuwein and Allis, 2001). 
Acetylation is mediated by histone acetyltransferase. Deacetylation is controlled by 
histone deacetylase, which in humans include the 18 different enzymes grouped in 4 
classes of which the sirtuins (class 3) are an important component. 
  Certain PTMs have been associated with up-regulation, or down-regulation, of 
the associated gene expression (Jenuwein and Allis, 2001). While it has been recognised 
for some time that bacteria and viruses can induce chronic changes to the epigenome 
influencing cancer susceptibility and the pathogenesis of chronic inflammatory diseases, 
the consequences of epigenetic changes during acute bacterial infections are not well 
understood (Esteller, 2007; Paschos and Allday, 2010). 
 
1.3.4 Epigenetic influences on macrophage development: 
 The processes governing the differentiation of monocytes into macrophages 
have been extensively studied (Saeed et al., 2014; Wallner et al., 2016). It has been 
demonstrated that circulating monocyte differentiation into macrophages is associated 
with the combinatorial histone modification lysine 9 methylation serine 10 
phosphorylation and lysine 14 acetylation on histone H3 (H3K9MeS10PhosK14Ac). 
However, differentiation into dendritic cells is associated with acetylation of lysine 16 
on histone H4 (H4K16Ac) (Nicholas et al., 2014). Prior exposure to certain stimuli ( 
Glucan or lipopolysaccharide (LPS) leads to the differential maturation of monocytes 
into macrophages and is also associated with specific PTMs (Saeed et al., 2014). 
Immature cells exposed to Histone deacytelase inhibitors (HDACi), such as Trichostatin 
A, develop greater acetylation levels on H3 and H4, which is associated with increased 
production of the pro-inflammatory cytokine tumour necrosis factor  (TNF-). 
Whereas dynamic changes in acetylation, which are higher in macrophages at baseline, 
do not appear to be a significant regulator of TNF- in mature macrophages, potentially 
as these acetylation changes are offset by other aspects of chromatin remodelling that 
occur during maturation (Lee et al., 2003). This implies that maturation of cells 
influences epigenetic regulation and the extent to which dynamic changes in acetylation 
regulate gene expression by external stimuli, leading to a better adaption to particular 
functional roles. Other studies have suggested that maturation-related changes in innate 
immune responses could be regulated by epigenetic changes in histones as a response to 
prior stimulation of pattern recognition receptors. Macrophages derived from stem cells 
exposed to Toll-like receptor (TLR) 2 agonists prior to differentiation or during it, were 
found to have decreased ROS production (Yáñez et al., 2013) compared to macrophages 
from unstimulated stem cells. More recently, the differentiation of monocytes into 
macrophages has been shown to involve the removal of DNA methylation mediated 
repression of genes implicated in phagocytosis, which are rapidly activated after the 
deposition of histone PTMs and miRNA changes (Wallner et al., 2016). 
 
1.3.5 Epigenetic regulation of macrophage function: 
 Macrophages fulfil diverse roles to enable the optimal functioning of the innate 
immune system. In order to perform these roles correctly, the macrophage is dependent 
on gene transcription. Genetic variation in the form of single nucleotide polymorphism 
for instance, contributes to the intensity of these responses influencing the susceptibility 
to infectious diseases. More recently, epigenetic variation has emerged as an additional 
point of regulation (Jenuwein and Allis, 2001). This allows a mechanism by which the 
environment can influence the transcriptional response (Galli et al., 2011). Epigenetic 
mechanisms have been shown to play a pivotal role in the regulation of macrophage 
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function in a range of different conditions. Smoking-induced inflammation in alveolar 
macrophages has been shown to be mediated by histone PTMs (Philibert et al., 2012), 
and the inflammatory response to particulate matter leading to decreases in DNA 
methylation by inhibiting DNMT1 activity (Miousse et al., 2014). 
 
1.3.6 Trained immunity: 
 The epigenetics of macrophages has mainly been studied in the context of 
macrophage functional phenotype and/or differentiation (Nicholas et al., 2014; Saeed et 
al., 2014; Satoh et al., 2010; Yáñez et al., 2013). Both DNA methylation and histones 
PTMs have been shown to play a role in this process. Importantly, epigenetic 
mechanisms also explain, in part, the emerging field of “trained immunity” (Netea et al., 
2011). Although the phenomenon of “trained immunity” has been recognized for a long 
time, it is only recently that we have been able to explain the mechanisms underpinning 
macrophage training. Indeed, as early as the 1970s observations were made of increased 
survival of mice following infection with the parasites Babesia microti and Babesia 
rodhaini after prior Bacillus Calmette-Guérin (BCG) vaccination (Clark et al., 1976). 
Increased survival in mice following pre-treatment with low dose Candida albicans 
when challenged subsequently with lethal doses of C. albicans or Staphylococcus 
aureus was also observed (Bistoni et al., 1986). There is evidence that macrophages are 
capable of developing a form of memory of antecedent events leading to a modified 
response and a survival advantage that appears to be mediated by epigenetic 
mechanisms. This evidence is also drawn from observations of individuals post BCG 
vaccination. Macrophages from individuals vaccinated with BCG were found to have 
increased TNF- and Interleukin 1 (IL-1) following repeat exposure to Mycobacteria 
tuberculosis and / or Candida albicans (Kleinnijenhuis et al., 2012). Observations such 
as these have been made in a number of different models deficient in adaptive 
immunity, such as plants, where it is termed “systemic acquired resistance” (Durrant 
and Dong, 2004) and in invertebrates (Moret and Siva-Jothy, 2003; Pham et al., 2007). 
Historically, crossover protection has been reported following vaccination in humans or 
challenge with one organism, which confer survival benefits against a subsequent 
infectious challenge. Experiments in healthy volunteers demonstrated that following 
vaccination with BCG, upon re-challenge with bacteria, Mycobacteria or Candida, 
monocytes had increased production of pro-inflammatory cytokines, and this was 
associated with increased levels of trimethylation of lysine 4 on Histone H3 (H3K4me3) 
(Kleinnijenhuis et al., 2012). Kleinnijenhuis and colleagues also demonstrated that the 
mechanism of training monocytes with BCG is independent of TLR2 and TLR4, instead 
it relies on nucleotide-binding oligomerization domain-containing protein (NOD) 2 
receptors. They then established the functional consequences of training macrophages in 
a lymphocyte-deficient murine model (using severe combined immunodeficiency 
(SCID) mice). They showed that BCG vaccination led to significant survival and 
decreased fungal burden in kidneys when mice were subsequently challenged with a 
lethal dose of C. albicans, thereby providing in vivo evidence of innate immune 
memory. 
 Innate memory has also been seen when pre-treating recombination activating 
gene (Rag1) deficient mice, which lack functional T- and B- cells and represent another 
model of severe combined immunodeficiency, with low dose C. albicans. Increased 
survival was observed compared to CCR2-deficient mice when re-infected with a lethal 
dose of C. albicans (Quintin et al., 2012), emphasizing that survival involves training of 
CCR2+ monocytes and not lymphocytes. Genome-wide chromatin immunoprecipitation 
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and sequencing (ChIP-Seq) for the histone PTM H3K4me3 showed increased levels of 
this PTM at the promoter regions of genes involved in inflammation, such as TNF-, 
interleukin 6 (IL-6) and interleukin 18 (IL-18). This highlights an epigenetic mechanism 
underlying the basis for training the innate immune system. 
 
1.3.7 Epigenetics and tolerance: 
 The macrophage response to external stimuli is a careful balancing act between 
generating a pro-inflammatory response to clear pathogens and the need to subsequently 
resolve the inflammatory process and generate a tissue healing response to prevent 
excessive and chronic inflammation leading to tissue injury. The mechanisms 
facilitating this include epigenetic regulation. The principal models used to study 
inflammation have been those of endotoxic shock. Acute lipopolysaccharide (LPS) 
exposure, signals via TLR4, to induce expression of a number of different pro-
inflammatory genes. In contrast, repeated exposure of monocytes to LPS leads to a 
tolerant monocyte, which produces markedly lower pro-inflammatory cytokines, such 
as TNF-, than when first exposed. In murine models of sepsis, following caecal 
ligation and puncture, LPS tolerance increases survival (Wheeler et al., 2008). Repeated 
exposure to certain stimuli, such as TLR4 agonists, stimulates tolerance, whereas the 
response to some other stimuli induces an accentuated pro-inflammatory response, 
consistent with the model of trained immunity (Ifrim et al., 2014). Tolerance helps 
decrease the risk of death from an exaggerated pro-inflammatory state, as observed in 
sepsis. Upon repeated LPS challenge, the activation of pro-inflammatory cytokine 
genes, such as IL-6, is reduced. As it is the same TLR4 pathway that is activated by 
repeated exposure to LPS, both signal transduction pathways and epigenetic changes 
regulate this response leading to the tolerance phenotype.  
 The promoter regions of pro-inflammatory genes in macrophages during the 
initial response and on re-challenge with LPS have been shown to be associated with 
varying levels of H3K4me3 and H4 acetylation (Foster et al., 2007). Foster and 
colleagues demonstrated that on LPS re-challenge, global H4 acetylation levels in the 
promoter regions of genes involved in LPS tolerance were decreased (Foster et al., 
2007). However, genes that continued to be actively transcribed on re-challenge 
maintained their H4 acetylation level. Foster and colleagues also showed that the TLR4 
response to repeated LPS exposure led to a loss of H3K4me3 in the promoter regions of 
genes that demonstrated LPS-tolerance, while in genes associated with non-tolerance, 
H3K4me3 was maintained. Furthermore, when pre-treated with Trichostatin A (a 
histone deacetylase inhibitor) during the initial LPS exposure, the pro-inflammatory 
gene expression of the macrophage is similar to the naïve macrophage upon re-
stimulation, restoring the secretion of IL-6. This was also seen when pre-treating with 
pargyline (an inhibitor of H3K4 demethylase), confirming that both H4 acetylation and 
H3K4me3 marks are important components in regulating responses during tolerance 
(Table 1 adapted from (Cole et al., 2014)). Interestingly, the authors observed that the 
LPS-induced gene responses that did not demonstrate LPS tolerance, included those 
involved in antimicrobial responses, ensuring these responses were not down-regulated 
on re-challenge (Foster et al., 2007). 
Table 1.1: Summary of selected histone PTMs discussed above. 
External stimuli 
Post-translational 
modification: 
Pathway Outcome 
Murine experiment 
outcome 
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BCG vaccine  me NOD2 
 TNF-, IL-1, 
IL-6, IL-18 
Increased survival in 
candidaemia 
LPS challenge  me  ac TLR4     
LPS re-challenge  me  ac TLR4 
 TNF- and 
IL-6 
Increased survival in 
caecal ligation and 
puncture model 
ROM A  me    IL-6   
Listeriolysin  H3S10phos & H4ac    IL-6   
 
1.3.8 Epigenetic control of macrophage polarisation: 
 Macrophage polarization is controlled in part by epigenetic regulation. 
Macrophage polarisation has been described in terms of M1 (or classically-activated) 
and M2 (or alternatively-activated) although in reality these occur across a spectrum. In 
particular, during the induction of an M1 phenotype in macrophages, the repressive 
marks trimethylation of lysine 27 (H3K27me3), trimethylation of lysine 9 (H3K9me3), 
and trimethylation of lysine 20 (H4K20me3) are removed, which is followed by an 
increase in the activator marks phosphorylation of serine 10 (H3S10phos), global levels 
of acetylation on Histone H4 and H3K4me3 (De Santa et al., 2009a; Stender et al., 
2012). This, in turn, leads to activation of genes involved in the acute response to 
external stimuli associated with the M1 phenotype. The epigenetic regulation of 
inflammatory responses has triggered interest in applying novel bromodomain 
inhibitors, such as the synthetic compound I-BET, to modulate these responses. The M2 
phenotype is associated with the removal of the H3K27me3 repressive mark and is 
mediated by the H3K27 demethylase Jumonji domain containing-3 (JMJD3) (Satoh et 
al., 2010). Satoh and colleagues suggest that JMJD3 is involved in both the mediation 
of M1 and M2 phenotypes, but only appears to play a minor role in the M1 response, 
enabling fine-tuning (De Santa et al., 2009a; Satoh et al., 2010). In contrast, it plays a 
more significant role in M2 polarization, allowing transcription of the transcription 
factor, interferon regulatory factor (Irf) 4, playing a crucial role in M2 polarization 
(Satoh et al., 2010). 
 Further studies have assessed global H4 acetylation levels, a PTM associated 
with enhanced transcription, in polarized macrophages. The results were mixed but 
showed that some genes, and in particular those whose expression was modified by the 
cytokines used to polarise the MDMs, had increased levels of H4 acetylation at their 
promoter regions (Zhang et al., 2011). However, not all genes whose expression varied 
during polarization showed changes in H4 acetylation levels. This suggests that multiple 
different PTMs may interact to govern polarisation. Furthermore, the association of 
DNA methylation and combinatorial PTMs have not been studied to date. 
 Thus macrophages are subject to epigenetic regulation by multiple mechanisms 
including histone PTMs, DNA methylation and miRNAs and these operate both during 
differentiation from monocyte to macrophage, but also in differentiated tissue 
macrophages. This complex regulation allows fine-tuning of both a strong initial 
response and protection from the sustained effects of innate immune activation. As 
illustrated above, epigenetic mechanisms play a role in a variety of processes including 
immune training, induction of tolerance and macrophage polarisation (Table 2, adapted 
from (Cole et al., 2014)). Finally, these regulatory mechanisms have also been shown to 
play a role in a number of different disease processes, such as cancer and coronary 
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artery disease. This may well contribute to the link between inflammatory responses 
(and by extension to infection) and the pathogenesis of cancer or atherosclerosis. 
Table 1.2: Summary of selected known PTMs and influence on macrophage 
polarisation. 
Phenotype Function Decreased PTMs 
Increased 
PTMs 
M1 (or “classically 
activated”) 
Secrete IL-1, IL-6, IL-12, NO 
generation, intracellular 
bacterial killing 
H3K27me3, 
H3K9me2, H4K20me3 
H4ac, 
H3S10phos, 
H3K4me3 
M2 (or “alternatively 
activated”) 
Repression of inflammation, 
Arginase production, anti-
helminthic properties 
H3K27me3   
 
1.4 Macrophages and infections:  
 The subversion of the host immune system is one of the key components of 
bacterial pathogenesis. In effect, microorganisms highjack the host gene expression to 
their benefit. In macrophages, post-translational modifications have been shown to be 
induced by a number of different bacterial components including LPS, listeriolysin and 
pneumolysin (Hamon et al., 2007). Experiments using both Legionella pneumophila 
(Rolando et al., 2013), and Listeria monocytogenes (Eskandarian et al., 2013) have 
shown that bacterial interaction with the THP-1 monocytic cell line also induces histone 
PTM. 
 In the case of Legionella the histone PTMs caused during infection have a direct 
survival benefit. Legionella pneumophila has been shown to use posttranslational 
modification to modulate the gene expression within the infected cell to aid intracellular 
replication (Rolando et al., 2013). This results in the pathogen secreting ROM A, a SET 
domain containing methyltransferase, leading to increased H3K14 methylation and 
decreased levels of acetylation. These histone PTMs were associated with the promoter 
regions of genes, such as IL-6. This in turn, shows that L. pneumophila modulates host 
gene expression in particular, in genes relating to innate immunity, to enhance its 
intracellular survival. 
 Listeriolysin (LLO), a pore-forming cytolysin similar to PLY, secreted by 
Listeria monocytogenes has been shown to cause dephosphorylation at serine 10 of H3 
and decreases in the levels of acetylated H4 in THP-1 cells. This correlated with a 
change in the transcriptional profile in HeLa cells, which was associated with a decrease 
in IL-6 and other genes involved in innate immune responses (Hamon et al., 2007). This 
lends strength to the theory that bacteria use epigenetic modulation in order to limit the 
inflammatory response and increase their survival. 
 The consequences of epigenetic changes during acute bacterial infections are not 
fully understood. They can enable pathogen subversion of the host’s immune responses, 
but may also be used by the host to modify the consequences of these responses, for 
example to limit the damage induced by sustained inflammation or enhance responses 
on re-challenge by training.  
 
1.5 Susceptibility to infection: 
1.5.1 Genetic susceptibility to infection: 
 The basis of susceptibility to infection is not fully understood. There is clear 
evidence that some host genetic factors play a role in host susceptibility to infection, as 
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evidenced by single gene defects, as is the case in IL-12R 1 receptor deficiency which 
is associated with invasive mycobacterial infections (Lammas et al., 2000), and by 
genome-wide studies identifying key polymorphisms (Chapman and Hill, 2012), such 
as single nucleotide polymorphisms in surfactant proteins and susceptibility to 
meningococcal infections (Jack et al., 2006). In the case of pneumococcal infection 
interleukin-1 associated kinase 4 (IRAK4) deficiency or nuclear factor B modulator 
protein (NEMO) deficiency (Brouwer et al., 2009) have been associated with disease 
susceptibility. However, this does not fully explain host susceptibility. It has recently 
been postulated that some of the factors influencing the development of our immune 
system are epigenetic (Gómez-Díaz et al., 2012) in nature and, as such, I propose that 
some of the susceptibility infections and in particular to pneumococcal infection may be 
epigenetic. 
 
1.5.2 Epigenetic susceptibility to infection: 
 Bacterial pathogens have evolved a number of different mechanisms to subvert 
the host’s defences. In particular, it has been recognized that they can manipulate the 
host’s own intracellular signalling and alter the host cell’s gene expression (Bhavsar et 
al., 2007). The importance of epigenetic changes occurring as part of the pathogenesis 
of infectious diseases is becoming increasingly understood. There are a number of 
examples of pathogens altering gene transcription by modifying the host cell’s 
epigenome, for example Legionella pneumophilia, Helicobacter pylori and Listeria 
monocytogenes have been shown to alter histone PTMs, thereby altering gene 
expression during infections (Ding et al., 2010; Hamon et al., 2007; Rolando et al., 
2013). 
 When gastric epithelial cells were infected with H. pylori, a time dependent 
dephosphorylation of serine 10 of histone H3 (H3S10) was observed as well as a 
decrease in actetylation levels on lysine 23 (Ding et al., 2010). In the case of 
dephosphorylation, the investigators found that these changes were associated with the 
promoter regions of genes involved in inflammation and were associated with induction 
of IL-8 in gastric epithelial cells. Interestingly, this mechanism is likely to be both 
organism and cell specific, since in THP-1 cells the dephosphorylation of serine 10 on 
Histone H3 (H3S10) was associated with the promoter region for the gene coding for 
IL-6 and was associated with an increase in release of IL-6 (Pathak et al., 2006). The 
exact mechanism by which H. pylori causes alterations in histone PTMs change is not 
fully understood, although it is apparent that it involves the cytotoxin-associated gene A 
pathogenicity island (cagPAI), since deletion of this, but not cagA or other factors, 
induced the dephosphorylation of H3S10 (Ding et al., 2010). These changes were also 
associated with up-regulation of the oncogene c-Jun and with down-regulation of heat 
shock protein (hsp) 70, showing they not only contribute to inflammation but also to 
tumour development. Fehri et al showed H. pylori infection resulted in 
dephosphorylation of H3S10 but also of threonine 3 of H3 (Fehri et al., 2009). These 
events were also linked to the cagPAI and a functional type 4 secretion system and were 
absent in a cagL mutant. cagL has been associated with binding to the cell surface. 
The changes were associated with bacterial induced reduction of cell division cycle 25 
phosphatase and a resultant reduction in activation of the H3 vaccinia-related kinase 
(VRK) I and H. pylori induced pre-mitotic arrest. 
 In the case of L. pneumophilia, the bacterium uses a type 4 secretion system 
effector regulator of methylation A (RomA), a SET domain containing 
methyltransferase, which trimethylates lysine 14 on histone H3 of the host cell and 
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reduces histone H3 lysine 14 acetylation (H3K14ac),  thus switching off gene 
transcription (Rolando et al., 2013). Following ChIP-Seq, the authors established that 
the switch to the repressive histone H3 lysine 14 trimethylation mark (H3K14me3) was 
associated with the promoter sites of genes involved in immune responses. In particular, 
cytokines such as TNF- and IL-6; PRR such as TLR5 which responds to flagellin, and 
the Nod-like receptor Nacht, LRR and PYD domains containing protein 3 (Nalp 3). 
This provides support to the theory that pathogens, including bacteria and viruses, can 
use chromatin remodelling strategies to turn off immune responses. 
 In the case of L. monocytogenes, secretion of the surface protein internalin B 
(InlB) leads to translocation of a host cell class 3 histone deacetylase (HDAC), sirtuin 2 
(Sirt2), to the nucleus where it deacetylates lysine 18 of H3. This is associated with a 
decrease in expression of genes involved in DNA binding and immune responses 
(Eskandarian et al., 2013). Moreover, L. monocytogenes also secretes listeriolysin O (a 
pore-forming cytolysin), which causes dephosphorylation of H3S10 and decreases the 
level of H4 acetylation (Hamon et al., 2007). These responses occurred by a pore-
forming independent mechanism. This correlated with a change in the transcriptional 
profile of HeLa cells, which was associated with a decrease in genes involved in innate 
immune responses including the neutrophil chemokine C-X-C motif ligand 2 (CXCL2) 
and dual specificity phosphatase 4 (DUSP4) , a phosphatase involved in regulating 
mitogen activated protein kinase (MAPK) signalling. 
 It remains unclear what the consequences of epigenetic changes during acute 
bacterial infections are. Since PLY plays a pivotal role in modifying multiple aspects of 
the host response to pneumococci, including microbiocidal activity, generation of pro-
inflammatory cytokines and immune cell viability, epigenetic modifications in 
macrophages in response to PLY have the potential to play a key contribution to the 
outcome of infection.  
 There is a growing body of evidence that epigenetic traits can be passed from 
one generation to the next. In rats, hepatic injury induced with the hepatotoxic 
tetracarbon CCL4, in the parent generation leads to a protective effect in the offspring, 
mediated by modulation in trimethylation levels of H3K27me3 (Zeybel et al., 2012). 
Moreover, it has been recognised for some time that bacteria and viruses can induce 
chronic changes to the epigenome inducing susceptibility to cancer and the pathogenesis 
of chronic inflammatory diseases (Esteller, 2007; Paschos and Allday, 2010). These 
heritable traits are transmitted without a change in DNA sequence, therefore it is 
possible that the heritable epigenetic make-up of an individual may determine the 
response of their off-spring to future infection and this may explain some differences in 
innate responses between individuals.  
 Therefore, it is possible that epigenetics could play a number of roles in the host 
pathogen interaction and determine susceptibility to infectious diseases. First, this could 
be due to a pathogen released virulence factor that alters histone PTMs and leads to 
conformational change in the chromatin in turn blocking transcription (as described in 
Figure 1.1) and therefore immune responses. In addition, it is possible that, as is seen in 
the response to LPS tolerance, repeated exposure leads to changes in the histone PTMs, 
again leading to conformational change of the chromatin which impairs gene 
transcription and leads to a reduced immune response (as is described in Figure 1.1.2). 
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Figure 1.1.2: Schematic representation of the role played by histone PTMs 
in the host pathogen interaction. Panel a depict the release of pro-inflammatory 
cytokines following exposure of macrophage to a pathogen. This is then impaired when a 
virulence factor released by the pathogen leads to transformation from euchromatin in the 
nucleus to heterochromatin and therefore the inability for RNA polymerase to bind to the DNA 
and initiate gene transcription leading to a decrease in the innate immune response. Panel b 
illustrates the phenomenon of tolerance, whereby upon repeated exposure to a stimuli such as 
LPS, epigenetic changes occur to impair the release of pro-inflammatory cytokines and 
therefore hamper the immune response. 
 
 
1.6 Epigenetic manipulation of macrophages and infection: 
 There is mounting interest in the use of HDACi in the fields of oncology, HIV 
and inflammatory disorders. Their use has been associated with survival benefits in 
murine models of sepsis. In lethal LPS challenge models, the use of suberoylanilide 
hydroxamic acid (a HDACi) was associated with increased survival (Li et al., 2010). 
However, other groups have reported detrimental effects of HDACi on macrophage 
killing ability with decreased clearance of bacteria and fungi (Mombelli et al., 2011; 
Roger et al., 2011). Rodger demonstrated decreased nitric oxide (NO) and reactive 
oxygen species (ROS) production in macrophages treated with a HDACi, thereby 
impairing microbial killing of Escherichia coli and Staphylococcus aureus. 
Nevertheless, they also observed increased survival following LPS challenges. 
Tubustatin (a HDAC6 inhibitor) was associated with increases in circulating monocytes 
numbers and the authors suggested that this may lead to faster bacterial clearance and 
therefore explain the survival advantage seen when used in the CLP model in mice (T. 
Zhao et al., 2014b). They also showed Tubustatin reversed the increased acetylation 
levels seen in sepsis and thereby the organ dysfunction, lymphoid apoptosis and the 
attenuated stress responses (T. Zhao et al., 2014a). Moreover, recent studies of the use 
of Cambinol (a Sirtuin 1 & 2 inhibitor) was associated with anti-inflammatory 
properties and led to attenuation of innate immune responses protecting mice from 
endotoxic and toxic shock (Lugrin et al., 2013). Therefore, it is likely that HDACi could 
play a role in the control of inflammatory responses, such as sepsis and other 
autoimmune conditions, but, as they may impair initial macrophage response to 
infection, further studies will be required to optimize the timing of such drug therapy. 
Other strategies are likely to be developed, with the advent of specific small molecules 
targeted at individual modifications, such as the novel JMJD3 H3K27 demethylase 
inhibitors which lead to a modulation in the inflammatory response to LPS (Kruidenier 
et al., 2012). These conflicting results and possible future developments are summarised 
in Figure 1.2.  
Macrophage
Macrophage
Spn
Spn
Macrophage
Macrophage
a) b)
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Figure 1.2: Potential epigenetic modulation. This figure summarises the current 
knowledge of the conflicting outcomes associated with the use of HDACi on macrophage function. The 
green box suggests what might be possible in the future using novel epigenetic modulators such as 
CRISPR CAS9 editors to alter PTM and specifically enhance or repress individual gene expression, or by 
influencing polarisation of the macrophage control inflammation. 
 
 Most of the pharmacological interventions to date have involved HDACi, and it 
is well recognised that these have a range of off-target effects. Furthermore, older 
studies have used pan HDACi. This may explain the conflicting results associated with 
their use in animal studies with these agents demonstrating both protection in shock but 
also impairment of microbial killing. As more specific compounds arise, such as 
specific bromodomain inhibitors and / or advances in clustered regularly interspaced 
short palindromic repeats associated protein 9 (CRISPR/CAS9) technology, (see Figure 
1.3), this will enable targeted manipulation of macrophage function by inhibition of 
individual genes within a tissue-specific macrophage. These approaches should enable 
clinicians to more selectively modulate the inflammatory response or heighten key 
antibacterial responses, which will be potentially crucial in an era of ever-increasing 
antimicrobial resistance (Figure 1.2). Furthermore, if histone PTMs are associated with 
susceptibility to infections, they could be used to screen individuals for susceptibility to 
infection to enable preventative strategies such as targeted vaccination, or be themselves 
targets for novel therapies to induce a more favourable epigenetic profile. Indeed, recent 
advances in the field of clustered regularly interspaced short palindromic repeats 
(CRISPR) technology has enabled targeted modification of the epigenome in an effort 
to manipulate gene regulation. This approach uses a programmable CRISPR/CAS9 
construct fused with an acetyltransferase (p300), allowing the acetylation of the 
promoter region of specific genes (Hilton et al., 2015). This ground-breaking 
development paves the way for reversible editing of the epigenome and thereby a 
specific approach targeting cell function by influencing gene expression without 
altering the underlying DNA. This could lead to the targeted resolution of inflammatory 
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processes or to the manipulation of individual epigenomes to reduce the susceptibility to 
disease. 
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Figure 1.3: Diagram depicting different mode of actions of PTMs modulators. 
a) Schematic representation of the mode of action of HDACi. Leading to the maintenance of the acetyl 
post-translational modification and thereby ongoing gene transcription. b) Schematic representation of 
Bromodomain inhibitors such as I-BET151 or JQ1, these inhibit the binding of Bromodomains such as 
BRD4 to the underlying chromatin thereby inhibiting gene transcription. Bromodomains are involved in 
reading acetylation and are found on a variety enzymes such as methyltransferases, transcriptional co-
activators and are involved in recruiting multi molecular complexes that modify chromatin or contribute 
to gene transcription (Muller et al., 2011).c) Schematic representation of the mode of action of 
CRISPR/CSAS9 construct, this leads to the acetylation of the promoter region of a specific gene leading 
to its transcription. (Adapted from (Cole et al., 2016). 
 
1.7 Identification and characterisation of histone PTMs: 
 As discussed above, there is a growing body of evidence illustrating the 
importance of epigenetic changes in the host’s response to infection. Both Listeria 
monocytogenes and Legionella pneumophilia have been shown to alter the host 
epigenome to provide them with a survival advantage (Hamon et al., 2007; Rolando et 
al., 2013). Furthermore, the underlying macrophage polarisation and therefore its 
response to bacterial challenge, is associated with distinct histone PTMs (Ivashkiv, 
2013).  Of the different aspects of the epigenome, microRNA, DNA methylation and 
histone PTMs, the later have been most extensively studied in the context of infections.  
Therefore, I chose to study histone PTMs in the context of host response as they are key 
to further understand the host-pathogen interaction. 
 
1.7.1 Antibody based approaches: 
 Several different approaches have been developed for the study of histone 
PTMs. The commonest of which is the use of antibodies developed against individual 
histone PTMs. This allows a semi-quantitative detection of a PTMs using western 
blotting or dot blot. This approach has been successfully used by a number of groups to 
determine the changes in abundance of histone PTMs following infection (Hamon et al., 
2007). However, as with all techniques, there are a number of limitations with respect to 
antibody based techniques for probing histone PTMs, including problems associated 
with selectivity, epitope occlusion and cross reactivity (Egelhofer et al., 2011; Fuchs et 
al., 2011). Furthermore, it is not currently commonplace to establish combinatorial 
modifications by these approaches and they require prior knowledge of the modification 
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to be identified, introducing bias, and moreover won’t allow the detection of novel 
PTMs. 
 
1.7.2 Characterising histone PTMs by mass spectrometry: 
Mass spectrometry (MS) has emerged as a powerful method to characterize and 
quantify histone PTMs. It allows unbiased identification and quantification of multiple 
histone PTMs including combinations in a single analysis; a significant advantage over 
other antibody based semi-quantitative approaches, such as western blotting. Recently, a 
plethora of different approaches have been described to perform the study of histone 
PTMs (Moradian et al., 2014; Young et al., 2010) These include different types of 
analysis, from intact proteins in top down (Pesavento et al., 2004, 2008), large peptides 
following Glu-C digestion in middle down (Molden and Garcia, 2014; Phanstiel et al., 
2008), and smaller peptides following digestion with trypsin or Arg-C in bottom up 
approaches (Minshull et al., 2016; Plazas-Mayorca et al., 2009). Each approach has its 
own merits (summarised in Figure 1.4) (Karch et al., 2016; Moradian et al., 2014; 
Zheng et al., 2016) 
 
Figure 1.4: Schematic representation of different mass spectrometry 
approaches for the analysis pf histone PTMs.  
Bottom up approaches are preceded by endoproteinase Arg-C or trypsin digestion resulting in multiple 
small peptides that are then analysed, Middle down approaches are preceded by an endoproteinase Glu-C 
digestion leading to longer peptides and therefore more combinatorial information but is limited by 
increased difficulty in analysis, Finally, Top down analysis allows study of intact protein without 
digestion but is limited by the necessity for complex bioinformatics pipeline set ups. 
 
The top down analysis provides information about combinatorial modifications 
by analysing the intact protein. However, in light of the extensive modifications of 
histones and since many of these are isobaric and can co-elute, this results in very 
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complex spectra where the identification of individual proteoforms proves challenging. 
Furthermore, certain histone PTMs are not abundant and identifying these proves 
difficult and requires large amounts of initial protein. In order to maximize coverage, 
extensive 2 dimensional fractionation is required, limiting its use as a high-throughput 
approach (Pesavento et al., 2008). 
The middle down approach provides a compromise between the other two 
approaches. It allows for larger peptides than bottom up methods. However, it is 
hampered by the complexity of analysing tandem mass spectrometry spectra (MS2) to 
correctly identify the proteoforms. Although it has recently been shown to be equivalent 
to bottom up approaches for quantification (Sidoli et al., 2015a; Sidoli and Garcia, 
2017), it remains rarely used due to the requirement for complex sample separation and 
bioinformatics analysis. 
Bottom up approaches have been the most extensively employed for the study of 
histone PTMs. These allow improved quantification of individual proteoforms and 
separation of isobaric peptides by use of reverse phase high performance liquid 
chromatography (HPLC) and offers a high throughput method (Karch et al., 2016; 
Minshull et al., 2016; Plazas-Mayorca et al., 2009; Sidoli et al., 2016, 2015b, 2015c). 
Given the requirement for complex bioinformatics support to analyse top down 
and middle down approaches and that the bottom up approach shows comparable results 
to middle down (Sidoli et al., 2015a), I focused on the development and application of 
bottom up approaches to analyse histone PTMs. 
 
1.7.3 Data acquisition methods: 
1.7.3.1 Data dependent acquisition: 
Not only are there different sample preparation approaches to MS, but several 
different data acquisition strategies have been developed and employed for the analysis 
of bottom up histone PTMs (Karch et al., 2016; Sidoli et al., 2015b, 2015c, 2016). The 
commonest approach is data dependent acquisition (DDA) as this doesn’t require any 
prior knowledge of the PTMs to be identified (Plazas-Mayorca et al., 2009). During the 
analysis, the top N-eluting peptides are selected for fragmentation and analysis. 
However, the quantification of isobaric co-eluting peptides using this approach proves 
challenging. In addition, low abundant proteoforms may not be selected for 
fragmentation and tandem MS (MS/MS) and therefore won’t be identified and 
quantified. In an effort to optimize the number of histone PTMs identified using lower 
speed instruments such as maXis Time of Flight (ToF) mass spectrometer, off line 2D-
HPLC fractionation methods have been developed (Minshull et al., 2016). Although the 
use of fractionation increases the number of PTMs identified, it does so at the cost of 
speed as up to 20 hr of MS time were required for each sample. 
 
1.7.3.2 Targeted data acquisition: 
In light of this, selective reaction monitoring methods (SRM) and parallel 
reaction monitoring (PRM) have been developed (Peach et al., 2012;,Bourmaud et al., 
2016; Peterson et al., 2012). These approaches rely on the establishment of an isolation 
list for all of the PTMs to target for MS/MS. These are then monitored throughout the 
HPLC gradient and selected for fragmentation and analysis. These approaches improve 
the sensitivity, especially for low abundant proteoforms, but are constrained by total 
cycle time for multiple PTMs as these can elute in different charge states. They are 
limited by the number of transitions to be monitored throughout the gradient and the 
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need for prior knowledge of which ones to target. Moreover, they will not allow 
retrospective analysis for novel PTMs. 
 
1.7.3.3 Data independent acquisition: 
In order to overcome some of these limitations data independent acquisition 
(DIA) methods have been gaining popularity for discovery proteomics and are 
particularly suited to the study of PTMs (Krautkramer et al., 2015; Sidoli et al., 2015c, 
2015b, 2016). A number of different DIA methods have been used to study histone 
PTMs. One of the first methods developed was SWATHTM (ABSciex), designed for 
triple ToF instruments. This method was successfully used to identify and quantify 
histone PTMs (Sidoli et al., 2015b). It involves a series of 85 isolation windows of 
variable sizes spanning the range of mass to charge ratios (m/z) in which histone PTMs 
are found (see Appendix table 1.1). Subsequently, Krautkramer et al. used a DIA 
method with regular 10 m/z isolation windows to identify and quantify the changes in 
histone PTMs following histone deacetylase inhibitor treatment (Krautkramer et al., 
2015). Using this approach enabled a greater reproducibility than conventional DDA 
with consistently high numbers of proteoforms identified and with lower Coefficient of 
Variations (CV) in the relative abundance in DIA runs when compared to DDA. Indeed, 
both the SWATHTM and DIA were able to detect low abundance proteoforms. Previous 
studies have shown that DIA protocols can be adapted to low resolution ion trap 
instruments (Sidoli et al., 2015c). In this study from the Garcia group, they 
demonstrated the adaptability of low resolution DIA using 50 m/z sequential windows. 
Furthermore, the same group had previously compared both a high resolution to a low 
resolution instrument for the analysis of Histone PTMs in DDA mode (Karch et al., 
2014). 
The new mass spectrometry instruments possess increasingly higher speeds 
making the use of higher resolutions more practical in a high throughput manner. It has 
been shown that histone PTMs can be studied using low resolution instruments (Karch 
et al., 2014; Sidoli et al., 2015c). In particular, previous studies have focused on 
comparing instruments with different resolutions or different data acquisition methods. 
But the comparison between high and low resolution modes on the same instrument has 
yet to be done. In this study, I look to optimise and establish the best possible method 
for the study of histone PTMs. 
 
1.7.4 Chromatin immunoprecipitation and sequencing: 
 Despite the clear advantages of MS-based techniques to study chromatin 
modifications, they do not provide any information about the relationship of these 
protein PTMs with the bound DNA. They are indeed limited to describing changes 
occurring at a global level and cannot further characterise the changes in histone PTMs 
occurring at an individual gene level. In order to explore the function of the PTMs and 
the associated DNA sequence chromatin immunoprecipitation combined with next 
generation sequencing (ChIP-Seq), techniques have been developed (Barski et al., 2007; 
Johnson et al., 2007). Briefly, these techniques rely on using an antibody to bind the 
histone PTMs (or transcription factor) of interest and then the antibody is used to pull 
down the cross-linked DNA sequence, which is then purified and sequenced. This can 
then provide information about the position of histone PTMs in relation to gene 
sequences. ChIP-Seq approaches have allowed large consortium such as NIH Roadmap 
Epigenomics Consortium, to establish the association of the different patterns of histone 
PTMs to be associated with certain genetic regions such, as enhancer or promoter 
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regions, and be associated with activated / repressed gene expression (Roadmap 
Epigenomics Consortium et al., 2015). However, as with the western blot approaches, 
these techniques are limited by prior knowledge of the histone PTM, antibody 
availability and cross reactivity issues. 
 
1.8 Aims and Hypothesis: 
 S. pneumoniae remains responsible for significant morbidity and mortality, 
despite the advent of vaccination. The pathogenesis of IPD is not fully understood, 
although it is clear that IPD is preceded by nasopharyngeal colonisation. As the 
macrophage is a key component in the innate immune response, it is likely that the host 
pathogen interaction between S. pneumoniae and the macrophage will therefore be 
crucial in controlling the progression to IPD. It is increasingly recognised that 
epigenetic mechanisms play key roles in the host pathogen interaction. 
 
 I hypothesise that S. pneumoniae induces changes in the host’s epigenome by 
altering histone PTMs, which in turn regulates the innate immune responses by 
modulating gene expression and may explain some of the variation observed in the 
susceptibility to invasive pneumococcal disease. 
As a key modulator of responses, I propose that the bacterial virulence factor 
pneumolysin may be responsible for some of these epigenetic modifications and in turn 
influence key effector functions with consequences for the innate immune.  
 
My aims are to: 
1)  Study the changes in host’s epigenome at the level of histone PTMs 
in response to S. pneumoniae. 
a) establish a proteomic approach to determine the extent and nature of 
PTMs in primary human macrophages. 
b) determine the contribution of pneumolysin to changes in histone 
PTMs in following infective challenge of MDMs with S. pneumoniae 
and isogenic pneumolysin deficient mutant. 
2)  Study the effector consequences of the bacterial virulence factor 
pneumolysin on the host’s immune response. 
a) establish the differential gene expression occurring in a pneumolysin 
dependent manner. 
b) establish the changes occurring at the proteomic level in a 
pneumolysin dependent manner. 
3)  Use the combined omics approach to determine the relationship 
between gene expression levels and PTMs of the associated histones. 
a) establish the differential transcript expression occurring in response to 
S. pneumoniae challenge using RNA-seq in paired samples. 
b) establish the enriched genomic locations following challenge with S. 
pneumoniae using ChIP-seq in paired samples 
c) integrate the datasets to infer the role played by histone PTMs in 
innate immune responses. 
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Chapter 2: Materials and Methods 
Table 2.1: List of consumables and suppliers. 
Chemical Supplier 
 5 x Gel Loading Dye New England BioLabs 
100 bp DNA ladder New England BioLabs 
2 µm Yellow-Green Fluorescent latex beads  Sigma 
4',6-diamidino-2-phenylindole (dapi) Vectorshield 
Acetone  Thermo Fischer Scientific 
Acetonitrile (ACN) Thermo Fischer Scientific 
Acrylamide Thermo Fischer Scientific 
Agarose Sigma-Aldrich 
Ammonium bicarbonate  Sigma-Aldrich   
Ammonium hydroxide  Sigma-Aldrich   
Ammonium sulphate Sigma-Aldrich   
Benzylpenicillin  CrystapenTM, Genus 
Pharmaceutical   
BIX-01294  Sigma-Aldrich   
Blue pre-stained standard Broad range protein ladder  New England BioLabs 
Bovine serum albumin (BSA) Sigma-Aldrich 
Brain Heart Infusion broth  Oxoid 
Bromophenol blue Sigma-Aldrich   
Calf histone standard  Sigma-Aldrich .  
CD-CHO media Cobra Biologics  
CHO-S cells  Cobra Biologics  
ClarityTM Western ECL BioRad 
Colloidal commassie brilliant blue dye  Sigma-Aldrich   
Colombia blood agar (CBA) Oxoid 
Dithiothreitol (DTT) Sigma-Aldrich   
Ethanol FischerScientific  
Ethidium Bromide  Sigma-Aldrich 
Ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid 
(EGTA) 
Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich 
Fetal calf serum (FCS) Biosera 
Fluorescein isothiocyanate labelled (FITC) goat anti human IgG 
antibody  
Sigma-Aldrich   
Ficoll-paque  GE Healthcare Life sciences   
Gentamicin  Sanofi  
Glacial acetic acid  Thermo Fischer Scientific 
Glycerol  Sigma-Aldrich   
Glycine  Thermo Fischer Scientific 
Heat inactivated low endotoxin newborn calf serum  Gibco, Life technology .  
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Hepes-KOH  Sigma-Aldrich 
Heptafluorobutyric acid (HFBA) Thermo Fischer Scientific 
HPLC grade dihydrogen monoxide  Thermo Fischer Scientific 
HT supplement  Thermo Fischer Scientific 
Iodoacetic acid (IAA) Sigma-Aldrich 
Isopropanol  Thermo Fischer Scientific 
L-Glutamine  Gibco, Life technology  
Magnesium chloride (MgCl ) Sigma-Aldrich   
Magnetic Protein A  Invitrogen 
Magnetic Protein G Invitrogen 
Methanol   VWR Chemicals 
Milk Sigma-Aldrich 
N-Laurosyl-sarcosine (NLS ) Sigma-Aldrich 
NEBNext® Multiplex Oligos for Illumina (Index primers sets 1-3)  New England BioLabsNew 
NEBNext® Ultra™ 2 DNA Library Prep Kit for Illumina®  New England BioLabs 
Nonidet P-40 (NP40) Fissons laboratory reagents 
Nuclease free water   Quiagen 
Orthophosphoric acid Thermo Fischer Scientific 
Paraformaldehyde  Thermo Fischer Scientific 
Phosphate buffered saline (PBS) Lonza  
Polyvinylidene fluoride membrane (PVDF) Immobilon 
Porcine pancreas trypsin   Sigma-Aldrich 
Potassium chloride (KCl) Sigma-Aldrich   
Propionic anhydride  Sigma-Aldrich   
Proteinase K Sigma-Aldrich 
Puromycin  Gibco 
Quantifast SYBR Green  Quiagen 
RNAse A Sigma-Aldrich 
Roche Complete EDTA free , Protease inhibitor Roche 
RPMI 1640  Lonza  
Saponin  Sigma-Aldrich   
Sodium chloride (NaCl) Thermo Fischer Scientific 
Sodium dodecyl sulphate (SDS) Sigma-Aldrich   
Sodium dodecyl sulphate running buffer National Diagnostics 
Sulphuric acid (H2SO4) Thermo Fischer Scientific 
Tri Reagent Sigma-Aldrich ,  
Trichloroacetic acid (TCA) Thermo Fischer Scientific 
Triethylammonium bicarbonate buffer (TEAB) Sigma-Aldrich 
Trifluoroacetic acid (TFA) Thermo Fischer Scientific 
Tris–Cl pH 8.0,  Sigma-Aldrich   
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) Sigma-Aldrich 
Triton X-100,  ThermoFischer 
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Tween-20  Sigma-Aldrich   
Ultra pure Formaldehyde Sigma-Aldrich 
Ultra-pure Lipopolysacharide (LPS) Enzo 
β-mercaptoethanol Sigma-Aldrich   
Plastics: 
50mL centrifuge tube  Sarstedt 
T75 flasks  Corning  
24 well plates  Corning   
6 well plates  Corning  
96 well ELISA plates  Corning   
1.5mL microcentrifuge tubes  Sarstetd  
2mL lo-bind eppendorfs  Eppendorf  
1.5 mL TPX tubes  Diagenode 
MicroAmp fast optical 96-well plate Applied Biosystems 
 
 
2.1 Growth of bacterial stocks: 
 Streptococcus pneumoniae serotype 2 strain D39 and the isogenic mutant D39-
PLY ((PLY ), which has a single amino acid substitution in the pneumolysin (PLY) 
sequence generating a STOP codon and therefore doesn’t express PLY), were kindly 
obtained from Prof T. Mitchell (University of Brimingham). 
 All strains were grown in brain heart infusion broth and 20% FCS  growth 
curves were established for all strains using optical density, measured on a 
spectrophotometer (Jenway 6300) over time, and by plotting the number of colony-
forming units (cfu) (by the Miles Misra surface viability count method) plated on 
Colombia blood agar plates (CBA) at regular time intervals. Stocks were then grown up 
to mid log phase then frozen at -80C. 
 
2.1.2 Opsonisation of Streptococcus pneumoniae: 
 Aliquots of bacteria were thawed, washed in PBS twice, the pellet was then re-
suspended in RPMI 1640 supplemented with 10% pooled human immune serum from 
previously vaccinated volunteers with demonstrable antibody levels to serotype 2 
pneumococci. The aliquot was incubated for 30 minutes at 37C in 5% carbon dioxide 
(CO2). Then it was centrifuged at 900 relative centrifugal force (rcf)  for 3 minutes and 
the pellet washed in PBS twice prior to re-suspension in RPMI and L-Glutamine and 
10% FCS containing low LPS (Dockrell et al., 2001). 
 
2.3 Human monocyte-derived macrophage isolation: 
 Ethical approval was granted by South Sheffield Regional Ethics committee 
(07/Q2305/7). Whole blood was obtained from healthy staff and student volunteers at 
Sheffield Teaching hospitals NHS Foundation Trust following written informed 
consent. The blood was separated by differential centrifugation using a Ficoll-Paque 
gradient. Whole blood was layered on Ficoll-Paque in a 2:1 ratio in a 50mL centrifuge 
tube and centrifuged at 600rcf for 23 minutes. The peripheral blood monocytes in the 
cloudy layer at the surface were then transferred to a fresh 50 mL tube and washed in 
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PBS and centrifuged for 10 minutes at 300rcf. The pellet was then washed a second 
time and then re-suspended in RPMI 1640 medium with 2 mmol/L of L-glutamine and 
10% heat inactivated low endotoxin newborn calf serum. The cells were then seeded 
with or without cover slips at a density of 2.106 cells/mL, incubated at 37°C in 5% CO2. 
At 24 hours, the cells were washed in PBS and re-suspended in fresh media RPMI 1640 
with 2 mmol/L of L-glutamine and 10% heat inactivated FCS. The media was changed 
every 3-4 days. The monocyte derived macrophages (MDM) were subsequently 
maintained in RPMI + 10% FCS + 2mmol/L L-glutamine for 13 days. 
 
2.3.1 MDM challenge: 
 14 day old MDM were washed in PBS, then fresh media (RPMI, 10% FCS and 
L-Glutamine as above) was replaced. Opsonised D39, ∆PLY bacteria or fresh media 
(for mock infected) were subsequently added to the cells at a MOI of 10, rested on ice 
for 1 hour and incubated at 37°C in 5%CO2 for a further 2 or 3 hours. The MOI was 
confirmed by measuring the number of cfu following 24hr incubation at 37°C in 
5%CO2 for each aliquot of bacteria. All infections were started at the same time of day 
(09:00). 
 
2.4 MDM functional assays: 
2.4.1 Microscopic assessment of internalisation of S. pneumoniae: 
 Following infection with S pneumoniae (with or without pre-stimulation) cells in 
a 24 well plate seeded on cover slips were washed three times with PBS then 250 L of 
2% paraformaldehyde was added to each well. After at least 30 minutes incubation each 
well was washed three times in distilled water then the coverslips were incubated with 
fluorescein isothiocyanate (FITC) labelled goat anti human IgG antibody for 12 
minutes. The cover slips were mounted on a glass slide with DAPI and sealed prior to 
fluorescent microscopy. 
 
2.4.2 S. pneumoniae internalisation assay: 
 At either 3 or 4 hours following infection with S. pneumoniae, MDMs in 24 well 
plates were washed three times in ice cold PBS, then incubated for 30 minutes in media 
containing RPMI, 10% FCS, 2mmol/L L-glutamine and 40 units/mL of benzylpenicillin 
and 20 mg/mL gentamicin. The cells were then washed three times in PBS. Cells were 
then incubated in 250 L of 2% saponin for 12 minutes at 37°C in 5%CO2, then 750 L 
of PBS was added, followed by vigorous pipetting. The number of internalised viable 
bacteria were measured by counting the number of cfu on CBA after 24 hours 
incubation at 37°C in 5%CO2 contained in these lysates (using the Miles and Misra 
Method). 
 
2.4.3 Cytokine production measurements: 
 Supernatants were obtained from cells having been infected at 0, 0.5, 1, 2, 3, and 
4 hours, then stored frozen at -80°C prior to analysis. 
 
2.4.4 TNF- and IL-6 measurements: 
  Supernatants were analysed as per the manufacturer’s guidelines using either 
Tumour necrosis factor alpha (TNF-) or interleukin 6 (IL-6) kit (Ready-set-go!TM, 
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eBioscience). Briefly, 96 well ELISA plates were coated with capture antibody 
(Purified anti-human TNF-  (MAB1) or purified anti-human IL-6) and then left sealed 
overnight at 4 °C. They were washed four times, in 0.05% Tween-20 and PBS, and the 
wells blocked in assay diluent at room temperature for 1 hour. The supernatants were 
then added as were the standards (recombinant human TNF- or recombinant human 
IL-6) and incubated for 2 hours at room temperature. The wells were then washed five 
times and the detection antibody (biotin-conjugated anti-human TNF- or anti-human 
IL-6) was added and left to incubate for 1 hour. After washing a further five times 
avidin-horse radish peroxidase (HRP) was added to each well and left at room 
temperature for 30 minutes. Plates were then washed a further six times, prior to adding 
tetramethylbenzidine substrate solution for 15 minutes at room temperature. The 
reaction was stopped by adding 2M sulphuric acid (H2SO4), the plate was then read at 
450nm (Multisckan EX, Thermo Scientific), and the data analysed in GraphPad 
Prysm version 7.0c. (GraphPad Software). 
 
2.4.5 Flow Cytometry: 
Samples were run on a 4 colour FACScaliburTM (BD Biosciences) in the 
University of Sheffield’s core facility using CellQuest Pro (version 6.0). 10 000 gated 
events were counted and Forward scatter (FSC) and Side scatter (SCC) were used to 
define populations. Data analysis was performed in FlowJoTM software (version 10.1r5).  
 
2.4.5.1 Flow cytometry confirmation of opsonisation: 
 Aliquots of 106 cfu of serotype 2 D39 S. pneumoniae were washed twice in PBS. 
Then incubated in RPMI with 10% human immune serum for 30 min at 37C in 5% 
CO2. The bacteria were spun down at 900 rcf for 3 min then washed twice in PBS and 
fixed in 0.5% PFA. The bacteria were then washed once and incubated in 100 µL PBS 
with 1:100 FITC labelled goat anti human IgG antibody for 20min at room temperature. 
The bacteria were then washed in PBS and re-suspended in final volume of 300 µL of 
PBS prior to analysis in the core facility. 
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Figure 2.1: Opsonisation assay. 
In order to confirm that the human immune serum was opsonizing the bacteria the following Flow 
cytometry approach was used. Panels A illustrates the gating strategy used to exclude debris and non-
specific FL1 signal. The dot plots and histograms in panels B show the shift in FL1 signal corresponding 
to the binding of FITC secondary antibody to the bacteria without gating. Panels C how the results of the 
gated FL1 analysis. 
 
2.5 mRNA analysis: 
 After 3 hours of infection, cells were washed three times in PBS and lysed in Tri 
Reagent, then transferred to 1.5mL microcentrifuge tubes and stored at -80°C. 
 
2.5.1 RNA extraction using Direct-Zol:  
 Messenger ribonucleic acid (mRNA) extraction was performed following the 
manufacturer’s guidelines for Direct-ZolTM RNA miniPrep (Zymo). Briefly, samples in 
Tri Reagent were centrifuged at 12 000 for 1 minute, then the supernatant was 
transferred to a fresh 1.5 mL tube, 100% ethanol was added in a 1:1 ratio and well 
mixed. This was then transferred to the Zymo-spinTM column, centrifuged for 1 minute, 
then washed using Direct-zolTM RNA pre-wash, centrifuged again, then washed in RNA 
wash buffer and again centrifuged. Finally, the RNA was eluted out in DNase/RNase 
free water and samples frozen at -80°C. 
 
2.5.2 Microarray mRNA expression analysis: 
Using the University of Sheffield’s core facility services, Affymetrix chip 
micro-array (Human Genome U133 plus 2.0 array, Santa Clara, CA) analysis of 
samples from three individuals was undertaken to further characterise gene expression. 
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Data analysis was performed in collaboration with Dr Richard Emes at the Advanced 
Data Analysis Centre (University of Nottingham) using R version 3.4.0. CEL files were 
read in using Simpleaffy version 2.52.0; background intensity correction, median 
correction and quantile normalisation was performed using robust multi-array average 
expression with help of probe sequence (GCRMA), using AffyPLM version 1.52.1. The 
quality control matrix was generated using Simpleaffy and AffyPLM. Principal 
component analysis was performed in R. The probes whose intensity were within the 
lowest 20th centile were removed, using Dplyr version 0.7.1. Differential gene 
expression was calculated using Limma version 3.32.2. 
 
2.5.3 Pathway analysis: 
 Pathway analysis was performed from the differentially-expressed gene lists 
generated. Hypergeometric tests were calculated in R, using GO.db version 3.4.1 to 
search the Gene Ontology (GO) database for molecular function, cellular component, 
and biological process, using p value cut off of 0.01 and minimum of 3 genes. The 
Reactome database was searched using ReactomePA version1.20.2 with a q value cut 
off of 0.01. The Kyoto Encyclopaedia of Genes and Genomes (KEGG) databases was 
searched using gage version 2.26.1 and visualised using pathview version1.16.1. 
 
2.5.4.1 Next Generation RNA Sequencing: 
In addition to microarray mRNA analysis, samples from cells infected with 
S.pneumoniae were also sent for Next Generation Sequencing (NGS). RNA sequencing 
(RNASeq) via the core facility of the University of Sheffield. Total RNA was checked 
on a nanodrop and 2100 Bioanalyser RNA nano chip (Agilent) (Figure 2.2). The mRNA 
was purified using the NEBNext® Poly(A) mRNA Magnetic Isolation module. The 
sequencing libraries prepared using the NEBNext® UltraTM 2 Directional RNA kit. 
Samples indexed using the NEBNext® Multiplex Oligos for Illumina® (Index 
Primers Set 2) (summarised in Table 2.2). Libraries were checked on a Bioanalyser high 
sensitivity DNA chip to check average fragment size. (Figure 2.1) Libraries were 
pooled and run across 2 lanes of an Illumina HiScanTM SQ (Illumina), paired end 2 
x100 base pairs (bp). 
 
Table 2.2: RNA-Seq oligo barcode details. 
Sample Condition Index Sequence 
3/5 D39 S pneumoniae 13 AGTCAA 
3/5 M Mock Infected 14 AGTTCC 
12/4 D39 S pneumoniae 15 ATGTCA 
12/4 M Mock Infected 16 CCGTCC 
25/5 D39 S pneumoniae 18 GTCCGC 
25/5 M Mock Infected 19 GTGAAA 
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2.5.4.2 Next Generation RNA-Sequencing data analysis: 
 RNA-Seq runs were converted to FASTQ files by the core facility. The 6 
samples were run as an indexed pool across two lanes, therefore there are 4 FASTQ per 
sample (2 forward and 2 reverse reads). Quality checks were performed for each sample 
FASTQ files in FASTQC (version 0.11.5). Data analysis was then performed in 
GALAXY (version 17.05) following the “new tuxedo” protocol (Pertea et al., 2016), 
files were concatenated, then alignment was performed using HISAT2 (Galaxy version 
2.0.5.2)(Kim et al., 2015) against the HG38 human genome. The transcript assembly 
and quantification was performed in Stringtie (Galaxy version 1.3.3)(Pertea et al., 2015) 
using annotations from Hg38 GENCODE v24 downloaded from University of 
California Santa Cruz (11/08/2017) and NCBIrefseq (genome) downloaded 
(20/09/2017). Differential transcript expression was then performed in R using 
Ballgown package (version 2.8.4)(Pertea et al., 2016). In addition, quasi-mapping was 
performed using Salmon and the UCSC NCBIrefseq transcriptome followed by 
differential expression analysis carried out using edgeR (Robinson et al., 2010). 
 
2.6 Cell preparation for mass spectrometry:  
 In order to make the best use of primary cells these were not used for the 
optimisation of mass spectrometry methods. Instead, a Chinese Hamster Ovary (CHO) 
cell line was used. CHO-S cells were grown in CD-CHO supplemented with 8mM L-
glutamine, 0.012mg/ml puromycin and HT supplement media for either 2 or 4 days then 
washed in PBS and pelleted into 4x106 cell aliquots before being frozen -20 C. 
 For infections and pre-stimulation experiments, MDMs were washed three times 
in ice cold PBS and scrapped in ice cold PBS with added protease inhibitors ((PI) 
Roche Complete EDTA free), before being pelleted at 900rcf for 10 minutes then frozen 
at -80°C prior to preparation for mass spectrometry. 
 
2.6.1 Histone extractions and purification: 
 All steps were done at 4°C in lo-bind Eppendorf’s. Cell pellets were lysed in 
histone extraction hypotonic lysis solution, left to rotate for 30 minutes, then pelleted at 
10 000 rcf for 10 minutes. The supernatant was discarded, the pellet re-suspended in 0.2 
M H2SO4 and rotated for 4 hours. The tubes were then centrifuged at 16 000 rcf for 10 
minutes to remove debris. The supernatant was transferred to a new lo-bind tube and the 
histones were precipitated out by adding TCA drop wise to a final concentration of 
33%. The samples were then left to stand overnight. They were then centrifuged at 16 
000 rcf for 10 minutes, the supernatant removed, and the histone smear washed in 
acetone twice. Finally, the histones were re-suspended in 100 L of high performance 
liquid chromatography (HPLC) grade dihydrogen monoxide (H2O) and transferred to a 
fresh tube prior to freezing at -80°C. 
 
Table 2.3: Histone extraction hypotonic lysis solution. 
Histone extraction hypotonic lysis solution: 
10 mM  Tris–Cl pH 8.0,  
1 mM  KCl 
1.5 mM  MgCl  
1 mM  DTT 
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1 tablet / 10 mL Roche complete EDTA free Protease inhibitor tablet 
 
2.6.2 Protein purity and concentration estimation: 
 5 l aliquots of purified histones were run on 12% sodium dodecyl sulphate 
(SDS) polyacrylamide gel. Briefly, 5 l of H2O was added to 5 l of samples or to the 
calf histone standard. This was then diluted in Loading buffer at a 1 to 1 ratio and 
denatured at 95°C for 5 minutes. The samples were then loaded on the 0.75mm 12% 
SDS gel in SDS running buffer along with a 5L of Blue pre-stained standard broad 
range ladder. The current was set at 200V for 45 minutes or until the dye had reached 
the bottom of the gel. The gel was then stained with Commassie stain and agitated at 
room temperature overnight. The following morning the gel was de-stained by washing 
in distilled H2O. 
Table 2.4: Western blot protein Loading buffer. 
Western blot protein loading buffer  
50 mM  Tris-HCl 
0.10% bromophenol blue,  
2% SDS 
100 mM  β-mercaptoethanol 
10% Glycerol  
 
Table 2.5: Commassie stain. 
Commassie stain  
1.60% Orthophosphoric acid 
20% Ethanol 
8% Ammonium sulphate 
0.08% Colloidal Commassie brilliant blue dye  
 
Table 2.6: 12% SDS page gel recipe. 
 Stacking gel Resolving Gel  
Distilled Water 3.66 mL 4.38 mL 
40% Acrylamide (Fischer Scientific) 750 L 3 mL 
4 x Upper Buffer (0.5MTris pH6.2 0.4% SDS) 1.5 mL  
4 x Lower Buffer (1.5M Tris pH 8 0.4% SDS)  2.5 mL 
10 % Ammonium persulfate (Sigma) 75 L 100L 
Tetramethylethylenediamine (TEMED) 15 L 20L 
 
 53 
 
Figure 2.3: Commassie stained 12% SDS PAGE analysis of acid extracted 
histones. Following acid extraction from three samples, 5 L aliquots were loaded along with 5 g of 
calf histone standard and a protein molecular weight marker as indicated. The histone H3, H2A/B and H4 
are highlighted. There is some variability in the quantities of histone isolated as is illustrated by the 
variability in the intensity of the bands when compared to the calf histone standard.  
 
 
2.6.3 Chemical derivitization and trypsin digestion: 
 In order to facilitate the identification of isobaric peptides that ordinarily would 
coelute, peptides were chemically derivitised to increase their hydrophobicity by the 
addition of proprionyl groups (Garcia et al., 2007).  
  10 L of 100 mM ammonium bicarbonate pH 8 and 4 l of ammonium 
hydroxide was added to 10 g of histone sample. Then 10L of propionic anhydride in 
isopropanol (1:3 ratio) was added and ammonium hydroxide used to keep the pH >8.0. 
The sample was incubated at 37°C for 15 minutes. Then it was dried down in a vacuum 
centrifuge (Concentrator plus, Eppendorf) and the process repeated. The samples were 
re-suspended in 40 L of 100mM ammonium bicarbonate and then tryptically digested 
overnight. The digestion was stopped by addition of glacial acetic acid and freezing at -
80°C for 5 minutes. Finally, the samples were dried down before undergoing a further 
two rounds of proprionylation. 
2.6.4 Fractionation of samples using porous graphitic column: 
 To aid the identification of co-eluting peptides, samples were fractionated 
(Minshull and Dickman, 2015) using a porous graphitic column (PGC, HypercarbTM (50 
x 2.1 mm), Thermo Scientific). Samples were re-suspended in 0.1% Trifluoroacetic acid 
(TFA), and fractionated using an Ultimate 3000 (Dionex, Thermo Scientific) at 30°C 
with a flow rate of 0.2 mL/min. Fractions were collected from 8 minutes until 32 
minutes, using a stepwise gradient as described below. The individually collected 
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fractions were then dried down in SpeedVac and frozen to -80°C prior to Mass 
spectrometry analysis. The ultraviolet (UV) detection was set at 214 nm (50Hz) 
throughout the fractionation process.  
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Table 2.7: Stepwise gradients for fractionation of proteins on HPLC. 
HPLC fractionation of histones:  HPLC fractionation of Proteomes: 
Time: 
(min) 
Buffer 
A1 
Buffer 
B1  
Time: 
(min) 
Buffer A1 Buffer B1 
0 100% 0%  0 98% 2% 
25 30% 70%  110 40% 60% 
30 10% 90%  115 10% 90% 
39 95% 5%  116 98% 2% 
45 100% 0%  125 98% 2% 
Buffer A1 3% ACN 0.1% TFA  
Buffer B1 90% ACN 0.1% TFA 
 
2.6.5 HypersepTM Hypercarb tip clean up: 
 An alternative approach to fractionating samples is to use a HypersepTM 
Hypercarb tip to clean the samples of the chemical derivitisation residues. This 
approach was termed “one dimension” (1D) sample (Minshull and Dickman, 2015). 
These samples were prepared for mass spectrometry on Orbitrap QE HF, by re-
suspending them in 20 L 0.1% TFA and 3% HPLC grade ACN. Then following the 
manufacturer’s protocol, the Hypersep Hypercarb TM  (ThermoScientific) tips were 
primed by 3 washes (20 L each) with elution solution (60% Acetonitrile 0.1% TFA), 
followed by 5 washes (20 L each) in cleaning solution (0.1% TFA). The sample was 
then re-suspended on the tip by pipetting up and down 50 times. The tip was cleaned in 
3 x 20 L of 0.1%TFA, then in a fresh low-bind tube, the samples were eluted using 5 x 
20 L of elution solution 1 (60% ACN 0.1% TFA) and pipetted up and down 10 times, 
then 5 x 20 L of elution solution 2 (90% ACN 0.1% TFA). The samples were then 
dried down in Speedvac and frozen at -80C prior to mass spectrometry (MS) analysis. 
2.6.6 Histone post-translational mass spectrometry: maXis (Brucker): 
 The samples were re-suspended in 0.1% TFA and analysed using reverse phase 
high performance liquid capillary chromatography (Ultimate 3000,Thermo Scientific) 
on a C18 column (150 mm x 75 m internal diameter, PepMap reversed phase column 
(Dionex UK)) interfaced with an Ultra-High Resolution Time of Flight mass 
spectrometer (maXis, Bruker Daltonics), using a captive Electrospray ionisation (ESI), 
on a stepwise 60 minute gradient (as illustrated below). MS and MS/MS scans were 
acquired in positive ion mode (m/z 100-1800). 
Data was then processed using automatic internal calibration (lock mass 
1221.99) and analysed in DataAnalysis v4.1 (Brucker Daltronics). The mascot generic 
files (mgf) were created in DataAnalysis, the sum peak finder was used with signal to 
noise ratio of 100 and minimum intensity of 5000. These files were used for Mascot 
searches performed in Mascot Daemon v2.5.1 (Matrix science). 
The following search parameters were used: MS and MS/MS tolerance was set 
at 0.15 Da, searched against the SwissProt database, using homo sapiens taxonomy; the 
fixed modifications were set as propionylation of lysines (K ) and N terminus; the 
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variable modifications were defined as: methylpropionylation, dimethylation, 
trimethylation and acetylation of lysines, phosphorylation of serines and threonines, the 
digestion enzyme was set as Arg-C with up to 2 missed cleavages, and charge states set 
at 2+, 3+ and 4+. 
After manual verification, quantification was carried out by the integration of 
smoothed (Gauss method) extracted ion chromatograms and correction factors (to 
account for the differences in efficiency in ionisation, were applied to the results (Lin et 
al., 2014) and the process automated in Hist-o-matic (in house software courtesy of T 
Minshull).  
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Table 2.8: Stepwise gradients for mass spectrometry. 
Gradient for the maXis: 
 
Gradient for the Orbitrap QExactive HF: 
Time: (min) Buffer A2 Buffer B2 
 
Time: (min) Buffer A2 Buffer B2 
0 97% 3% 
 
0 97% 3% 
30 75% 25% 
 
8 90% 8% 
40 15% 50% 
 
51 75% 25% 
41 10% 90% 
 
81 40% 60% 
48 97% 3% 
 
82 10% 90% 
55 97% 3% 
 
86 10% 90% 
 
   
87 97% 3% 
Buffer A2: 3% ACN 0.1% FA 
Buffer B2: 80% ACN 0.1% FA  
101 97% 3% 
 
2.6.7.1 Histone posttranslational mass spectrometry: Orbitrap QE HF: 
 The samples were re-suspended in 0.1% TFA (or 0.05% heptafluorobutyric acid 
(HFBA), loaded into and run on Ultimate 3000 online capillary liquid chromatography 
system with PepMap300 C18 trapping column (Thermo Fischer), coupled to Orbitrap 
Q-Exactive HF ((QE), Thermo Fischer). Peptides were eluted onto a 50 cm x 75 m 
Easy-spray PepMap C18 column with a flow rate of 300 nL/min. Peptides were eluted 
using a stepped gradient (as described in Table 2.8). 
 Data acquisition was performed in a number of different modes (as described in 
Table 2.10). Briefly, Data Dependent Acquisition (DDA) was performed in full scan 
positive mode, scanning 375 to 1500m/z, with an MS1 resolution of 120 000, and 
Automatic Gain Control (AGC) target of 1x106 and a maximum fill time of 450ms. The 
top 10 most intense ions from MS1 scan were selected for collision induce dissociation 
(CID). MS2 resolution was set at either 120 000 (DDA120), 60 000 (DDA 60),) or 30 
000 (DDA30) with AGC target of 1x105 and maximum fill time of 450, 220 and 100ms 
respectively, with isolation window of 2m/z and scan range of 200-2000 m/z, 
normalised collision energy 27 (NCE). 
Data Independent Acquisition (DIA) was performed in three different settings. 
Firstly, DIA60 (DIA60) had a full scan at a resolution 60 000, AGC target of 3x106, 
maximum fill time of 55ms, scanning range of 300 to 900 m/z. followed by 10 DIA 
windows at a resolution of 30 000, AGC target of 1x106, isolation windows of 20m/z 
and NCE of 26 for DIA60. DIA30 (DIA30) had full scan resolution of 30 000, AGC 
target of 3x106, maximum fill time 100ms, scanning range of 300 to 900m/z; followed 
by 10 DIA windows at a resolution of 15 000, AGC target 1x106, isolation windows of 
20 m/z, NCE 26. For DIA60 and DIA30 the isolation lists were the same (see Table 
2.9). 
Finally, DIA variable window (DIAvw) had full scan resolution of 30 000, AGC 
target of 3x106, maximum fill time 100ms, scanning range of 300 to 900m/z; followed 
by 85 DIA windows at a resolution of 15 000, AGC target 1x106, maximum fill time 
115ms, with an isolation window scheme which varied to resemble SWATHTM 
(ABSciex), the variable isolation windows are summarised in Table 2.11, and NCE 26. 
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The DIA method used for the study of MDMs was identical to DIA60 except 
that the scanning range was adjusted to 300 to 1100 m/z. 
Table 2.9: Isolation lists. 
 
 
Table 2.10: Characteristics of data acquisition methods. 
 
 
 
DIA60/30 isolation list
310.390973 292 580 730
330.400068 359 585 735
350.409163 378 590 740
370.418258 397 595 745
390.427353 416 600 750
410.436448 432.5 605 755
430.445543 446.5 610 760
450.454638 458 615 765
470.463733 465 620 770
490.472828 470 625 775
510.481923 475 630 780
530.491018 480 635 785
550.500113 485 640 790
570.509208 490 645 795
590.518303 495 650 800
610.527398 500 655 805
630.536493 505 660 812
650.545588 510 665 823.5
670.554683 515 670 840
690.563778 522.5 675 859
710.572873 530 680 880.5
730.581968 535 685 904.5
750.591063 540 690 928.5
770.600158 545 695 965
790.609253 550 700 1014.5
810.618348 555 705
830.627443 560 710
850.636538 565 715
870.645633 570 720
890.654728 575 725
DIAvw isolation list
Data	Dependent	Acquisition Data	Independent	Acquisition
DDA	120 DDA	60 DDA	30 DIA	60 DIA	30 DIA	vw
Resolution 120	000 60	000 30	000 60	000 30	000 30	000
AGC 1.00E+06 1.00E+06 1.00E+06 3.00E+06 3.00E+06 3.00E+06
Fill	time	(ms) 450 450 450 55 100 100
Sacn	range	(m/z) 375-1500 375-1500 375-1500 300-900* 300-900 300-900
Resolution 120	000 60	000 30	000 30	000 15	000 15	000
AGC 1.00E+05 1.00E+05 1.00E+05 1.00E+06 1.00E+06 1.00E+06
Fill	time	(ms) 450 220 100 Automatic Automatic 115
loop	count 10 10 10 10 10 85
isolation	window 2 2 2 20m/z 20m/z variable
NCE 27 27 27 26 26 26
scan	range	(m/z) 300-900 300-900 300-1100
M
S2
M
S1
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Table 2.11: DIAvw isolation window size and loop count. 
DIA vw isolation list  
isolation 
window (m/z) 
loop 
count 
115 1 
19 4 
26 2 
9 1 
5 11 
10 1 
5 56 
9 1 
14 1 
19 1 
24 3 
49 1 
50 1 
 
 
Figure 2.4: Data independent acquisition schemes. 
This figure shows the two isolation window schemes use in panel a) the DIA 60 or DIA30 20m/z 
isolation windows from 300 to 900m/z. panel b) shows the isolation windows for the DIA variable 
window method. 
 
2.6.7.2 Analysis of histone PTMs using QExactive HF: 
RAW files were converted to mgf using MSConvert (proteowizard) for DDA 
runs. Searches were performed using Mascot Daemon 2.5.0 (using CHO Uniprot 10029 
(downloaded 07/06/2017) for CHO cells searches, or Histone Bespoke database (all of 
the Human Histone proteins downloaded from Uniprot 31/03/2016). The following 
search parameters were used: peptide tolerance 10 ppm, MSMS tolerance 0.01 Daltons 
(Da); digestion enzyme was Arg-C with no missed cleavages; peptide charges of 2, 3 
and 4+; fixed modifications (propionyl (K) and propionyl (N-term)) and variable 
modifications (acetyl (K), methylpropionyl (K), dimethyl (K) and trimethyl (K)), false 
discovery rate (FDR) was set to less than 2%. 
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Relative abundance quantification was performed in conjunction with Skyline 
(Schilling et al., 2012) to extract the area for each peptide proteoform. The relative 
abundance of histone peptides was determined by the integration of the extracted ion 
chromatograms to determine the area under the curve (AUC). This value was then used 
to determine relative abundances for each peptide, by dividing the AUC of one 
proteoform of a peptide by the sum total of the AUC of all forms of that peptide. For 
DIA PTM identification was performed in Skyline (using prior knowledge of elution 
profile, isotope dot Product > 0.90 and <5 parts per million (ppm) (Schilling et al., 
2012). Relative abundance of Histone PTMs and identification was also determined 
using Epiprofile 2.0 (Yuan et al., 2015). 
 
2.6.8 Label-free proteome analysis: 
 In order to prepare protein samples for shotgun proteomic analysis, 14 day old 
MDMs were challenged with opsonised S. pneumoniae D39 or ∆PLY for either 3 or 6 
hours prior to being washed three times in PBS, scrapped in PBS and Roche Complete 
EDTA free Protease inhibitor and then centrifuged 900 rcf for 10min. The cell pellet 
was then frozen at -80 C.  
 
2.6.8.1 Cell lysis: 
 Cell pellets were re-suspended in FASP Lysis buffer vortexed and then 
sonicated in water bath sonicator (Fisherbrand) for 10 seconds, then boiled for 5 
minutes at 95 C. The lysates were clarified by centrifuging at 16 000 rcf for 5 minutes. 
 
Table 2.12: FASP lysis buffer. 
FASP protein lysis buffer 
4% SDS 
100mM  TEAB  
0.1M TCEP  
 
2.6.8.2 Protein concentration estimation: 
In order to estimate the protein concentration in the lysates, a BioRad RC DCTM 
protein assay (Reducing agent and detergent compatible protein assay, BioRad) was 
performed as per the manufacturer’s instructions. Briefly, 5 µl of DC Reagent S was 
added to each 250 µl of DC Reagent A. Serial dilutions of bovine serum albumin (BSA) 
to form the protein standard were performed (from 0.2 mg/ml to 1.5 mg/ml protein).  
2.5 µL of lysates were diluted in 22.5 µL of HPLC grade H2O. Then 125 µl RC Reagent 
I was added to each tube, vortexed, and incubated for 1 minute at room temperature. 
Then 125 µl RC Reagent 2 was added into each tube, vortexed then centrifuged (15 000 
rcf for 5 minutes). The supernatant was discarded and the tube dried. 127 µl of Reagent 
A´ was added to the tubes, then vortexed and incubated at room temperature for 5 
minutes. 
Finally, 1 ml of DC Reagent B was added to each tube and vortexed then 
incubated at room temperature for 15 minutes, prior to the absorbance being read on a 
spectrophotometer at 750nm. 
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2.6.8.3 Filter aided separation of protein: 
In order to facilitate the preparation of the protein lysates prior to MS analysis, 
the samples were processed as per the Filter aided separation protocol 
(FASP)(Wiśniewski et al., 2009). 100 µg of protein lysates were mixed with 8M Urea 
dissolved in triethylammonium bicarbonate (TEAB) and added to the filter mounted in 
low-bind eppendorf. The tubes were centrifuged at 14 000 rcf for 30 minutes, the flow 
through discarded and further two 200 µL wash performed.  
 Then 100 µL Iodoacetic acid (92 µg in 8M Urea) was added to each filter to 
alkylated the proteins. The membranes were then incubated in the dark at room 
temperature for 20 minutes. Then centrifuged at 14 000 rcf for 30min. The flow-through 
was discarded. Then the membrane was washed three times with 100 µL of 8M urea, 
followed by 15 minute centrifugation at 14 000 rcf. The membranes were then washed 
three times in 100 µL of 100 mM TEAB, followed by 20 minute centrifugation at 14 
000 rcf. 
 The lysates were then subjected to trypsin (2 µg, porcine pancreas) digestion 
overnight at 37 C. 
 The following morning the filters were transferred to fresh low-bind tubes and 
the digested proteins were eluted in 40 µL of TEAB by centrifuging 14 000 rcf for 10 
minutes repeated once, and finally 40 µL of 0.5M sodium chloride was used to elute the 
final peptides from the filter. The peptides were then frozen at -20 C. 
 
2.6.8.4 Commassie stain of protein digestion: 
 In order to confirm that the FASP preparation had indeed resulted in digestion of 
the proteins, an aliquot was run on a 12%SDS page and then post stained with 
Commassie (as described 2.6.2). 
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Figure 2.5: Commassie stained protein lysates. 
12% SDS gel with broad range protein ladder in lane 1, whole cell lysate in lane 2, then post trypsin 
digestion and FASP separation in lane 3. There are no discernible proteins suggesting a complete 
digestion occurred. 
 
2.6.8.4 Hypercarb tip clean up: 
In order to desalt the peptides prior to mass spectrometry analysis, they were re-
suspended in 100 µL of 0.1%TFA 3% ACN. 1 µL was then further diluted up to 20 µL 
prior to being bound to the HypersepTM Hypercarb tip (as described in 2.6.5) The 
desalted peptides were then dried down using SpeedVac and frozen at -20 C. 
 
2.6.8.5 Hypercarb fractionation of FASP prepared peptides: 
In order to reduce the complexity of the peptide mixture, samples were 
fractionated using a HypercarbTM HPLC Column (100 x 2.1 mm, ThermoScientific). 
Samples were re-suspended in 0.1% TFA and 3% ACN, and fractionated using an 
Ultimate 3000 (Dionex, Thermo Scientific) at 30°C with a flow rate of 0.2 mL/min. 3 
minute fractions were collected from 15 minutes until 90 minutes, using a stepwise 
gradient as described below (Table 2.9) resulting in 25 fractions. The individually 
collected fractions were then dried down in SpeedVac and frozen at -80°C prior to Mass 
spectrometry analysis. The UV detection was set at 214 nm (50Hz) throughout the 
fractionation process. 
Prior to mass spectrometry, the fractions were pooled as described in Table 2.13. 
The first few fractions and the last were not run as they have previously been shown not 
to contain any peptides of interest. The pooled fractions were dried and re-suspended in 
3% ACN 0.1% TFA. 
 
Table 2.13: Pooling of FASP fractions. 
 
 
2.6.8.6 Shot gun proteomic analysis of label-free proteome: 
The trypsin-digested pooled fractions were re-suspended in 0.1%TFA and 3% 
ACN and loaded into and run on Ultimate 3000 online capillary liquid chromatography 
Time 
fraction 
collected 
(min) 
Pooled 
fraction: 
Time fraction 
collected 
(min) 
Pooled 
fraction: 
16-18  51-53 E 
19-20  54-56 E 
21-23 A 57-59 E 
24-25 A 60-62 E 
26-28 B 63-65 C 
29-31 B 66-68 C 
32-34 C 69-71 B 
35-37 C 72-74 B 
38-40 D 75-77 A 
41-43 D 78-80 A 
44-46 D 81-83  
48-50 D 84-86  
  87-89  
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system with PepMap300 C18 trapping column (Thermo Fischer), coupled to Orbitrap 
Q-Exactive HF (Thermo Fischer). Peptides were eluted onto a 50 cm x 75 m Easy-
spray PepMap C18 column with a flow rate of 300 nL/min. Peptides were eluted using a 
gradient of 3% to 35% over 75 minutes. Data acquisition was performed in full scan 
positive mode, scanning 375 to 1500m/z, with an MS1 resolution of 120 000, and AGC 
target of 1x106. The top 10 most intense ions from MS1 scan were selected for CID. 
MS2 resolution was of 30 000 with AGC target of 1x105 and maximum fill time of 
60ms, with isolation window of 2m/z and scan range of 200-2000 m/z, normalised 
collision energy 27. 
 
2.6.8.7 MaxQuant data analysis: 
The raw data from the MS runs were analysed in MaxQuant (version 1.5.6.5). 
The search settings were as follows: trypsin/P digestion, with up to 2 missed cleavages, 
fixed modification was Carbamidomethyl (C), variable modifications were oxidation 
(M) and acetylation (Protein N-term), Label Free Quantification (LFQ) was performed 
with a minimum neighbours of 3 and average number of neighbour of 6. Peptide 
tolerance was set at 4.5ppm and minimum peptide length of 7 Amino acid (AA), 
maximum peptide mass of 4600Da, Protein FDR was set at 0.01. 
 
2.6.8.8 Statistical analysis: 
Downstream analysis was performed in R version 3.4.0. The protein 
identification files were read in. Initial filtering of likely false identifications was 
performed by excluding results matched to a reverse sequence database entitled 
“Reverse”, then those matching contaminant database search were also removed. 
Finally, only the identifications with at least 2 unique peptides (peptides unique to one 
protein thereby reducing the ambiguity) were taken forward to the rest of the analysis. 
The label-free intensities were then median-corrected for each sample and log2 
transformed. Differential protein expression was calculated using Limma version 
3.32.2. Principle component analysis was performed to assess the impact of biological 
variations. 
 
2.7 Chromatin immunoprecipitation: 
2.7.1 Cross linking cells for ChIP-Seq: 
 14 day old MDM following challenge with opsonised D39 or mock infected 
were washed in PBS at 3 or 4 hours then fixed in 1% ultra pure formaldehyde in 1640 
RPMI and 10% FCS and 2mmol L-glutamine for 10 minutes at room temperature with 
gentle agitation then quenched by the addition of 0.125 M glycine for 5 minutes at room 
temperature with gentle agitation. The cells were then washed in PBS x 3 and scraped, 
then pelleted at 900 rcf for 10 minutes prior to freezing at -80C for storage prior to 
chromatin immunoprecipitation (ChIP). 
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2.7.2 Chromatin purification: 
Table 2.14: Chromatin immunoprecipitation lysis buffers. 
ChIP lysis buffer 1 
50mM  Hepes-KOH pH7.5  
140mM  NaCl  
1mM EDTA 
10% Glycerol  
0.50% Nonidet P-40  
0.25% Triton X-100 
1 tablet / 10 mL Roche complete EDTA free Protease inhibitor tablet  
ChIP lysis buffer 2 
200mM  NaCl 
1mM  EDTA 
0.5mM  EGTA  
5mM  Tris pH 8  
1 tablet / 10 mL Roche complete EDTA free Protease inhibitor tablet  
ChIP lysis buffer 3 
1mM  EDTA 
5mM  Tris pH 8  
0.5mM EGTA 
0.50% N-Laurosyl-sarcosine  
1 tablet / 10 mL Roche complete EDTA free Protease inhibitor tablet  
 
The cross-linked cell pellet was re-suspended in 1mL of Lysis buffer 1, rocked 
at 4C for 30 minutes, then centrifuged for 5 minutes at 4C 900 rcf. The pellet was 
then re-suspended in 1 mL of lysis buffer 2, rocked for 30 minutes at room temperature. 
Then it was centrifuged for 10 minutes at 4C 900 rcf. Finally it was re-suspended in 
300 L of lysis buffer 3 and rested on ice for 10 minutes prior to sonication. 
 
2.7.3 Sonication: 
 Samples were transferred to 1.5mL TPX tubes and sonicated 4 x 10 minutes + 1 
x 5 minutes on high, 30 seconds on 30 seconds off, in ice cold water on a Bioruptor 
(Diagenode). The samples were then centrifuged at 14000 rcf for 10 minutes at 4C. 
The sheared chromatin was then divided into aliquots and frozen at -80C. 
 
2.7.3.1 Sonication efficiency evaluation: 
30 l of sample was diluted to up to 200 l with water. Then it was 
incubated at 95oC for 20 minutes for a quick de-crosslinking. This was then 
incubated for 10 minutes at 37oC with 0.5 mg/ml RNase A and then this was 
followed by 30 minutes incubation at 50oC with 0.5 mg/ml Proteinase K. 
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2.7.3.2 MinElute PCR purification kit (Quiagen): 
After reversal of the crosslinking the DNA was cleaned on Quiagen MinElute 
PCR purification kit as per manufacturer’s protocol. 1 mL of PB buffer was added to 
200 l of sample and 40 l 3M sodium acetate pH5.2. This was added to the MinElute 
column and centrifuged at 17 900 rcf for 1 minute. The flow-through was discarded. 
The column was washed in 700 l of PE buffer and centrifuged for 1 minute, the flow-
through discarded and then re-centrifuged and the column transferred to a new low-bind 
tube. 10 l of EB buffer was added to the centre of the column and centrifuged for 1 
minute then a further 10l of EB buffer was added and the centrifugation repeated. 
 
2.7.3.3 Nanodrop measurement: 
The Optical Density (OD) of 2l of the eluted DNA was measured on a 
NanoDrop 2000 Spectrophotometer (Thermo Scientific) to estimate the concentration. 
 
2.7.3.4 1% Agarose gels: 
 Table 2.15: TAE buffer. 
TAE buffer 
40mM Tris pH8.0 
20mM Acetic acid 
1mM EDTA 
 
Sonication evaluation was performed by running the remaining eluted DNA 
(18l) on a 1% agarose gel. Briefly, 1g of Agarose was dissolved in TAE buffer by 
heating. It was then allowed to cool prior to addition of 5l Ethidium Bromide. The 4l 
of 5 x Gel Loading Dye was added to each sample prior to loading on the gel and 
running for 45 minutes at 80V or until the dye had reached the end of the gel. In 
addition, a 100bp DNA ladder was also run. 
 
 2.7.4 Chromatin immunoprecipitation: 
Table 2.16: Chromatin immunoprecipitation wash and elution buffers. 
Chip Dilution buffer 
0.01% SDS, 
1.10% Triton X-100 
1.2 mM EDTA 
16,7 mM Tris-HCl pH 8.0 
167mM NaCl, 
1 tablet / 10 mL Roche complete EDTA free Protease inhibitor tablet  
ChIP wash buffer A 
50mM  Tris pH8 
150mM  NaCl 
1mM  EDTA 
0.10% SDS 
 66 
1% NP40 
0.50% Deoxycholate 
ChIP wash buffer B 
1% NP40 
50mM  Tris pH8 
500mM  NaCl 
1mM  EDTA 
0.10% SDS 
0.50% Deoxycholate 
ChIP wash buffer C 
50mM Tris pH8 
250mM Lithium Chloride 
1mM EDTA 
1% NP40 
0.50% Deoxycholate 
Elution buffer 
1% SDS 
0.1M Sodium bicarbonate 
 
50l of sheared chromatin was used for each pull down. It was diluted up to 300 
l with Chip Dilution buffer. The appropriate amount of histone antibody (see Table 
2.17) was added (or not, for beads only pull downs) and incubated with rotation 
overnight at 4oC. The next day 30l of Magnetic Protein A and Protein G beads (50:50 
mix, Invitrogen) was added to each immunoprecipitation and rotated in the cold room 
for 4 hours. The beads were then washed twice with 500 l of wash buffer A. The 
samples were rotated for 1 minute, before being put back on magnetic rack between 
washes. Then they were washed once with 500 l of wash buffer B. They were then 
rotated for 1 minute and put back on the magnetic rack. 
 Finally, the samples were washed once with 500 l of wash buffer C, rotated for 
1 minute and put back on the magnetic rack. Following the washes, the DNA was eluted 
from the beads in 200 L of Elution buffer, by incubating on a Thermomixer (Eppendorf) 
for 40 minutes at 65oC, shaking at 600 rpm.  
 The 10% input samples were processed from this point by adding Elution buffer 
up to 200l. 
 The samples were then incubated at 37oC for 15 minutes with 5μl RNAase A 
(10mg/ml). Then 2 μL of Proteinase K (20 mg/ml) and 20 μl of NaCl (5M) were added 
and it was incubated overnight on a Thermomixer at 65 oC shaken at 600rpm. The 
following day the samples were processed cleaned on MinElute PCR purification kit as 
described in 2.12.2.2 MinElute PCR purification kit (Quiagen). This was then frozen 
at -20 oC prior to NGS or quantitative polymerase chain reaction (qPCR). 
 
Table 2.17: Antibodies for pull downs. 
Antibody Quantity (μg) Suplier Lot number 
Total H3 2 Abcam ab1791 GR103804-2 
H3K4me1 2.5 Abcam ab8895 GR312093-1 
H3K4me3 3 Active Motif 39159 12613005 
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H3K9me2 4 Abcam ab1220 GR183500-3 
H3K27ac 5 Active Motif 39133 3184008 
H3K27me3 3 Millipore 07-449 2826067 
 
2.7.5 Quantitative polymerase chain reaction: 
2.7.5.1 Preparing primer-mixes for qPCR: 
Primers were designed using Primer-BLAST (NCBI) or obtained from the 
literature (Yoshida et al., 2015a). Settings for design were PCR products of length < 
250 bases, not spanning an exon junction, from the Genome for Homo Sapiens. Primers 
were obtained from Sigma. Working stocks of 100 μM of each oligonucleotide were 
made in nuclease-free water (Quiagen) following the instruction from Sigma. These 
were mixed by gentle pipetting and allowed to rest at room temperature for 15 minutes. 
Then 20 μl of Forward and 20 μL of Reverse primer were mixed with 960 μL of 
nuclease-free water to make 2 μM stocks aliquoted in 100 μL and frozen -20 C. Table 
2.19 summarises the primers used. 
 
2.7.5.2 Quantitative Polymerase Chain Reaction: 
Following PCR clean-up, the 2 μl of Deoxyribonucleic Acid (DNA) from CHIP 
was diluted in 8 μL nuclease-free water and added to 2.5 μL of primer mix (final 
concentration of 200 mM per primer) and 12.5 μL of Quantifast SYBR Green mixed by 
gentle pipetting and then transferred to a MicroAmp fast optical 96-well plate. These 
then underwent qPCR analysis using a 7500 fast real-time PCR system (Applied 
Biosystems). In addition to DNA samples, negative controls containing no DNA were 
also run for each primer mix. The amplification settings were as described in Table 
2.18. In addition Melting Curve analysis was performed for each new primer used from 
60 to 95 C. 
 
Table 2.18: qPCR Amplification settings. 
Temperature Time Cycles 
95 C 5 min  
95 C 15 s 
40 
60 C 60 s 
5 C Until end  
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Table 2.19: Primer characteristics. 
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2.7.6.1 Library preparations for next generation sequencing for ChIP-Seq: 
The library preparation for NGS was performed in conjunction with the 
Microarray and Next Generation Sequencing Core Facility of the University of 
Sheffield. A selection of samples was checked on a 2100 Bioanalyser to confirm the 
size of the input DNA. The input quantity was checked using the high sensitivity Qubit 
dsDNA kit. The DNA from the chromatin immunoprecipitations and the 10% input 
samples were prepared as per the manufacturer’s guidelines using NEBNext® Ultra™ 2 
DNA Library Prep Kit for Illumina® (New England BioLabs). Samples were indexed 
using NEBNext® Multiplex Oligos for Illumina (Index primers sets 1-3) (NewEngland 
Biollabs), adaptor contamination was removed using bead purification, then pooled into 
two by the core facility and then sent for sequencing to the Edinburgh Genomics facility 
for sequencing on HiSeq 4000. (Table 2.20 summarises the pooling and indexing 
strategies). 
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Table 2.20: ChIP-Seq indexing and pooling strategies. 
Sample Index Sequence Pool Sample Index Sequence Pool 
M2527AC 3 TTAGGC A D2527M3 1 ATCACG B 
M25K4M3 4 TGACCA A M2527M3 2 CGATGT B 
D254M3 5 ACAGTG A D327M3 11 GGCTAC B 
M1227AC 15 ATGTCA A M25K9 12 CTTGTA B 
M327AC 16 CCGTCC A M327M3 13 AGTCAA B 
M25K4M1 18 GTCCGC A D25K9 14 AGTTCC B 
D327AC 20 GTGGCC A M1227M3 19 GTGAAA B 
D1227AC 22 CGTACG A D1227M3 21 GTTTCG B 
D25K4M1 23 GAGTGG A M3K9 26 ATGAGC B 
M25% 25 ACTGAT A M12K9 31 CACGAT B 
D3K4M1 27 ATTCCT A D3K9 34 CATGGC B 
M12% 17 GTAGAG A D12K9 42 TAATCG B 
M3% 24 GGTAGC A 
    
M3K4M1 28 CAAAAG A 
    
M12K4M1 29 CAACTA A 
    
D3% 32 CACTCA A 
    
D12% 33 CAGGCG A 
    
D25% 35 CATTTT A 
    
D12K4M1 36 CCAACA A 
    
D2527AC 6 GCCAAT A 
    
D12K4M3 7 CAGATC A 
    
D3K4M3 8 ACTTGA A 
    
M3K4M3 9 GATCAG A 
    
M12K4M3 10 TAGCTT A 
    
 
2.7.6.2 Next generation sequencing for ChIP-Seq data analysis: 
The ChIP-Seq runs were converted to FASTQ files by the core facility. The 
FASTQ files were aligned to human genome by Dr Tom Giles (University of 
Nottingham) using the Human genome HG38 assembly downloaded from UCSC. 
Briefly, the FASTQ files for each ChIP were concatenated. Then the FASTQ file was 
cleaned using the Illuminaclip function of Trimmomatic followed by trimming of 
leading and trailing ends and Sliding Window trimming. The reads were then mapped 
using Burrows-Wheeler Aligner. The SAM file was then sorted using samtools and the 
files deduplicated using Picard tools. Then, MACS2 was used to perform the peak 
picking and BEDTools to look for the overlap between the biological replicates. Finally 
statistical significant enriched genomic locations were calculated using Diffbind in R 
(Ross-Innes et al., 2012). 
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2.8 Western blot analysis: 
Table 2.21: Laemmli buffer recipe. 
Laemmli buffer (2X) 
0.125M Tris pH6,8 
4% SDS 
20% Glycerol 
100mM DTT  
Bromophenol blue 
 
Following infection and / or pre-stimulation, cells were washed three times in 
PBS and then lysed in Laemmli buffer. The samples were then drawn through an insulin 
syringe in order to homogenise them prior to boiling for 5 minutes. The samples and 5μl 
of Blue Wide Range Protein ladder were then loaded on to a 12% SDS page gel and run 
at 200V for 45min or until the dye had reached the bottom of the gel. 
 
2.8.1 Semi-dry transfer: 
The proteins were then transferred from the resolving gel to a polyvinylidene 
fluoride (PVDF) membrane. To achieve this, the PVDF membrane was activated in 
methanol then equilibrated in transfer buffer (47mM Tris-Base, 0.04% SDS) and then 
placed on top of filter paper imbibed with transfer buffer, the resolving portion of the 
SDS page gel was then placed on top of the membrane and above this, a further filter 
paper layer was applied. The gel sandwich was then mounted in the cassette of a Tran-
Blot Turbo (BIO-Rad) and run for 15 minutes at 25V. 
 
2.8.2 Chemiluminescence: 
Following the transfer, the PVDF membrane was blocked in 5% milk in 0.1M 
Tris-HCL, 0.16M sodium chloride, 0.05% tween-20 (TBS/tween) by gentle agitation at 
room temperature. The membrane was then incubated overnight in fresh 5% milk in 
TBS/tween with the primary antibody (1:2500, except for -tubulin used at 1:2000), at 
5C while rotating. The antibodies used are listed in Table 2.17 as well as Polyclonal 
anti-mouse -tubulin. The following day the membranes were washed three times in 
TBS/tween, then incubated for 1 hr with rotation at room temperature in 5% milk in 
TBS/tween with the secondary antibody (HRP-linked goat anti-mouse or goat anti-
rabbit (Dako), used at 1:5000). 
 The membranes were then washed a further three times in TBS/tween prior to 5 
minutes incubation with ClarityTM Western ECL and were then imaged on ChemiDocTM 
XRS+ system (BioRad). Images were exported as TIFF and densitometry of the bands 
analysed in Image J (version 1.50g). In order to correct for protein loading differences 
the ratio of the modified Histone H3 signal to that of -tubulin was calculated. 
 
2.9 Statistical analysis: 
Statistical analysis was performed using either R for the transcriptomic and 
proteomic analysis, or for all other experiments in Prism version 7.0c (Graphpad). Data 
is presented as mean and standard deviation (SD) or standard error of the mean (SEM). 
For all experiments a minimum of 3 biological replicates was used. Comparison 
between two paired groups employed a paired t-test, for comparison of 3 or more a one-
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way Analysis of variance (ANOVA)  with Tukey’s post-test was performed. For 
comparison of multiple observations in more than two groups a 2-way ANOVA with 
Tukey’s multiple comparison test was used. Distribution was analysed using Shapiro-
Wilk test in R. 
Chapter 3: Development and optimization of mass spectrometry workflows 
for the analysis of histone PTMs 
 
3.1 Introduction: 
Mass spectrometry (MS) has emerged as a powerful method to characterise and 
quantify histone PTMs. It allows unbiased identification and quantification of multiple 
histone PTMs including combinations in a single run.  
There are several different data acquisition strategies that have been developed 
and employed for the bottom up analysis of histone PTMs. Data dependent acquisition 
(DDA) is most commonly used and doesn’t require any prior knowledge of the PTMs 
(Plazas-Mayorca et al., 2009). During the analysis, the top N eluting peptides are 
selected for fragmentation and analysis. However, the quantification of isobaric co-
eluting peptides using this approach proves challenging. In addition, low abundant 
proteoforms may not be selected for MS/MS and therefore won’t be identified and 
quantified. 
In light of this, selective reaction monitoring methods (SRM) and parallel 
reaction monitoring (PRM) have been developed (Bourmaud et al., 2016; Peach et al., 
2012; Peterson et al., 2012). These approaches rely on the establishment of an isolation 
list for all of the different peptide proteoforms to target for tandem mass spectrometry 
(MS/MS). These are then monitored throughout the high performance liquid 
chromatography (HPLC) gradient and selected for fragmentation and analysis. 
Although these approaches improve the sensitivity, they are constrained by total cycle 
time for multiple PTMs. They are limited by the number of transitions to be monitored 
throughout the gradient and the need for prior knowledge of which ones to target. 
Moreover, they will not allow retrospective analysis for novel PTMs. 
In order to overcome some of these limitations, data independent acquisition 
(DIA) methods have been gaining in popularity for discovery proteomics and are 
particularly suited to the study of PTMs (Krautkramer et al., 2015; Sidoli et al., 2015c, 
2015b, 2016). A number of different DIA methods have been used to study histone 
PTMs (as discussed in Chapter 1). One of the first methods developed was SWATHTM 
(ABSciex), designed for triple TOF instruments. This method was successfully used to 
identify and quantify histone PTMs (Sidoli et al., 2015b). It involves a series of 85 
isolation windows of variable sizes spanning the range m/z in which histone PTMs are 
found (see Tables 2.9 and 2.11). Subsequently, Krautkramer et al. used a DIA method 
with regular 10m/z isolation windows to identify and quantify the changes in histone 
PTMs following histone deacetylase inhibitor treatment (Krautkramer et al., 2015). 
Using this approach enabled a greater reproducibility than conventional DDA with 
consistently high numbers of proteoforms identified and with lower coefficient of 
variations (CV) in the relative abundance in DIA runs when compared to DDA. Indeed, 
both the SWATHTM and DIA were able to detect low abundance proteoforms. In 
addition previous studies have shown that DIA protocols can be adapted to low 
resolution ion trap instruments (Karch et al., 2014; Sidoli et al., 2015c). 
The latest mass spectrometry instruments possess increasingly higher speed and 
resolution. The increased resolution however, comes with increased scanning time. As it 
has been shown that histone PTMs can be studied using low resolution instruments 
(Karch et al., 2014; Sidoli et al., 2015c), initial work focused on studying the effects of 
higher resolution over increased number of scans for the analysis of histone PTMs. In 
particular, as previous studies have focused on comparing instruments with different 
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resolutions or different data acquisition methods, in this chapter I sought to compare a 
range of alternative data dependent acquisition (DDA) methods and data independent 
acquisition (DIA) methods for the identification and quantification of the histone PTMs. 
 
The purpose of this chapter is to develop and adapt existing methodology to 
enable the identification and quantification of previously identified histone PTMs.  
 
I hypothesised that a data independent acquisition method would allow 
identification and quantification of histone PTMs with greatest ease and flexibility. 
 
The aim of this chapter was to: 
• Develop and optimise a one dimensional liquid chromatography 
mass spectrometry (LC-MS/MS) method for the study of histone 
PTMs on a high resolution QExactive HF Orbitrap mass 
spectrometer.  
• Compare a range of data acquisition methods in conjunction with 
varying resolution and cycle times to determine which method is 
best suited for the analysis of histone PTMs in conjunction with 
downstream bioinformatics.  
 
In addition, I compared these approaches with previously optimised two 
dimensional liquid chromatography separation (2D) methods in conjunction with ultra-
high resolution time of flight mass spectrometry. 
In order to minimize the use of primary cells for the optimization of the MS 
method, I used Chinese hamster ovary (CHO) cells, an important biological system for 
the production of biopharmaceuticals. Despite their prevalent use in industry, the 
epigenetics of CHO cells have not been widely studied. In this section of my thesis I 
characterized and quantified changes in histone PTMs of a CHO-S line between day 2 
and day 4 of culture. 
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3.2 Results and Discussion: 
3.2.1 Comparative analysis of histone PTMs on a maXis (UHR TOF) and 
QExactive HF Orbitrap: 
Initially the analysis of PTMs was carried out using protocols developed in 
collaboration with Dr Minshull (Department of Chemical and Biological Engineering, 
University of Sheffield) using a novel 2D HPLC method coupled to high resolution 
time of flight mass spectrometer (maXis, Bruker). However, this method required 
extensive sample fractionation and lengthy MS analysis time. Therefore, a novel 
approach was developed in conjunction with a new mass spectrometer in the laboratory, 
a QExactive HF Orbitrap. 
 
3.2.2 Comparative analysis of 2D vs 1D LC MS for the analysis of histone 
PTMs: 
Previous studies have shown that in order to obtain good coverage of histone 
PTMs sample fractionation was required when using the MaXis MS (Minshull et al., 
2016). However, this is associated with having to run multiple fractions for each sample 
resulting in up to 20 hours of MS time for each histone analysis. In order to decrease the 
MS time needed to analyse samples, the results of fractionated samples (2D) were 
compared to an unfractionated single sample desalted using HypersepTM Hypercarb tip 
(1D). Histones were purified from CHO cell pellets grown to day 2 or day 4, by 
hypotonic lysis and acid extraction (as described in 2.6.1. Histone extraction and 
purification). The purified histones were subsequently analysed on a 12% SDS page gel 
to assess purity and estimate concentration when comparing to a known calf histone 
standard (as illustrated in Figure 2.3). 10 g of purified histones was then subjected to 
chemical derivatization and digestion (Benjamin A Garcia et al., 2007) before being 
either desalted and fractionated offline using reverse phase HPLC with Hypercarb 
column (Minshull et al., 2016) prior to RP LC MS analysis (2D LC MS) or desalted 
using Hypersep Hypercarb tips prior to RP LC MS analysis (1D LC MS). Both the tips 
and the column use the same porous graphitic carbon (PGC) as the stationary phase to 
achieve the desalting. Analysis was performed on two different mass spectrometers a 
maXis UHR TOF and the QExactive HF Orbitrap (QE) (Figure 3.1). 
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Figure 3.1: Schematic representation of mass spectrometry workflow. 
a) CHO cells are collected and undergo hypotonic lysis, b) the purified histones are propionylated, 
digested and re-propionylated, The peptides are then desalted using either c) HypersepTM Tip (1D), or d) 
desalted and fractionated on Hypercarb column on a HPLC (2D). The single sample or fractions are then 
analysed on either e) the maXis or the f) QE. 
 
For the data acquired using the maXis, the identification of PTMs was carried 
out using Mascot searches in combination with manual verification of PTMs using Data 
Analysis (BrukerDaltronics). The relative abundance was calculated using in house 
software (Hist-O-Matic). For the data acquired on the QE, the analysis was carried out 
using Epiprofile and / or Skyline for the manual verification of the PTMs, as well as the 
relative abundance quantification. As the analysis of datasets from each instrument was 
performed using separate software, it is not ideally suited to a direct comparison 
between instruments. 
However, it is possible to compare the sample preparation methods on each 
instrument. A summary of the identification and relative quantification of the histone 
PTMs is shown in Figure 3.2. The same number of histone proteoforms were identified 
using the two sample preparation methods. Next, the relative abundance of the two 
sample preparation methods was compared. This showed that using the MaXis, I 
identified the same number of histone PTMs and their relative abundance was 
consistent using the two different sample preparation techniques (Figure 3.2). 
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Figure 3.2: Comparison of sample preparation methods on relative 
abundance of Histone PTMs.  
The relative abundance of histone H3 PTMs from day 4 CHO cells was measured using a one hour 
gradient on the maXis for samples prepared using either 1D LC MS dimension (blue) or 2D LC MS (red). 
There were no significant differences between the two methods for the five principle peptides of Histone 
H3 shown here. n=4. 
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 The comparison of the two different sample preparation methods was also 
carried out using the QExactive HF (Figure 3.3). The results show that similar to the 
data obtained on the maXis instrument, the two different  sample preparations gave 
equivalent relative abundances across a wide number of peptide proteoforms, and that 
the 1D LC MS method identified all of the PTMs seen in the 2D LC MS sample 
preparation method (one of the limitations of 1D preparations previously observed on 
the MaXis (Minshull et al., 2016)). 
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Figure 3.3: Comparison of sample preparation methods on the relative 
abundance of Histone PTMs using QExactive HF Orbitrap. 
The relative abundance of histone H3 PTMs from day 4 CHO cells was measured using a 105min run on 
the QE in DDA for samples prepared using either 1D LC MS(blue) or 2D LC MS (red). There were no 
significant differences between the two methods. n=4. 
 
 The two different MS instruments had different analytical columns and gradient 
times which makes the direct comparison between the two instruments difficult. 
Moreover, during the optimization of the QE methodology the HPLC coupled to the MS 
methods included a 5 minute wash period prior to the valve change and the MS analysis 
starts, to ensure the instrument didn’t become contaminated. This led to the loss of early 
eluting proteoforms such as H3 lysine 9 dimethylation (H3K9me2) (Figure 3.4) and 
makes a detailed comparison in the relative abundances between the two instruments 
challenging. 
 
Figure 3.4: Comparison of 1 min and 5 min wash periods prior to MS 
analysis on the relative abundance of histone PTMs. 
The relative abundance of the different acetylation and methylation proteoforms for the KSTGGKAPR 
peptide are compared. In blue are the abundances obtained following a 1 min wash showing higher 
abundance of the early eluting proteoforms (dimethylation and trimethylation of lysine 9 on histone H3 
(H3K9me2, H3K9me3), and the combinatorial marks histone H3 lysine 9 dimethylation and 
trimethylation with lysine 14 acetylation (H3K9me2K14ac  and H3K9me3K14ac) than was obtained 
following a 5min wash (in red) from a repeat injection of the same sample. (n=1) 
 
3.2.3 Comparison of number of proteoforms identified on a QExactive HF 
Orbitrap to that of the maXis (ToF): 
 As previously established, the number of histone PTMs identified using the 
maXis in a 1D LC MS approach was inferior to that of the 2D LC MS method 
(Minshull et al., 2016), although a significant reduction in the amount of MS time was 
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achieved using the 1D approach. In order to overcome this, the QExactive HF Orbitrap 
was used in light of its faster speed, reduced scanning time and high resolution. As one 
of the main limitations of 1D LC MS workflows on the maXis was a reduced number of 
different PTMs identified when compared to 2D LC MS analysis, a comparison of the 
total number of PTMs identified between the two instruments would indicate whether 
the 1D LC MS analysis was a suitable approach on the QExactive HF. 
The number of proteoforms identified using the 1D LC MS method on each 
instrument was compared (Figure 3.5). The results show that a greater number of 
peptide proteoforms were identified on the QExactive HF compared to the 2D LC MS 
analysis on the maXis. This highlights the benefits of the newer instrument, the 
QExactive HF, in identifying more PTMs than the maXis. Furthermore, it is able to 
achieve this using the 1D LC MS workflow, in effect reducing the MS time by 18 hours 
per biological sample, as total run time for 1D LC MS on the QE is 105 minutes 
compared to around 20 hours for a 2D LC MS workflow on the maXis. 
 
Figure 3.5: Comparison of number of proetoforms identified on each 
instrument.  
The number of proteoforms for Histone H3 identified by manual verification of the spectra following 
analysis on the MaXis was compared to that of the number of proteoforms identified by Epiprofile and 
manually verified in Skyline following analysis on the QE from 4 separate replicates. 
Given that two different data analysis approaches were used for each instrument a direct 
comparison in the relative abundances is however, not possible.  
 
3.2.3 Development and optimization of MS workflows on the QE HF for the 
characterization and quantification of histone PTMs: 
Following demonstration of the ability of the QE HF to rapidly identify large 
numbers of peptide proteoforms and histone PTMs in comparison to previously 
developed methods on the maXis (UHR TOF) instrument, further studies were 
performed to develop and optimize MS workflows on the QE HF for the 
characterization and quantification of histone PTMs. 
Initial work focused on studying the impact of MS2 resolution in data dependent 
acquisition methods (described in Chapter 2) for the characterization and quantification 
of histone PTMs. Three different DDA methods with MS2 resolutions of 120 000, 60 
000 and 30 000 were compared. In addition to DDA methods, I also studied DIA 
methods and the impact of reducing the resolution with MS2 isolation windows of 20 
m/z at a resolution of 30 000 or 15 000. Finally, an emulated SWATHTM protocol with 
variable window size (DIAvw) was studied as this was one of the first DIA methods 
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developed for the study of histone PTMs (Sidoli et al., 2015b). 
In order to establish which data acquisition approach (DDA or DIA) is best 
suited to the study of histone PTMs and to determine the influence of different MS2 
resolution settings on the identification and quantification of histone PTMs each sample 
was run in the 6 different data acquisition methods (summarized in Table 2.10). 
The baseline characteristics of each data acquisition method were established. 
The duty cycles for each method were calculated (Figure 3.6 panel a). This illustrates 
that the higher the resolution used, the slower the instrument scanned, resulting in 
longer cycle times. This however was kept below 5 seconds for the DDA allowing at 
least 7 MS1 scans in a 30 second peak which is typical for the elution of the different 
peptide proteoforms using the online chromatography employed in this study. The 
DIAvw had the longest duty cycle of 5.1 seconds and the shortest 1.4 seconds with 
DDA30. As would be expected as the resolution was decreased and the cycle time 
decreased. 
Next the number of MS1 and MS2 scans for each method was examined using 
RawMeat. The lower resolution methods were associated with increased numbers of 
MS1 scans which should enable greater accuracy in the label-free quantification (Figure 
3.6 panel b). A higher number of MS2 scans was obtained in DIA mode which should 
enable greater discrimination and quantification of isobaric peptides (Figure 3.6 panel 
c). 
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Figure 3.6: Comparison of the effect of different data acquisition methods 
on the duty cycle time and number of MS1 and MS2 scans. 
a) The duty cycle time for each data acquisition method is represented. As the resolution is decreased the 
duty cycle time decreases. b) This shows the number of MS1 and c) the number of MS2 scans for each 
data acquisition method. As less time is spent on MS2 scans more MS1 scans are undertaken. (n=6) 
 
3.2.4 Comparison of the impact of resolution on the identification of histone 
PTMs using data dependent acquisition: 
 To assess the ability of the three different DDA methods to accurately identify 
histone PTMs, the RAW files were converted to mgf using MSConvert (proteowizard). 
Searches were performed using Mascot Daemon 2.5.0 as this has previously been 
shown to be the most reliable for the identification of histone PTMs (Yuan et al., 2014). 
The mgfs were searched using CHO proteome (downloaded from Uniprot (downloaded 
07/06/2017), using Arg-C digestion, a peptide tolerance 10 ppm, and an MSMS 
tolerance 0.01 Da, no missed cleavages, Peptide charges of 2, 3 and 4+; fixed 
modifications (propionyl (K) and propionyl (N-term)) and variable modifications 
(acetyl (K), methylpropionyl (K), dimethyl (K) and trimethyl (K)), FDRs were set to 
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less than 2%. 
In order to ascertain the impact of the variation in resolution of the DDA 
methods on the ability to accurately identify histone PTMs, the number of peptide 
sequence matches (PSMs) and total number of queries in each of the different DDA 
methods were analysed (see Figure 3.8). The results show that the lower resolution 
scans were associated with greater number of queries and consequently a greater 
number of PSMs. However, the conversion rate (the proportion of PSMs to the number 
of queries) was lower in the DDA30 method.  
 I next examined the results of Mascot searches in the three different DDA 
methods, and their ability to correctly identify the PTMs of histone H3. The Mascot 
search results give a peptide proteoform ion score based on the probability of this being 
identified by chance. A score of 46 or greater is associated a 5% confidence threshold. 
(The results are summarized in Figure 3.8 panel a). The results show that as the MS2 
resolution decreased, more scans were performed and more peptide proteoforms were 
identified. To determine the accuracy of these potential identifications the Mascot ion 
scores associated with each proteoform were examined. The highest Mascot ion score, 
and therefore the most confident identification, was the same across all three methods 
despite the increasing ppm error in the lower resolution scans (Figure 3.8 panel b). 
Indeed, the proportion of proteoforms with Mascot ion scores greater than 46 was 
higher in the higher resolution scans (77%, 75% and 70% respectively). 
Correctly identifying the position of PTMs can be challenging given that histone 
peptides are heavily modified and the near isobaric nature of acetylation and 
trimethylation. In order to further disambiguate the position of PTMs, the Mascot Delta 
score was calculated for each of the proteoforms identified across the different methods. 
Previous work in the field of Phosphoproteomics has determined that a Mascot Delta 
score of greater than 17 was associated with accurate location of phosphorylation 
(Savitski et al., 2011). Mascot Delta scores were calculated by taking the difference 
between the highest ion score for a given proteoform and the score for the next possible 
proteoform (Figure 3.7). 
The results show that despite identifying a greater number of total proteoforms, 
the lower resolution scans did not do so with the same degree of confidence. The higher 
resolution scans had a higher proportion of proteoforms with a Mascot ion score greater 
than 46. However, the proportion of proteoforms with a Mascot Delta score of greater 
than 17 was the same with all three data acquisition methods (approximately 20% 
(Figure 3.8 panel A)).  
In summary, the results show that the increased number of MS2 scans afforded 
by the lower resolution DDA method (DDA30) resulted in a higher number of queries, 
PSMs and a higher number of peptide proteoforms identified with a Mascot Ion score 
greater than 46, with no difference in the proportion of peptide proteoforms with Delta 
scores >17. These results indicate that no significant benefit is gained by performing 
DDA analysis using high resolution MS2 scans on the QE HF for the analysis of histone 
PTMs. 
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Figure 3.7: Delta Score calculation. 
This figure shows the Mascot search result for the KQLATKAAR peptide with a single acetylation at 
lysing 18. The Delta score calculation is illustrated. From the highest Mascot Ion score for the query 
(54.2) the score for the next possible match (KKEQKAAR, 15.0) is subtracted giving a Delta score of 
39.2. 
 
 
Delta Score:
54.2 - 15.0 = 39.2
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Figure 3.8: Analysis of data dependent acquisition methods. 
A) The DDA runs were searched using Mascot Daemon, FDR was set at less than 2% using a reversed 
sequence library. Peptides from H3.1 and H4 were examined. The proteoforms with Mascot Ion scores 
>46 and Delta Score >17 are represented. The peptide sequence matches above the identity threshold and 
the conversion rate are also represented for each method. There were significantly more peptide sequence 
matches in the lower resolution runs B) This panel illustrates the number of peptide proteoforms 
identified in each data dependent acquisition methods and the highest Mascot score associated with it and 
the average ppm error for each correct identification. There were significantly less peptide proteoforms 
identified in the higher resolution DDA120 than in the DDA30. C) The number of peptide proteoforms 
identified using Epiprofile 2.0 in each different data acquisition method illustrates that there was slightly 
higher number of peptide proteoforms identified with the DIA 60 approach. n=6, represented are the 
mean and standard deviation. (* p<0.05, *** p<0.0005, **** p<0.0001; one way ANOVA with Tukeys 
multiple comparisons test). 
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3.2.5 Comparison of data independent and data dependent acquisition 
methods for the analysis of histone PTMs: 
Having examined the ability of the different DDA methods to identify PTMs, 
further analysis was performed on the QE HF using DIA methods (described in Chapter 
2) to enable a comparison between DDA and DIA methods. In order to establish the 
identification of proteoforms in DIA runs, data analysis was performed using the 
software Epiprofile, which was specifically developed for the identification and 
quantification of Histone PTMs and is capable of handling both DDA and DIA data 
(Yuan et al., 2015). 
 Briefly, the three DIA methods (described in greater detail in Chapter 2) 
employed are: 
DIA60, a method using sequential 20m/z isolation windows from 300 to 900m/z 
with MS1 scans every 10 at a resolution of 60 000 at 200m/z and an MS2 resolution set 
at 30 000 at 200 m/z; 
DIA30, a method using sequential 20m/z isolation windows from 300 to 900m/z 
with MS1 scans every 10 at a resolution of 30 000 at 200 m/z and an MS2 resolution set 
at 15 000 at 200 m/z; 
DIAvw, a method using 85 sequential variable isolation windows to mimic the 
SWATHTM method. 
 The total number of peptide proteoforms identified across all of the different 
acquisition methods in Epiprofile for histones H3 and H4 was compared (Figure 3.8 
panel c). The results showed that on average 69 proteoforms were identified in each 
method (ranging from 60 to 77). 47 proteoforms were identified in all of the runs (68% 
of average identified) and 90% of all proteoforms were identified in at least 3 out of 6 
runs in each method. This showed that DIA60 identified slightly more proteoforms 
(although this did not reach statistical significance), 75 across all 6 runs, of which 96% 
were identified in at least 3 runs, than the other methods. 
 
3.2.6 Quantification of histone PTMs: 
Having established that all of the DDA and DIA methods were able to 
consistently identify the same pattern of lysine methylation and acetylation on Histone 
H3 and H4 and that this is consistent with the number of different acetylation and 
methylation sites identified in the literature (albeit in different cell lines) (Kulej et al., 
2015), their ability to accurately report the relative quantification of histone PTMs was 
assessed. The relative abundance of each histone proteoform is calculated by measuring 
the area under the curve (AUC) of the extracted ion chromatogram (XIC) corresponding 
to the individual PTMs for each peptide, dividing the AUC of one PTM of a peptide by 
the sum total of the AUC of all PTMs for that peptide (DiMaggio et al., 2009).The 
quantification was performed in Epiprofile (Yuan et al., 2015). In addition to the use of 
Epiprofile further validation of the relative quantification was performed in Skyline 
(MacLean et al., 2010; Schilling et al., 2012), which can analyse data from both DIA 
and DDA, and determine the relative abundance for each peptide proteoform . 
The relative abundance of histone PTMs in CHO cells has been shown to vary 
over time and in response to evolutionary pressures (Feichtinger et al., 2016). 
Furthermore, it has been shown that global levels of H3 acetylation decrease over time 
(Paredes et al., 2013). Therefore, the relative abundances of histone PTMs between day 
2 and day 4 of culture, as I expected to find a difference between the two, was analysed 
across each of the different acquisition methods (Figure 3.9). The results show a wide 
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range of histone PTMs were identified and quantified (summarised in Figure 3.10). In 
order to further analyse the quantitative differences obtained across these different 
methods I focused on a number of peptide proteoforms that were initially identified as 
having changed in abundance between day 2 and day 4.  
 
Proteoform Day	2 Day	4 Fold	Change Signifiacnt:
KSTGGKAPR -1.12 **
Kme1STGGKAPR -0.71 **
Kme2STGGKAPR 0.68 **
Kme3STGGKAPR 0.65 **
KacSTGGKAPR 2.78
KSTGGKacAPR -1.91
Kme1STGGKacAPR -1.64
Kme2STGGKacAPR -6.54 **
Kme3STGGKacAPR -6.90
KacSTGGKacAPR -0.74
KQLATKAAR -0.08 **
KQLATKme1AAR 0.21
Kme1QLATKAAR -0.28
Kme1QLATKme1AAR 0.62
KacQLATKAAR 0.52
KQLATKacAAR 0.33 **
KacQLATKacAAR 0.81
KSAPATGGVKKPHR 0.74 **
KSAPATGGVKme1KPHR -0.54
Kme1SAPATGGVKKPHR 0.59 **
Kme2SAPATGGVKKPHR 0.31 **
KSAPATGGVKme2KPHR -0.19
Kme3SAPATGGVKKPHR -0.48 **
KSAPATGGVKme3KPHR 0.23
Kme2SAPATGGVKme1KPHR -0.63 **
Kme1SAPATGGVKme2KPHR -0.83 **
Kme1SAPATGGVKme1KPHR -0.74 **
Kme3SAPATGGVKme1KPHR -1.41 **
Kme1SAPATGGVKme3KPHR -1.23
Kme2SAPATGGVKme2KPHR -0.98 **
Kme3SAPATGGVKme2KPHR -1.83
KacSAPATGGVKKPHR 0.87
YQKSTELLIR 0.00
YQKme1STELLIR 1.24
YQKme2STELLIR 0.31
YQKacSTELLIR -0.02
EIAQDFKTDLR -0.03 **
EIAQDFKme1TDLR 0.04
EIAQDFKme2TDLR -0.11
EIAQDFKacTDLR 2.06 **
VTIMPKDIQLAR -0.88 **
VTIMPKacDIQLAR 8.40 **
GKGGKGLGKGGAKR -0.59 **
GKacGGKGLGKGGAKR -2.54
GKGGKacGLGKGGAKR -2.71 **
GKGGKGLGKacGGAKR -2.21 **
GKGGKGLGKGGAKacR 0.76 **
GKacGGKacGLGKGGAKR -2.11
GKacGGKGLGKacGGAKR -1.39
GKacGGKGLGKGGAKacR 0.89
GKGGKacGLGKacGGAKR -2.31
GKGGKacGLGKGGAKacR 1.01 **
GKGGKGLGKacGGAKacR 0.14
GKacGGKacGLGKacGGAKR -1.40
GKacGGKacGLGKGGAKacR 1.78
GKacGGKGLGKacGGAKacR 0.38
GKGGKacGLGKacGGAKacR 0.93
GKacGGKacGLGKacGGAKacR 1.17
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Figure 3.10: Heatmap of all of the different PTMs identified for histone H3 
and H4 using DIA 60 for day 2 and day 4 CHO cells. 
This figure illustrates the total number of different histone PTMs identified across histone H3 and H4 and 
the ability of DIA 60 to identify changes in relative abundance between the two days. n=3, ** p<0.05 
Students t test. 
As the overall ion intensity of a proteoform may influence the accuracy of both 
correct identification and quantification, examples of proteoforms with high, medium 
and low ion intensities (which was arbitrarily defined as XIC intensities of >9x109, 
>8x107,>3x105 respectively) were studied. A number of peptide proteoforms covering 
both a range of different ion intensities (low, medium and high) and a range of different 
relative abundances, where relative abundance reflects the percentage of the peptide 
proteoform with respect to the total abundance of all peptide proteoforms for the 
corresponding peptide on both histone H3 and histone H4 were selected. 
 
3.2.6.1 High intensity PTMs: 
Figure 3.9 panel A shows that each method was able to confidently demonstrate 
the change in relative abundance of the highly abundant peptide 
GKGGKGLGKGGAKR, from histone H4, between day 2 and day 4.The ability to 
correctly identify changes in the single acetylated form of KQLATKAAR peptide of 
histone H3 on lysine 23 was examined next (see Figure 3.9 panel A). In light of the 
isobaric nature of the acetylation on K18 or K23 and as both forms co-elute, the relative 
abundance is based on the proportion of diagnostic y and b ions belonging to one form 
or the other (Yuan et al., 2015). The results show that all of the different methods, 
except DIA30, reported the change in relative abundance of the peptide proteoform. 
However, it should be noted that the DIA30 analysis showed the same trend with an 
increase in K23 acetylation with reciprocal decrease in the unmodified form, but failed 
to reach statistical significance. For the KQLATKAAR peptide the DIA30 analysis 
showed the same trend in increasing in K23 acetylation with reciprocal decrease in the 
unmodified form, but failed to reach significance. 
 
3.2.6.2 Mid Intensity PTMs: 
In the mid intensity peptides, such as the dual acetylated peptides 
GKGGKacGLGKGGAKacR of H4 or KacQLATKacAAR of H3, the difference in 
relative abundance between day 2 and day 4 samples were observed in all methods, 
reaching statistical significance except in the DIA30 (Figure 3.9 panel B). 
In addition to looking for changes in relative abundances between the two days, 
I also looked at the relative abundance of a peptide in which I did not expect to see a 
change in abundance, such as the unmodified peptide YQSTELLIR (Figure 3.9 panel 
B). All of the DDA, the DIA60 and DIA30 showed the same relative abundance 
between the two days. Although the relative abundance of the unmodified YQSTELLIR 
peptide from H3 across all of the methods was consistent, the DIAvw method showed 
greater variability compared to the other data acquisition methods with a low level of 
change in between the abundance of the day 2 and day 4 samples. 
 
3.2.6.3 Low intensity PTMs: 
Finally, in the lower intensity, proteoforms such as YQKacSTELLIR on histone 
H3 were analysed (see Figure 3.9 panel C). The results showed that there were no 
significant differences between the methods. However, increased variability was 
observed between replicates, for all of the methods, as would be expected for low 
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intensity, low abundance peptide proteoforms. When the changes in the relative 
abundance of KacSAPATGGVKKPHR (H3K27ac) between day 2 and day 4 were 
examined, an increase in acetylation in all three DDA methods and in both DIA60 and 
DIAvw was observed. The DIA30 was unable to distinguish the increase seen in the 
relative abundance of H3K27ac (Figure 3.9 panel C). 
Overall, all of the DIA methods used in this study were able to identify the same 
trend in changes in the relative abundance of the more prominent PTMs (Figure 3.9 
panel D). The DIA30, that has lower resolution, displayed greater variability in the fold 
change in abundance between the two days as evidenced by the greater standard 
deviations in the KacQLATKacAAR peptide. The DIAvw that has the greatest cycle 
time displayed greater variability in the fold change in abundance between the two days 
for the YQSTELLIR peptide. 
 
 
Figure 3.9: Comparison of relative abundance of histone PTMs between 
data acquisition methods. 
The relative abundances of histone post-translational modifications for day 2 and day 4 CHO cells were 
calculated using Epiprofile 2.0 for the different data acquisition methods. Panel A illustrate three histone 
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PTMs with high MS1 intensity GKGGKGLGKGGAKR on histone H4, KQLATKacAAR and the 
unmodified form on histone H3. There is good concordance between the different methods except for the 
DIA 30, which showed the same trend but didn’t reach statistical significance. Panel B illustrates the 
relative abundance of a three peptide PTMs with middle intensity of MS1 signal. 
GKGGKacGLGKGGKacR and KacQLATKacAAR representing both lower relative abundance peptides 
for the respective peptides and YQSTELLIR the unmodified form of which is highly abundant. Panel C 
illustrates two peptide PTMs of both low relative abundance and low MS1 intensity. Overall there is good 
concordance between the different data acquisition methods in their ability to distinguish significant 
difference between the abundance of PTM between day 2 and day4 CHO cells. In addition, with the 
exception of DIAvw, the peptide PTMs which didn’t change between the two days were correctly 
identified. Panel D illustrates the fold change between the relative abundance of PTM for day 2 and day4 
CHO cell for the YQSTELLIR peptide and the KacQLATKacAAR peptide. For all the panels, n=3, bar 
charts represent the mean and standard deviation, * p<0.05, ** p<0.01, *** p<0.001 Students t test. 
 
3.2.7 Reproducibility of the relative abundance quantification: 
In order to establish the reliability of the relative abundance measurements of 
each method, three technical replicates for day 2 and day 4 were examined and the 
coefficient of variation (CVs) calculated for each peptide proteoform identified in all 
replicates (see Figure 3.11). The results show, as expected, that there was greater 
variability in the proteoforms with the lowest intensities in all data acquisition methods. 
Three quarters of the CVs were 20% or below for the DIA60 method. The median CV 
varied from 10% for DIA60 to 15% for DIA30. In comparing all of the proteoforms 
together there was a trend to smaller CVs with the DIA60 compared to the other 
methods (Figure 3.11), suggesting this is the most reliable quantification method. 
 
Figure 3.11: Coefficient of variation. 
The coefficient of variation was calculated for all of the quantified PTM in each of the different data 
acquisition methods for both day 2 and day 4 samples (n=6). As expected the PTM with very low relative 
abundance had greater variation. Overall the DIA 60 had a trend towards lower CVs. n=6 mean and 
standard deviation represented. 
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each run, there was excellent reproducibility (CVs <1% between replicates) 
demonstrating that the variability in correctly quantifying the proteoforms is due to the 
lower number of MS1 scans. Furthermore, the chromatography for each proteoform was 
comparable between each data acquisition method (Figure 3.12). Typically, proteoforms 
are seen eluting over 30 seconds this would equate to between 6 MS1 scans in DDA120 
and up to 20 in DDA30 due to the shorter cycle time. Furthermore, the DIA60 would 
result in 9 MS1 scans whereas DIA30 would have 14, suggesting that the modest 
decrease in the CVs is due to improved resolution rather than the number of MS1 scans. 
 
3.3 Conclusions: 
In this chapter, a number of different data acquisition methods were compared 
on a QExactive HF Orbitrap mass spectrometer for the identification and quantification 
of histone PTMs. The 1D LC MS workflow analysed on the QE identified more histone 
PTMs when compared to the 2D LC MS workflow in conjunction with the maXis, 
demonstrating the advantages of this instrument for the analysis of histone PTMs. 
Furthermore, the relative abundances of both the 2D LC MS and 1D LC MS analysis 
was identical thereby validating this workflow on the QExactive HF Orbitrap. Both data 
dependent and data independent methods were used to analyse changes in relative 
abundance of histone PTMs in CHO cells. This approach was able to identify 71 histone 
proteoforms for histone H3 and H4 and quantified 64 across each of the different 
acquisition methods. 
The advantages of DDA mean that the confidence in correctly identifying and 
quantifying PTMs can be achieved with lower resolution MS2 scans when coupled with 
search engines such as Mascot. Indeed, the lower resolution DDA30 method was 
associated with the greatest number of PSMs (p<0.001; Figure 3.8), with equal ability to 
obtain high ion peptide scores following Mascot searches than the higher resolution 
scans. However, the advantages of DIA methods over DDA, namely the ability to 
accurately apportion relative abundances to isobaric co-eluting proteoforms and the fact 
that they offer greater flexibility to re-search data for novel PTMs, outweigh any 
disadvantages incurred by the technique. Moreover, the DIA60 was associated with 
increased reliability in terms of lower CVs for the relative abundance of PTMs as 
compared to the other data acquisition methods. Therefore, these results demonstrate 
that this approach is the optimum method from the range of methods studied and will be 
utilized for all subsequent analysis of histone PTMs on the QExactive HF Orbitrap.  
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Chapter 4: The impact of pneumolysin on the Epigenomic landscape  
 
4.1 Introduction: 
 Pneumolysin is one of the key virulence factors of S. pneumoniae (Kadioglu et 
al., 2008b). It is present in the majority of clinical isolates causing IPD (Gray et al., 
1980; Hu et al., 2015). In murine models of bacteraemia pneumolysin sufficient mutants 
are associated with increased lethality compared to pneumolysin deficient mutants, 
linking the toxin to virulence (Benton et al., 1995). Pneumolysin has been shown to be 
responsible for the differential expression of multiple genes in undifferentiated THP-1 
cells (Rogers et al., 2003) but its impact on gene expression in primary MDMs has not 
yet been established. Furthermore, the transmission of S. pneumoniae between hosts has 
been linked to the presence of inflammation in the nasopharynx and pneumolysin has 
been shown to promote inflammation, increase transmission and foster the survival ex 
vivo of the S. pneumoniae (Zafar et al., 2017). It has been also been suggested that 
pneumolysin facilitates blood stream invasion by S. pneumoniae (Hu et al., 2015). This 
highlights the importance of pneumolysin as a key virulence factor of S. pneumoniae 
due to its role in the transmission of S. pneumoniae between hosts, in the progression 
from nasopharyngeal colonisation to IPD, the stimulation of inflammation and 
pneumolysin’s cytotoxic effects (Kadioglu et al., 2008b). 
The purpose of this chapter is to establish the pneumolysin-dependent changes 
in the host’s response following challenge with S. pneumoniae. As a key bacterial 
virulence factor, pneumolysin may be responsible for epigenetic modification and these 
in turn influence key effector functions with consequences for the innate immune 
response. It is proposed to study pneumolysin-dependent perturbation of the 
transcriptome, proteome and epigenetic level in primary MDMs. It is planned to study 
differential gene expression in primary MDMs using microarrays, and differential 
protein expression using label-free quantitative proteomics. Next, having established the 
optimal MS method to study histone PTMs (Chapter 3), this method will be used to 
describe pneumolysin-dependent changes in relative abundance of histone PTMs. 
Finally, the transcriptomics and proteomics datasets will be integrated in order to tease 
out greater understanding of the host’s response. Chapter 5 will focus on the integration 
of the histone PTM profile with the associated transcriptomic data sets in order to draw 
out conclusion regarding the role played by the histone PTMs in the host-pathogen 
interaction. 
 
In this chapter I set out to test the following hypothesis: 
 Is pneumolysin responsible for changes in histone PTMs and is this associated 
with changes in effector functions such as transcriptomic and proteomic profiles?  
 
4.2 Results: 
Changes in histone PTMs have been shown to occur as early as 20 minutes 
following exposure to listeriolysin (LLO) (Hamon et al., 2007). Therefore, initial 
experiments were performed to determine the earliest time at which MDMs changed 
their activity in response to bacterial challenge, initially by measuring release of pro-
inflammatory cytokines following exposure to S. pneumoniae or its pneumolysin 
deficient mutant (∆PLY). In order to assess the role played by pneumolysin in the 
challenge of MDMs I used an isogenic mutant of the D39 parent strain which has a 
STOP codon inserted at the beginning of the pneumolysin (PLY) gene resulting in no 
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pneumolysin being produced. This mutant will be referred to throughout the rest of the 
chapter as ∆PLY. 
 
4.2.1 Model of infective challenge in MDMs: 
 In order to establish the transcriptional, epigenetic and proteomic changes, 
MDMs were challenged with opsonised S. pneumoniae serotype 2 stain D39 or the 
isogenic mutant lacking pneumolysin (∆PLY) or mock infected.  
 
4.2.2 Pro-inflammatory cytokine release during infection: 
 In order to establish the earliest time point at which the host’s response is 
modified by the bacterial challenge, cytokine production was measured establishing the 
kinetics of the host cell’s functional response. Supernatants were collected at time 0, 
0.5, 1, 2, 3, 4, 5, 6 and 7 hours following challenge with both strains. The levels of the 
pro-inflammatory cytokines TNF- and IL-6 were measured in the supernatants using 
ELISA. The results presented in Figure 4.1 show that the release of TNF- and IL-6 is 
detectable as early as 3 hours following exposure to bacteria. The data shows that at 4 
hours following exposure to bacteria the MDMs have recognised the pathogen and 
started releasing pro-inflammatory cytokines in response to either strain (p<0.001). The 
pneumolysin-deficient strain is associated with significantly higher amounts of TNF- 
released than isogenic parent strain at the 4 hour time point. This may be due to the 
increased variability seen in response to S. pneumoniae and the small number of 
replicates (n=3). 
 
Figure 4.1: Pro-inflammatory cytokine release following challenge with S. 
pneumoniae with or without pneumolysin. 
Alterations in production of TNF- and IL–6 over time. Mean and Standard Error of the Mean (SEM) of 
3 biological replicates run in technical duplicates are shown. There is a significant difference in the rise of 
TNF- between the two strains at 4 hr, (black line highlights differences between control and ∆PLY, red 
line between control and S pneumoniae, blue line S pneumoniae, and ∆PLY, * p<0.05, ** p<0.01, **** 
p<0.0001). 
 
 
4.2.2 Intracellular estimation of viability: 
 In order to ensure that both strains of S. pneumoniae are internalised by MDMs 
to similar extents and therefore provide comparable numbers of intracellular bacteria to 
stimulate alterations in the proteome and transcriptome and host epigenome, the number 
of viable intracellular bacteria at 3 hours in cells challenged with either strain were 
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measured. The results show that both strains were readily phagocytosed by the MDMs 
(Figure 4.2) and there is no significant difference in the number of viable bacteria 3 
hours following challenge with S. pneumoniae or ∆PLY. 
Therefore, following 3 hours of exposure, MDMs have ingested bacteria in 
similar numbers and started to release pro-inflammatory cytokines. These results 
confirm that 3 hours is a suitable time point to use for the study of early changes in 
abundance of PTMs of histones. Furthermore, a similar time point has been used to 
study transcriptomic effects of pneumolysin in undifferentiated THP-1 cells (Rogers et 
al., 2003) and changes in response to exogenous pneumolysin have been demonstrated 
to occur as early as 20 min following exposure (Hamon et al., 2007). Therefore, this 
time point should enable me to elicit the impact of pneumolysin on the epigenome, 
transcriptome and proteome. 
 
Figure 4.2: Intracellular bacteria following 3 hour challenge with S. 
pneumoniae or ∆PLY mutant. 
14 day old MDMs were challenged with either S. pneumoniae or the isogenic pneumolysin negative 
mutant ∆PLY. At 3 hours the cells were lysed. The lysates were then plated out to count the number of 
viable intracellular bacteria. The number of bacteria in the wash were subtracted from the lysates and the 
results expressed as log10 of cfu/mL and represented as box plots with min and max whiskers. (n=8, 
paired t test p=0.66)  
 
 
Part A. Studying the effect of S pneumoniae infection on the transcriptomic 
response in MDMs. 
 
4.3 Establishing pneumolysin-dependent differential gene expression in 
MDMs: 
 It has been previously shown that in undifferentiated THP-1 cells (a human 
monocytic cell line) differential gene expression in a pneumolysin-dependent manner 
was observed (Rogers et al., 2003). These included a number of immune response genes 
such as macrophage inflammatory protein 1  (MIP-1), mannose binding lectin 1, IL-8 
and prostaglandin E synthase. To date it is not known whether these pneumolysin-
dependent transcriptional differences occurred in primary human macrophages or not. 
In order to answer this question and establish if any of these transcriptional differences 
occurred in a pneumolysin-dependent manner, a transcriptome wide analysis was 
performed following exposure of MDMs to either the parent strain D39 or ∆PLY to 
quantify changes in mRNA expression. 
S
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 Three hours following the infection of MDMs with either D39 or ∆PLY, mRNA 
was extracted and hybridised to the Human Genome U133 Plus 2.0 Array affymetrix 
Chip for analysis, that is comprised of 54 675 probe sets which according to the 
manufacturers literature gives almost complete coverage of the human protein coding 
genes, was carried out by the University of Sheffield’s core facility (as described in 
Chapter 2). Data analysis was performed in R. Briefly, quality control of each sample 
was estimated using AffyBatch function from the simpleaffy package (version 2.52.0) 
(quality control plots Appendix figure 4.1.1-3). The probes whose intensity fell within 
the lowest 20th centile were removed (as these often correspond to noise) leaving 39 344 
(of 54 675) probe-sets. Probes-sets were then background corrected using gcRMA 
(Figure 4.3).  
 
Figure 4.3: Boxplots of microarray samples before and after background 
correction. 
These boxplots represent the intensities of all of the probes on each microarray before and after gcRMA 
background correction. 
 
 Next, I established the statistically significant differences between the probe-sets 
due to differences between donors (using cut-off of adjusted p value <0.05, from the 
moderated F statistic test for each probe). This resulted in 34 probe-sets which were 
excluded from subsequent analysis (Appendix table 4.1). 
 Then, the differences between the probe sets due to the different conditions 
(mock infected (MI), S. pneumoniae, ∆PLY) were established (using a cut-off of 
adjusted p value <0.05, from the moderated F statistic test for each probe). This resulted 
in 1 872 probe-sets whose expression changed significantly as a result of either bacterial 
strain used in the challenge. “Next, in order to look for the differentially expressed 
genes between the MI and S. pneumoniae challenged cells within those 1 872 probes, 
adjusted p values (to account for multiple test correction, using FDR) were calculated 
from the moderated t statistics using an empirical Bayes method in limma. This has 
become one of the key approaches for the analysis of microarray experiments (Ritchie 
et al 2015) as it allows detection of small differences between sample, especially if n 
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number is small, by taking into account all of the expression data from a replicate to 
estimate the variance for each gene and compute a t statistic which in turn is used to 
calculate and adjusted p value. Next, the comparison between the MI and ∆PLY 
challenged cells was performed in the same manner. Briefly, adjusted p values were 
calculated from the moderated t statistic giving rise to a list of differentially expressed 
genes. Finally, the comparison between S. pneumoniae and ∆PLY challenged cells was 
performed to determine which probe-sets were differentially expressed in a 
pneumolysin-dependent and independent manner.” 
The fold changes for each comparison was also performed and Volcano plots were 
drawn (Figure 4.5) illustrating the fold change and log10 p value. This resulted in 1 596 
probe-sets with a p value <0.05 and 1 243 after multiple test correction (p<0.05 and 
false discovery rate (FDR <0.05; Appendix table 4.2). Figure 4.4 illustrates the overlap 
in differentially expressed probe-sets. There are 503 which are differentially expressed 
in a pneumolysin-dependent manner and 234 in an independent manner. 
 
 
Figure 4.4: Butterfly plot of differentially expressed probe-sets greater than 
2 fold change. 
The butterfly plot illustrates the differentially expressed probe-sets with an adjusted p value of <0.05 and 
an absolute fold change greater than 2. There are 742 probes differentially expressed in response to 
challenge with Spn, of which 348 were up-regulated and 394 were down-regulated. In response to 
challenge with the mutant strain there were 403 probes with 103 up-regulated and 300 down regulated. 
There were 221 probes whose expression was up-regulated in response to challenge with Spn and down 
regulated in the PLY mutant challenge. There were also 80 probes whose expression was increased in 
the absence of PLY and decreased in the challenge with Spn. n=3,  adjusted p value <0.05, fold change 
>2 or <-2. 
 
MI	vs	 PLY	down-regulated
MI	vs	 PLY	up-regulated MI	vs	Spn up-regulated
MI	vs	Spn down-regulated
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Figure 4.4.1 Heatmap of the 1 872 probes identified by ANOVA as being 
significantly different.  
The first three replicates correspond to the mock infected samples, then the next three are the 
samples challenged with the mutant PLY, and finally the last three samples are those 
challenged with Streptococcus pneumoniae. 
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Figure 4.5: Volcano plots of the differentially expressed probe-sets. 
These volcano plots illustrate the comparisons between either mock infected (MI) and S. pneumoniae, MI 
and ∆PLY or between ∆PLY and S. pneumoniae. The probe-sets in blue have a p value <0.05, in red an 
adjusted p value <0.05 (following FDR correction) and in green an adjusted p value <0.05 and an 
absolute fold change greater than 1. There are more probe-sets that are down regulated in response to 
infection (64% in each case). 
 
These results are consistent with previous research in THP-1 cells that showed 
142 genes to be differentially expressed in a PLY dependent manner and 40 to be PLY 
independent (Rogers et al., 2003). This highlights that pneumolysin elicits a strong host 
response with more probe-sets being differentially expressed than following challenge 
with the ∆PLY mutant. 
 
4.3.2 Bioinformatic analysis of differentially expressed genes: 
 In order to further analyse the transcriptional differences between each 
condition, the probe-sets were converted to Ensembl identifiers and pathway enrichment 
analysis was performed on the list of differentially expressed genes (Appendix table 
4.2) for both comparisons. 
 
4.3.2.1 Gene ontology: 
 The list of differentially expressed genes for both comparisons was used to 
assess which of the gene ontology (GO) pathways are enriched using GoStats package 
to perform the hypergeometric test for Molecular function, Biological Process and 
Cellular component. 
 
4.3.2.1.1 Cellular component: 
 The top ten GO Cellular component terms were similar between both sets of 
differentially expressed genes (Figure 4.6). There were more terms enriched in the 
pneumolysin intact strain than the mutant ∆PLY strain (61 vs 35). This is likely to be 
secondary to the greater number of differentially expressed genes in the S. pneumoniae 
infection. 
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Figure 4.6: Gene Ontology Cellular component term enrichment. 
This figure shows the top ten enriched GO cellular component terms in both the pneumolysin mutant and 
the parent strain analysis. The bubble size and colour correspond to the number of genes that have been 
identified as belonging to that GO term. The bubbles are plotted along the x axis according to the –log10 p 
value for the enrichment.  
 
4.3.2.1.2 Gene ontology biological processes: 
 Next the enrichment for the GO biological process terms were examined. This 
revealed that the top ten most enriched terms in both cases were predominantly related 
to cell metabolism (Figure 4.7). However, there were also a number of terms relating to 
cellular responses to “stress” (17 in S. pneumoniae challenge and 15 in the ∆PLY) and 
in particular to oxidative stress responses. The host’s oxidative stress responses have 
been highlighted as playing a key role in the host-pathogen interaction following 
infection with S pneumoniae in lung epithelial cells (Zahlten et al., 2015). Furthermore, 
nuclear factor erythroid 2 (NRF2), the master regulator of antioxidant responses, plays a 
pivotal role in the protection against lung injury (H. Zhao et al., 2017). Indeed, NRF2 
knockout mice had higher mortality rates in response to lethal intraperitoneal LPS 
injections or CLP than there NRF2 positive counterparts (Thimmulappa et al., 2016). 
Moreover, this was associated with greater inflammatory response in the lungs of NRF2 
knockout mice following intra-tracheal LPS instillation. Therefore, the oxidant stress 
response pathways are pivotal in the response to infections through the regulation of 
inflammatory responses. 
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Figure 4.7: Gene ontology biological processes enriched terms. 
This figure shows the top ten enriched GO biological processes terms in both the pneumolysin mutant 
and the parent strain analysis. The bubble size and colour correspond to the number of genes which have 
mapped to the GO term. The bubbles are plotted along the x axis according to the –log10 p value for the 
enrichment. 
 
 The volcano plots for the differentially expressed genes belonging to the GO 
term for oxidative stress response were then plotted for each strain (Figure 4.8). These 
results highlighted that the differentially expressed genes in the pneumolysin-dependent 
manner were predominantly upregulated whereas the comparison involving the 
pneumolysin deficient mutant showed these were downregulated. Indeed, the TNF, 
HMOX1 and PTGS2 genes were strongly up-regulated in a pneumolysin-dependent 
manner and down regulated in the ∆PLY response. 
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Figure 4.8: Volcano plot of the genes belonging to the oxidative stress 
response pathways for the responses to infective challenge with either S. 
pneumoniae or ∆PLY. 
This figure represents two volcano plots with the changes in the gene expression for the members of GO 
term for oxidative stress response pathway, compared to MI. The highlighted genes are found within the 
significantly expressed list (q value <0.05). In red are the gene names that are found in challenge with 
both strains, in blue the gene that is only found in the response to ∆PLY challenge and in orange the 
pneumolysin-dependent genes. 
 
4.3.2.1.3 Gene ontology Molecular Function terms: 
 The GO enriched terms belonging to the molecular functions were also 
evaluated (see Figure 4.9). This highlighted predominantly “binding” and “nuclear 
functions” in response to both infections. 
 
Figure 4.9: Gene Ontology Molecular Functions Enriched terms. 
This figure shows the top ten enriched GO biological processes terms in both the pneumolysin mutant 
and the parent strain analysis. The bubble size and colour correspond to the number of genes that have 
mapped to the GO term. The bubbles are plotted along the x axis according to the –log10 p value for the 
enrichment. 
 
4.3.2.2 Kyoto encyclopaedia of genes and genomes enrichment: 
 The Kyoto encyclopaedia of genes and genomes database (KEGG ) was also 
used to perform pathway enrichment searches for the differentially expressed genes as a 
result of challenge with either strain (see Table 4.1). In both comparisons the TNF- 
pathway and the NF-Kappa B signalling pathway were enriched in response to infective 
challenges with either S. pneumoniae or PLY. In addition, in response to the PLY 
challenge the NOD-like receptor signalling, MAPK signalling pathway and Toll-like 
receptor signalling pathway were also significantly enriched. 
Overall the transcriptomic analysis has demonstrated a number of innate 
immune responses to be enriched following challenge with S. pneumoniae. Indeed, the 
TNF- signalling pathway, the NFB pathway and the oxidative stress response are 
differentially expressed. Furthermore, there are more genes that are differentially 
expressed in a pneumolysin dependent manner. The gene ontology analysis of these 
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demonstrated that there were several metabolic pathways enriched than in the 
pneumolysin independent analysis. 
 
Table 4.1: Summary of significantly enriched KEGG pathways relevant to 
infection. 
  MI vs S. pneumoniae MI vs △PLY 
Pathway p.val q.val p.val q.val 
MAPK signalling pathway 2.18E-04 5.20E-02 1.36E-06 3.16E-04 
ErbB signalling pathway 1.53E-04 3.65E-02 8.82E-03 1.00E+00 
Cytokine-cytokine 
 receptor interaction 
1.22E-03 2.93E-01 2.27E-08 5.29E-06 
Chemokine signalling 
 pathway 
1.85E-02 1.00E+00 1.68E-08 3.92E-06 
NF-kappa B signalling  
pathway 
1.51E-09 3.60E-07 6.67E-13 1.55E-10 
Apoptosis 2.80E-08 6.68E-06 1.76E-08 4.10E-06 
Necroptosis 2.78E-07 6.63E-05 6.05E-06 1.41E-03 
Toll-like receptor signalling 
pathway 
2.66E-03 6.35E-01 4.40E-08 1.03E-05 
NOD-like receptor signalling  
pathway 
2.12E-06 5.06E-04 2.10E-07 4.90E-05 
TNF signalling pathway 8.34E-09 1.99E-06 1.93E-15 4.50E-13 
Fluid shear stress and 
 atherosclerosis 
2.05E-04 4.90E-02 1.50E-07 3.49E-05 
 
4.3.3 XGR enrichment analysis: 
 
 In addition to performing pathway enrichment of genes using NIPA (see chapter 
2), I also repeated the analysis of the differentially expressed genes using XGR which 
performs the similar hypergeometric enrichment analysis but can also perform 
background correction using the expression of monocyte derived macrophage cells to 
give a more cell type specific analysis. 
 Initially the canonical pathway analysis was performed for genes whose 
expression was up-regulated in response to challenge with Spn (adjusted p value <0.05). 
This revealed 32 over-represented pathways (Table 4.1.1). Importantly this 
demonstrated that both the TNF and the NFB signalling pathways were enriched. This 
mirrors the analysis seen without background correction looking at KEGG and GO 
biological process enrichment analyses.  
 Analysis of the 2 fold down-regulated terms did not reveal any enriched 
canonical pathways. 
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Table 4.1.1 Canonical pathway analysis of up-regulated differentially 
expressed probes following challenge of MDMs with Streptococcus 
pneumoniae using XGR. 
 
 
 
 Next the analysis was repeated looking at the differentially expressed genes 
whose expression was down-regulated by greater than 2 fold in response to challenge 
with the ∆PLY mutant. This revealed that the pathways for TNF, NFB and CD40 
signalling were significantly over-represented (Table 4.1.2). This highlights the 
importance of these pathways in the response to bacterial challenge. It also suggests that 
pneumolysin is responsible for the increase in pro-inflammatory signals being released 
and that the host is able to modulate its response to infection by decreasing these 
pathways in the context of the less virulent organism. 
Table 4.1.2 Canonical pathway analysis of down-regulated differentially 
expressed probes following challenge of MDMs with ∆PLY using XGR. 
Term Name FDR Genes 
Genes encoding secreted 
soluble factors 6.10E-12 
CCL1, CCL20, CCL3L3, CCL4, CLCF1, CXCL1, CXCL2, CXCL3, 
CXCL8, IL15, IL1A, IL1B, INHBA, KITLG, TNF, WNT5A 
Ensemble of genes encoding 
extracellular matrix and 
extracellular matrix-associated 
proteins  8.00E-10 
CCL1, CCL20, CCL3L3, CCL4, CLCF1, CRIM1, CXCL1, CXCL2, 
CXCL3, CXCL8, IL15, IL1A, IL1B, INHBA, KITLG, TNF, 
TNFAIP6, WNT5A 
Ensemble of genes encoding 
ECM-associated proteins 
including ECM-affilaited 
proteins, ECM regulators and 
secreted factors 2.20E-09 
CCL1, CCL20, CCL3L3, CCL4, CLCF1, CXCL1, CXCL2, CXCL3, 
CXCL8, IL15, IL1A, IL1B, INHBA, KITLG, TNF, WNT5A 
TNF receptor signaling pathway 
0.000001
3 
BIRC3, MAP4K5, NFKB1, NSMAF, SQSTM1, TNF, TNFAIP3, 
TRAF1 
Direct p53 effectors 0.000026 
AIFM2, ATF3, CDKN1A, DDIT4, DUSP5, JUN, MCL1, PMAIP1, 
PRDM1, TNFRSF10A 
CD40/CD40L signaling 0.000039 
BIRC3, JUN, NFKB1, TDP2, TNFAIP3, TRAF1 
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Calcineurin-regulated NFAT-
dependent transcription in 
lymphocytes 0.00013 
CREM, CXCL8, JUN, PTGS2, TLE4, TNF 
Validated transcriptional targets 
of AP1 family members Fra1 and 
Fra2 0.00017 
CXCL8, FOSL2, HMOX1, JUN, THBD 
IL23-mediated signaling events 0.00017 
CXCL1, IL1B, NFKB1, STAT4, TNF 
Ceramide signaling pathway 0.00017 
BIRC3, NFKB1, NSMAF, TNF 
Canonical NF-kappaB pathway 0.00017 
NFKB1, TNF, TNFAIP3, UBE2D3 
AP-1 transcription factor 
network 0.00023 
ATF3, CXCL8, FOSL2, JUN, MAFG, NR3C1 
IL1-mediated signaling events 0.00039 
IL1A, IL1B, JUN, NFKB1, SQSTM1 
Tumor Necrosis Factor Pathway. 0.00039 
BIRC3, JUN, NFKB1, TNF, TNFAIP3 
Validated targets of C-MYC 
transcriptional repression 0.00065 
CDKN1A, FOXO3, TJP2, WNT5A 
ATF-2 transcription factor 
network 0.0009 
ATF3, CSRP2, CXCL8, DUSP5, JUN 
IL27-mediated signaling events 0.0034 
IL1B, STAT4, TNF 
Validated transcriptional targets 
of TAp63 isoforms 0.0034 
CDKN1A, JAG1, PMAIP1 
HIF-1-alpha transcription factor 
network 0.0038 
HMOX1, JUN, MCL1, PKM 
Glucocorticoid receptor 
regulatory network 0.0055 
CDKN1A, CXCL8, JUN, NFKB1, NR3C1 
C-MYB transcription factor 
network 0.0063 
BIRC3, CDKN1A, KITLG, PTGS2 
HIV-1 Nef: Negative effector of 
Fas and TNF-alpha 0.0063 
BIRC3, NFKB1, TNF, TRAF1 
IL12-mediated signaling events 0.0063 
CCL4, IL1B, NFKB1, STAT4 
Signaling mediated by p38-alpha 
and p38-beta 0.0068 
JUN, MEF2A, PTGS2 
Regulation of nuclear SMAD2/3 
signaling 0.011 
ATF3, CDKN1A, FOXO3, JUN, NR3C1, RUNX2 
Validated transcriptional targets 
of deltaNp63 isoforms 0.013 
FOSL2, IL1A, RAB38 
Calcium signaling in the CD4+ 
TCR pathway 0.013 
CREM, JUN, PTGS2 
Caspase cascade in apoptosis 0.019 
BIRC3, LMNA, TNF 
Signaling events mediated by 
HDAC Class I 0.019 
MXD1, NFKB1, TNF 
LPA receptor mediated events 0.019 
CXCL8, JUN, NFKB1 
Regulation of retinoblastoma 
protein 0.019 
CDKN1A, JUN, RUNX2 
Fas Signaling Pathway 0.02 
CSNK1A1, CXCL8, IL1A, NFKB1 
Angiopoietin receptor Tie2-
mediated signaling 0.029 
CDKN1A, NFKB1, TNF 
Genes related to Wnt-mediated 
signal transduction 0.029 
CSNK1A1, JUN, WNT5A 
Regulation of Androgen receptor 
activity 0.04 
JUN, NR3C1, REL 
Regulation of Telomerase 0.04 
JUN, MXD1, NFKB1 
 
 Finally, the analysis of the up-regulated genes in response to challenge 
with PLY revealed 4 canonical pathways to be over-represented. Three of 
these were cell signalling pathways highlighting the role play by these during 
challenge with bacteria.  
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Table 4.1.3 Canonical pathway analysis of up-regulated differentially 
expressed probes following challenge of MDMs with ∆PLY using XGR. 
 
Term Name FDR Genes 
B Cell Antigen Receptor 0.0049 BLNK, ITPKB, PIK3CD 
Members of the BCR signaling pathway 0.0056 BLNK, NFATC1, PIK3CD 
Class I PI3K signaling events 0.0056 BLNK, PIK3CD, PLEKHA2 
BCR signaling pathway 0.016 BLNK, CAMK2G, NFATC1 
 
 Overall, the analysis of the microarray with background correction using XGR 
re-iterated the importance of the TNF and NFB pathways in the response to 
Streptococcus pneumoniae infections. It did not show significant difference between in 
the enriched pathways compared to analysis with NIPA. This is probably due to the fact 
that the NIPA analysis uses a similar background correction by taking into account all 
of the genes identified (including those not differentially expressed) during the analysis 
as part of the “universe” prior to performing its hypergeometric test.  
 
Part B Studying the effect of S pneumoniae infection on the proteome in 
MDMs 
4.4 Label-free proteomic analysis: 
 Having established that there is a transcriptional difference in the host cell 
response following challenge with S. pneumoniae or ∆PLY, further studies were 
performed to study the effects of S. pneumoniae on the proteome of MDMs.  
 
4.4.1 Three-hour following bacterial challenge: 
 Three hours following the exposure of MDMs with either S. pneumoniae or 
∆PLY, cells from three biological replicates were lysed and protein quantification 
carried out (see Chapter 2). Proteins were then subjected to reduction and alkylation 
prior to trypsin digestion with the use of FASP (see Chapter 2 for further details). 
Samples were then desalted using either HypersepTM tips or using hypercarb column 
and off line HPLC fractionation. The samples were then analysed using mass 
spectrometry on a Orbitrap QE HF. The RAW files from each condition (mock infected, 
challenged with S. pneumoniae and PLY) in the 3 biological replicates were then 
searched using MaxQuant to perform the protein identifications and label-free 
quantification (LFQ) as described in Chapter 2. Data analysis was performed in R. 
Briefly, the matches to the reverse and the contaminant database were removed, then 
only the majority protein identifications with more than two unique peptides were kept 
(Table 4.2 summarises the data filtering process). 
 
Table 4.2: Summary of protein identifications from MDMs following 
infection with either S. pneumoniae or ∆PLY. 
The three biological replicates are represented by A, B and C. The number of majority protein 
identifications at each stage are reported, showing the removal of reverse, contaminant and less than two 
unique peptide matches. 
  Mock Infected S pneumoniae △PLY   
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Donor A B C A B C A B C average 
Majority protein identifications 1318 1468 1435 1347 1385 1322 1410 1422 1418 1392 
reverse matches removed 1316 1465 1433 1346 1385 1317 1406 1414 1407 1388 
contaminant matches removed 1300 1449 1420 1331 1370 1304 1390 1399 1396 1373 
>2 unique peptide matches 1102 1232 1200 1150 1217 1130 1132 1172 1097 1159 
 
4.4.2 Label-free quantification: 
Following initial protein identifications from the MDMs infected with either S. 
pneumoniae or ∆PLY, further analysis was performed to identify those proteins 
differentially expressed. Protein quantification was performed using label-free 
quantification within the MaxQuant software (Cox et al., 2014) and see Chapter 2) 
 The LFQ intensity was then normalised by the median of the LFQ intensities for 
that sample and log2 transformed. (Figure 4.10 illustrates the correction of intensities.) 
 
Figure 4.10: Boxplot of LFQ intensities before and after median correction 
prior to differential analysis. 
These boxplots illustrate the log 2 LFQ intensity for the proteins identified before and after the median 
correction. 
 
 Then, a repeated measures ANOVA using Limma package of the LFQ 
intensities for the remaining majority protein identifications was performed, to enable 
comparison to the microarray analysis (Goeminne et al., 2016). This showed 5 majority 
protein identifications with an F statistic value of less than 0.05. The moderated t tests 
were then calculated for these five proteins and multiple test correction applied 
(summarised in Table 4.3).  
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Table 4.3: Differentially expressed proteins at 3 hours following challenge 
with S pneumoniae or PLY. 
 
 Complement component 1 Q subcomponent-binding protein (C1QBP) is a 
multifunctional protein involved in inflammation and infection. It has been associated 
with enabling entry of pathogens such as Listeria monocytogenes into cells (Braun et 
al., 2000). It has also been shown to be involved in complement mediated immune 
suppression via phosphoinositide-3-kinase (Waggoner et al., 2005). Furthermore, it is a 
competitive inhibitor of the hyaluronidase of S. pneumoniae (Yadav et al., 2009). 
C1QBP has been demonstrated to localise at the mitochondria, where in mice it has 
been shown to protect against oxidative stress mediated death (McGEE and Baines, 
2011). Conversely, it has also been demonstrated to be pro-apoptotic by allowing 
calcium influx to the mitochondria, and is inhibited by Mcl-1 (Xiao et al., 2014). In 
murine sepsis models, C1QBP has led to increased survival associated with decreased 
release of IL-6 compared to C1QBP deficient mice (Sasaki et al., 2017). Therefore, the 
decrease in the abundance of C1QBP in response to both bacterial challenges maybe 
due to the host releasing it to combat the pathogen’s hyaluronidase, be seen as a strategy 
to limit its inhibitory activity on the complement mediated immune response, be 
associated with the alteration in protection against oxidative stress or reduction in early 
apoptosis. 
 Rho guanine nucleotide exchange factor 2 (ARHGEF2) is thought to fulfil 
numerous roles including innate immune responses. It has been implicated in the 
detection of intracellular microbial components alongside NOD1 in Shigella flexneri 
invasion (Fukazawa et al., 2008). It has also been shown to regulate the microbial 
sensing via the NOD2 pathway (Zhao et al., 2012). Thus, the decrease in abundance 
may be secondary to the detection of intracellular S. pneumoniae. 
 Importin-5 is involved in the transport of ribosomal proteins into the nucleus 
(Jäkel and Gürlich, 1998). The increase in creatine kinase B abundance may reflect the 
increased energy demands placed on the host cell by infection. Surprisingly the ATP 
synthase subunit f, which is involved in the generation of ATP and therefore energy 
generation, is decreased in response to exposure to both strains. 
In light of the paucity of differentially expressed proteins a principle component 
analysis was performed for the proteins identified in all of the samples (Figure 4.11). 
The results show that the differences between donors is greater than the effect of the 
bacterial challenge at this early time point.  
 
 MI vs S pneumoniae MI vs PLY     
Majority 
Protein ID log FC p val q val log FC p val q val protein name Gene name 
Q07021; 
I3L3Q7; 
I3L3B0 -1.88 0.002 0.012 -1.014 0.133 0.133 
Complement component 1 
Q subcomponent-binding 
protein, mitochondrial C1QBP 
P56134; 
C9JJT5;C9J
U26;G3V325 -1.839 0.006 0.015 -2.801 0.010 0.017 
ATP synthase subunit f, 
mitochondrial ATP5J2 
V9GYM8; 
Q92974; 
Q5VY93 -0.748 0.029 0.048 -1.089 0.005 0.011 
Rho guanine nucleotide 
exchange factor 2 ARHGEF2 
P12277; 
G3V4N7 0.945 0.054 0.068 3.175 0.002 0.011 Creatine kinase B-type  CKB 
H0Y8C6; 
O00410 -0.422 0.337 0.337 -1.941 0.029 0.036 Importin-5 IPO5 
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Figure 4.11: Principle component analysis of the proteins identified in all of 
the runs. 
Principle component analysis of the majority protein identification seen in all of the 12 samples. The 
three donors are coloured red, green and blue respectively. The mock infected samples are represented by 
the letter M, the S pneumoniae challenged samples are represented by the letter D, and the PLY by the 
letter P. This illustrates that the majority of the difference between the samples is due to differences 
between donors rather than experimental condition. (n=3) 
 
 One possible explanation for the paucity of differentially expressed proteins 
following bacterial challenge may be that the changes in the cell’s proteome are not 
large enough to be detected by a shotgun proteomic approach at such an early time 
point. In light of this, the infections were repeated and extended to six hours to see if the 
later time point gave rise to larger differences in the global proteome. The cells were 
then collected and the label-free proteome characterised as for the 3 hour time point 
(described in Chapter 4.4.1; Appendix figure 4.2 shows the LFQ intensities following 
normalisation, Appendix table 4.2 summarises the data filtering process). 
 The filtered and median corrected LFQ intensities were then used to detect 
statistical differences by ANOVA followed by calculating the moderated t tests between 
the mock infected and either S. pneumoniae or PLY. This identified 32 majority 
protein identifications that were differentially expressed between the three conditions 
(summarised in Appendix table 4.3). The results show that 16 proteins are differentially 
expressed in response to infections with S pneumoniae, and 22 in response to PLY. 
Figure 4.12 illustrates the overlap between each bacterial challenge. The results show 
that 8 proteins were differentially expressed in a pneumolysin-dependent manner and 9 
were common to bacterial strains. Given the small number of differentially expressed 
proteins, pathway enrichment analysis is not appropriate.  
 Although the absolute number of differentially expressed proteins is small, this 
is in keeping with a number previously published proteomic studies. In a study of THP-
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1 cells infected with Mycobaterium tuberculosis only 61 proteins were found to be 
differentially regulated (P. Li et al., 2017). In a study of alveolar macrophages infected 
with porcine reproductive and respiratory syndrome virus only 95 proteins were 
differentially expressed (Qu et al., 2017). Furthermore, this study has used primary cells 
and the difference in-between donors is such that small differences as a result of 
treatment may be masked (as illustrated in Figure 4.11). 
 
 
Figure 4.12: Venn diagram of differentially expressed proteins after 6 hour 
infection. This Venn diagram illustrates the 32 proteins that were identified as differentially regulated 
following 6 hour challenge with wither S pneumoniae or PLY. 
 
 Of the pneumolysin-dependent differentially expressed proteins, the serine / 
threonine protein kinase 1, (also known as oxidative stress response protein 1, OXSR1) 
has been shown to regulate responses secondary to environmental stress (Chen et al., 
2004). This is interesting, as it complements the transcriptomic data where the oxidative 
stress responses were over-represented in the pathway analysis. 
 In addition, the probable global transcription activator SNF2L2 / Brahma  
protein encoded by switch/sucrose non-fermentable (SWI/SNF) related, matrix 
associated, actin dependent regulator of chromatin, subfamily A, member 2 / 
4(SMARCA 2 / 4 ) genes and the transcription activator Brahma-related gene 1 (BRG1) 
protein encoded by SMARCA4 are associated with regulation of gene transcription by 
chromatin remodelling (Wilson and Roberts, 2011). The ubiquitin domain-containing 
protein 1 (UBTD 1) is associated with the cellular senescence via a positive feedback 
loop with tumour protein (TP53; p53)(Zhang et al., 2015). The ATP dependent RNA 
helicase DDX46 (DDX46) is associated with pre-mRNA splicing (Will et al., 2002). 
The probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase encoded for by the 
NOP2 gene has been shown to be associated with the assembly of the large subunit of 
the ribosome and may play a role in cell cycle and proliferation (Sloan et al., 2013). The 
coiled-coil domain containing protein 22 (CCDC22 ) has been shown to be involved in 
the NFB signalling and its depletion leads to blockade of signalling (Starokadomskyy 
et al., 2013). The 6-phosphogluconolactonase protein is part of the pentose phosphate 
pathway (Collard et al., 1999). 
 Taken together, the pneumolysin-dependent differentially expressed proteins are 
predominantly involved in the regulation of gene transcription possibly by chromatin 
remodelling, modulation of the TP53 and NFB pathways as well as interference with 
the assembly of the ribosome. 
8 (26%) 9 (30%) 13 (43%)
MI vs S pneumoniae MI vs PLY
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4.5.1 Comparison of proteomic analysis of the 3 hour and 6 hour infective 
challenge time points: 
 The overlap between the differentially expressed proteins identified from the 3 
hour and 6 hour infective challenges was established (Figure 4.13). The results showed 
that of the total majority proteins identified in the mass spectrometry analysis, 38% 
were common to both analyses. Of the proteins identified as having changes in their 
abundance by the ANOVA analysis, 4 of the 5 at 3 hours and 16 of the 32 at 6 hours 
were identified in both searches. Of these 20 proteins, LFQ intensities were measured in 
both searches in 8 cases. The fold changes in the LFQ intensities at each time point are 
compared for both analyses (see Figure 4.14). 
 
 
Figure 4.13: Overlap of the proteins identified after 3 and 6 hour bacterial 
challenges. 
Venn diagram illustrating the overlap in the majority protein IDs from both the 3 hour and the 6 hour 
proteomes. 
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Figure 4.14: Fold change in abundance of proteins after 3 hours and 6 hours 
bacterial challenges. 
This figure illustrates the changes in the abundances of the proteins identified as differentially expressed 
by ANOVA between MI and S pneumoniae challenged cells (top) and the PLY challenged cells 
(bottom). The red bar shows the fold change at 3 hours and the blue bar that of the 6 hour analysis. 
Protein ID are the Uniprot identifiers or the majority protein identifications from the MaxQuant analysis. 
 
For 2 of the 8 proteins quantified in both searches the fold changes were in the 
same direction at both time points. Threonine-tRNA ligase was identified in both 
searches and in both comparisons as having decreased expression in response to 
infective challenges. Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase) was 
also found to have an increase in abundance in response to infection at both time points 
in both comparisons. 
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4.5.2 Integration of transcriptomic and proteomic analyses: 
 The central dogma of biology proposed by Crick in 1958 and widely accepted 
since, dictates that DNA is translated into mRNA, which is in turn translated into 
proteins (Crick, 1958). However, large number of studies have demonstrated that there 
is poor correlation between transcriptome and proteome data sets (Chen et al., 2002; 
Ghazalpour et al., 2011; Pascal et al., 2008; Stare et al., 2017). Indeed several 
mechanisms control the conversion of mRNA to protein that are not limited to 
transcriptional efficiency (abundance of mRNA) but also translational efficiency 
including post-translational modifications of the mRNA, half-life of mRNA transcripts 
and increased protein degradation which may explain the lack of correlation seen 
between the two datasets in some studies (Stare et al., 2017). More recently, the 
correlation between the two datasets has been improved by the use of RNA-to-protein 
ratios demonstrating that it is theoretically possible to infer the protein abundance from 
the transcript level, although this does remain controversial and requires a spike in PRM 
method to establish the absolute protein abundance for each cell line studied to obtain 
the RNA-to-protein ratios (Edfors et al., 2016). 
 Having established the changes in the transcriptome and the proteome of MDMs 
following challenge with S. pneumoniae or PLY, next the overlap between the two 
was examined. The 5 proteins that were identified at the 3 hour time point as being 
differentially regulated were mapped using Ensembl identifiers to the microarray data 
(Figure 4.15). This shows that although there appears to be reasonable correlation 
between the fold changes in mRNA transcripts and the fold changes in abundance of 
proteins, this is not statistically significant (p>0.05). This may be in part due to the 
microarray and proteomes coming from different donors or to the small number of 
comparisons being made (n=5) as I limited the comparison to the proteins that were 
differentially regulated. 
 
Figure 4.15: Correlation between proteomic data and microarray data 
obtained after 3 hour infective challenge. 
The scatterplots illustrate the correlation between the fold changes in the microarray probe intensities and 
the LFQ intensities between the MI and S. pneumoniae challenged cells (top), MI and PLY (middle) and 
S. pneumoniae and PLY (bottom). n=5, Pearson’s correlation and p values were calculated for each 
comparison. The regression line is plotted in red.  
 
In addition, the comparison between the microarray and the 6 hour proteome 
was carried out (see Figure 4.16). This shows poor correlation between the two data sets 
which maybe down to the small number of comparisons being made (n=32), to the 
different time points (3 hours for the microarray and 6 hours for the proteome) or due 
the fact that the two data sets are from different donors. 
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Figure 4.16: Correlation between proteomic data following a 6 hour 
infective challenge and microarray data following a 3 hour infective 
challenge. 
The scatterplots illustrate the correlation between the fold changes in the microarray probe intensities at 3 
hours and the LFQ intensities at 6 hours between the MI and S. pneumoniae challenged cells (top), MI 
and PLY (middle) and S. pneumoniae and PLY (bottom). n=32, Spearman rho and p values calculated for 
each comparison. The regression lines are plotted in green and the locally weighted scatterplot smoothing 
(Lowess) fits to the data are plotted in red. 
 
 However, the results show that the proteins that were found to be significantly 
differentially expressed at the 6 hour time point (by ANOVA), the corresponding 
Affymetrix probes for two of them were also differentially expressed at 3 hours (Table 
4.4). Neither or these proteins were identified in the 3 hour proteomic analysis. 
 The vacuolar protein sorting 13 C protein (VPS13C) is associated with 
mitochondrial function. Loss of VPS13C is associated with mitochondrial 
fragmentation, and loss of membrane potential as well as an increase in maximal 
respiration(Lesage et al., 2016). Haloacid dehalogenase like hydrolase domain 
containing 5 (HDHD5) protein is not well described in the literature, it is associated 
with cat eye syndrome in humans (Footz et al., 2001). Cat eye syndrome is a rare 
genetic disease caused by tri or tetrasomy of the short arm of chromosome 22. It is 
associated with a number defects affecting different organs, the commonest of which is 
a coloboma (up to 50%). 
Table 4.4: Differentially expressed proteins with corresponding changes in 
microarray values. 
 Microarray 
log fold change p value 
  
Name probe ID 
Spn vs 
MI 
△PLY vs 
MI 
Spn vs 
△PLY Spn vs MI 
△PLY vs 
MI 
Spn vs 
△PLY F.value 
VPS13C 218396_at -0.565 -0.337 -0.228 0.012 0.094 0.235 0.036 
HDHD5 218592_s_at -1.119 -0.989 -0.130 0.008 0.015 0.701 0.016 
 Proteome     
VPS13C Q709C8 -1.828 -2.059 0.231 0.002 0.0002 0.674 0.0005 
HDHD5 Q9BXW7 -0.874 -2.794 1.920 0.229 0.0002 0.001 0.0003 
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Part C Studying the effect of S pneumoniae infection on Histone PTMs in 
MDMs. 
4.6 Histone post-translational modifications: 
 Having established that there is pneumolysin-dependent effect on the 
transcriptome, and to a lesser extent on the proteome of MDMs, in the bacterial 
challenge model, subsequent studies were performed to study the effect on the PTMs 
landscape to provide further insight at the epigenetic level. As described in Chapter 2 
following challenge with either S pneumoniae or PLY, cells were collected and the 
histones purified, chemically derivitised, trypsin digested, desalted and analysed by 
mass spectrometry. Data analysis was performed in Epiprofile with manual verification 
using Skyline (as described in Chapters 2 and Chapter 3). 
 
4.6.2 Studying the effect of S. pneumoniae infection on Histone PTMs: 
 Histone samples were prepared as described in Chapter 2 and similarly to the 
sample preparation for analysis on the maXis (Chapter 4.5.1) acid extracted histones 
were propionylated twice, trypsin digested and re-propionylated. Then, they were 
desalted using HypersepTM tips and re-suspended in 0.05% HFBA and 3% ACN prior to 
analysis on the QExactive HF Orbitrap. Histone PTMs were identified using Epiprofile 
(Yuan et al., 2015) and manually verified using Skyline (Schilling et al., 2012). The 
quantification was performed in Epiprofile for all of the peptides except 
KSAPATGGVKKPHR and KSAPSTGGVKKPHR which were quantified manually 
using Skyline as Epiprofile failed to correctly assign all of the PTMs in these peptides. 
A summary of the relative quantification of the histone PTMs on histone H3 is shown in 
(Figure 4.18) 
 
Table 4.5: Summary of the significant changes in relative abundance of 
histone PTMs identified following bacterial challenge. 
Histone PTM S. pneumoniae △PLY 
H3K4me1 Up Down 
H3K9me2 Down Up 
H3K23ac Up Up 
H3K27me2 Down Up 
H3K27me2K36me2   Up 
H3K27me3K36me1   Down 
H3.3K27me2K36me1 Up Up 
H3.3K27me2K36me2 Down Down 
H3.3K36me2 Up Down 
H3K79me2 Down Up 
 
The results show that in response to challenge with S. pneumoniae there is an 
increase in H3K4me1 relative to the PLY, the decrease in H3K9me2 is maintained and 
interestingly in response to PLY the relative abundance of H3K9me2 is increased 
compared to MI (Figure 4.18 panel A). There is an increase in the level of H3K23ac in 
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response to both bacterial challenges, although the response to S. pneumoniae appears 
to be greatest (Figure 4.18 panel B). The results show a small decrease in H3K27me2 
following challenge S. pneumoniae when compared to PLY. In addition, there seemed 
to be a relative increase in the level of the combinatorial mark K27 and K36 
dimethylation (H3K27me2K36me2) and a reciprocal drop K27 trimethylation and K36 
monomethylation (H3K27me3K36me1) in response to PLY challenge compared to 
MI. 
The results also show that on the peptide KSAPSTGGVKKPHR of histone H3.3 
there is an increase in the relative abundance of K36me2. In addition, there was an 
increase in the combinatorial PTMs K27 dimethylation K36 monomethylation 
(H3.3K27me2K36me1), with a reciprocal drop in the dimethylation of lysines 27 and 
36 (H3.3K27me2K36me2). Analysis of the EIAQDFKTDLR peptide shows that 
although the trend to an increase in H3K79me1 in response to S. pneumoniae challenge 
was observed it does not reach significance in this dataset. However, a decrease in the 
level of the H3K79me2 was observed.  
There were no changes in the relative abundance of the histone PTMs on the 
YQSTELLIR and the VTIMPKDIQLAR peptides (Appendix figure 4.3). 
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Figure 4.18: Changes in the relative abundance of the PTMs on histone H3 
in a pneumolysin-dependent manner on the QE. 
These bar charts summarise the relative abundance in the histone PTMs identified on histone H3. Panel a) 
on the TKQTAR peptide there is a relative increase in the level of H3K4me1 following challenge with S. 
pneumoniae (Green) in comparison to the PLY (red). panel b) on the KSTGGKAPR peptide there is a 
drop in the level of H3K9me2 in a pneumolysin-dependent manner compared to both mock infected (MI; 
blue) and PLY. panel c) on the KQLATKAAR there is a relative increase in the level of H3K23ac in 
response to both bacterial challenges. Panel d) on the KSAPATGGVKKPHR peptide; there was relatively 
less abundant H3K27me2 following challenge with S. pneumoniae than with PLY. In addition there is 
an increase in the level of H3K27me2K36me2 and a reciprocal drop in H3K27me3K36me1 in response 
to PLY challenge compared to MI. Panel e) on the EIAQDFKTDLR peptide there is an increase in the 
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relative abundance of H3K79me2 following challenge with PLY. Finally, panel f) on the 
KSAPSTGGVKKPHR peptide of H3.3 there is an increase in H3.3K36me2 and in H3.3K27me2K36me1 
with a reciprocal drop in H3.3K27me2K36me2. (n=3. One way ANOVA, * p<0.05, ** p<0.01, *** 
p<0.001). 
 
 
 Having identified changes in relative abundance on histone H3, I then examined 
the changes in relative abundance for the GKGGKGLGKGGAKR and KVLR peptides 
of histone H4 (Figure 4.19). The results showed a significant increase in the abundance 
of acetylation on K16 (H4K16ac). In addition, there was also a decrease in the 
dimethylated form of K20 (H4K20me2) and a reciprocal increase in the 
monomethylated form (H4K20me1) in a pneumolysin-dependent manner. 
 
Figure 4.19: Relative quantification of histone H4 PTMs upon challenge with 
S. pneumoniae. 
These bar charts summarise the relative abundance in the histone PTMs identified on histone H4. a) 
Relative abundance of  GKGGKGLGKGGAKR peptide proteoforms reveals a relative increase in the 
level of H4K16ac following challenge with S. pneumoniae (green) in comparison to the PLY (red). b) 
Relative abundance of  KVLR peptide proteoforms reveals there is a decrease in the level of H4K20me2 
in a pneumolysin-dependent manner compared to both MI (blue) and PLY and a reciprocal increase in 
the H4K20me1. Conversely for the cells challenged with PLY there was a rise in H4K20me2 and a fall 
in the level of H4K20me1. (n=3. One way ANOVA, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001). 
 
 A summary of the changes in the relative abundance of PTMs in response to 
infection with S. pneumoniae in a pneumolysin-dependent manner is summarised in 
Table 4.5. The following sections will discuss the roles of these epigenetics marks.  
 
4.7.1 H3K4me1: 
 The relative abundance of H3K4me1 levels was shown to increase in response 
to infective challenge with S. pneumoniae when compared to the challenge with PLY 
(see Figure 4.18). H3K4me1 is predominantly associated with active or poised 
enhancers and also found, to a lesser extent, on promoters (Barski et al., 2007; 
Heintzman et al., 2007). However, a clear function for this mark has yet to be 
established. H3K4me1 has been found with K9 acetylation at the transcription start sites 
of genes (Liang et al., 2004). A careful balance occurs between the trimethylated and 
monomethylated form at promoter regions, as when H3K4me1 is found on its own it is 
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associated with gene repression but when it is in minority compared to H3K4me3 then 
it is seen at the site of actively transcribed genes (Cheng et al., 2014). It has been shown 
to delineate boundaries of promoters in conjunction with the H3K4me3 mark that are 
associated with active gene transcription (Cheng et al., 2014). Furthermore, the 
concomitant presence of H3K27ac at enhancer sites is associated with gene activation 
(Okabe et al., 2017). Although the exact contribution of H3K4me1 to active gene 
transcription is less clear, as gene transcription was only marginally impaired when 
H3K4me1 was removed from enhancers (Dorighi et al., 2017). 
In terminally differentiated cells such as macrophages, the enhancer landscape is 
remodelled by TLR4 stimulation and is associated with the formation of de novo 
enhancers marked by H3K4me1 (Kaikkonen et al., 2013). The deposition of H3K4me1 
at enhancer sites is associated with faster and stronger response following re-stimulation 
with LPS, which may represent a memory like mechanism for these cells (Ostuni et al., 
2013). Indeed the H3K4me1 PTM is maintained after the removal of H3K27ac (Saeed 
et al., 2014). Infection with Epstein Barr virus was associated with a loss of repressive 
marks and an increased in H3K4me1 and H3K27ac at enhancer sites highlighting the 
important role played by H3K4me1 in the host response to infection (Okabe et al., 
2017) Furthermore, H3K4me1 was shown to be deposited in the enhancer region of host 
defence genes in macrophages infected with Mycobacterium tuberculosis (Bouttier et 
al., 2016). H3K4me1 at enhancers has been shown to be associated with different 
transcriptional states depending on which PTMs it coexists with, suggesting that there 
are multiple layers of control over gene transcription at these sites (Soldi et al., 2017). 
The presence of both H3K4me1 and H3K27ac at enhancers has been associated with 
active transcription (Pradeepa, 2017), whereas the presence of both H3K4me1 and 
H3K36me2 was found at intronic and extragenic regions, the co-localisation of 
H3K4me1 with either H3K79me2 or H3K36me3 was mainly found at introns (Soldi et 
al., 2017). The authors went on to show that the combination of 
H3K4me1/H3K27ac/K79me2 and H3K4me1/H3K27ac/K36me3 at enhancers was 
associated with distinct aspects of the macrophage inflammatory response. The 
H3K4me1/H3K27ac/H3K79me2 enhancers were found to be associated with the GO 
term “positive response to JUN kinase activity” term, whereas the 
H3K4me1/H3K27ac/K36me3 was associated with the “response to lipopolysaccharide” 
term. The authors conclude that the distinct enhancer motif control different aspects of 
the inflammatory response. 
 H3K4me1 is removed by the demethylase lysine specific demethylase 1 
(LSD1)(Shi et al., 2004). It appears to not have any activity on trimethylated lysine 
residues. It is also responsible for demethylation of lysine 9 residues on Histone H3 
(Metzger et al., 2005). The exact mechanism of the demethylation is unclear but appears 
to be a flavin dependent mono amine oxidative process (Forneris et al., 2005). Set9 is 
the methyltransferase responsible for methylation of H3K4 (Nishioka et al., 2002). It 
was found that methylation of H3K4 was associated with inhibition of methylation of 
H3K9 by SET domain of the human homolog of Drosophila Su(var)3-9 (Suv39h1). As 
the methylation of H3K9 is associated with the formation of heterochromatin and gene 
repression, the authors suggest that H3K4methylation is therefore associated with the 
maintenance of active transcription (Nishioka et al., 2002). 
 Finally, the increase in H3K4me1 in response to challenge with S. pneumoniae 
infection in MDMs is consistent with the literature suggesting that after TLR4 
stimulation (Kaikkonen et al., 2013), LPS challenge (Ostuni et al., 2013), or infection 
with EBV (Okabe et al., 2017) the levels of H3K4me1 increase. Given that the majority 
of the literature supports a role for H3K4me1 at enhancers in active or poised genes, it 
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is likely that the increase observed in my system relates to the recruitment of genes to 
the immune response. 
 
4.7.2 H3K9me2: 
The relative abundance of H3K9me2 levels was seen to decrease in response to 
challenge with S. pneumoniae, but increase in response to challenge with PLY (see 
Figure 4.18).  
H3K9me2 is primarily associated with gene repression by orchestrating 
heterochromatin formation and covers large genomic domains (Kouzarides, 2002; 
Lienert et al., 2011; Tachibana et al., 2002). It is thought to play a critical role in the 
differentiation process of pluripotent cells into differentiated cells (Wen et al., 2009). 
Although some controversy persists, it has been suggested that dimethylation of H3K9 
occurs as part of the differentiation process of embryonic stem cells into tissue specific 
lineages (Wen et al., 2009). Following differentiation, up to 30% of the genome was 
found to be associated with regions of H3K9me2. However, more recently, the increase 
in global amounts of H3K9me2 upon differentiation has been challenged (Lienert et al., 
2011). The authors propose that local variations in H3K9me2 abundance rather than 
large changes in global levels play a role in the stabilisation of transcriptional response 
of differentiated cells compared to their pluripotent stem cell ancestors. They show that 
the presence of H3K9me2 is exclusive to the regions of active gene transcription. 
Regulation of the differentiation of monocytes into macrophages has been shown to 
involve the modulation of H3K9me2 levels (Hoeksema and de Winther, 2016). 
H3K9me2 has also been demonstrated to be key in regulating inflammatory 
responses in terminally differentiated cells such as macrophages. The presence of 
H3K9me2 at the promoter sites for genes involved in interferon and antiviral responses 
was associated with decreased gene transcription (Fang et al., 2012). The response to 
LPS challenge in macrophages was associated with removal of H3K9me2 and increased 
gene transcription (Saccani and Natoli, 2002). Furthermore, H3K9me2 has been shown 
to be removed from the promoter regions of previously transcriptionally silent genes 
involved in the inflammatory response following LPS stimulation, which are mediated 
via NFB dependent pathways (Essen et al., 2010). Indeed, in macrophages, the stress 
response transcription factor ATF7 has been show to recruit G9a leading to 
dimethylation of H3K9, which was reversed by stimulation with LPS (Yoshida et al., 
2015a). 
 Dimethylation of H3K9 is mediated by the methyltransferase G9a (Gazzar et al., 
2008; Scheer and Zaph, 2017; Tachibana et al., 2002). The removal of H3K9me2 can 
involve a number of different demethylases such as LSD1 (Metzger et al., 2005), amine 
oxidase flavin containing 1 (Aof1  also known as lysine-specific histone demethylase 2 
(LSD2) or lysine demethylase 1B (Kdm1b)(Essen et al., 2010), Kdm3a/Kdm3b . (Ebata 
et al., 2017) or PHD finger protein 8 (PHF8)(Zhu et al., 2010). 
 Finally, the decrease observed in the relative abundance of H3K9me2 following 
bacterial challenge may represent the removal of repressive pressure on certain genes to 
allow activation of distinct transcriptomic modules as part of the host’s immune 
response to infection. 
 
4.7.3 H3K23ac: 
 Following infective challenge with either S. pneumoniae or PLY in MDMs 
there is a rise in the relative abundance of H3K23ac compared to the mock infected 
cells (see Figure 4.18). 
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The acetylation of lysine 23 has not been extensively described in the literature. 
In Arabidopsis the presence of H3K23ac is associated with active gene transcription (Lu 
et al., 2015; L. Wang et al., 2017). In Drosophila H3K23ac was found at the promoter 
sites of actively transcribed genes (Bodai et al., 2012). In humans, the acetylation of 
H3K23 has been found to be recognised by tripartite motif containing 24 (TRIM24 ), 
which reads the combinatorial modification H3K4 unmodified and H3K23ac (Tsai et 
al., 2010). This in turn binds the oestrogen receptor and leads to increased oestrogen 
dependent gene expression. High levels of TRIM24 and H3K23ac in breast cancer 
tissue was associated with poor survival(Ma et al., 2016). Moreover, the lysine 
acetyltransferase 6A (KAT6A) has been shown to acetylate H3K23 recruiting TRIM24 
and play a role in the formation of gliomas (Lv et al., 2017). Therefore, given the 
increase in relative abundance of H3K23ac following infective challenge in my model, 
it is likely that this occurs at the site of genes that are actively transcribed and therefore 
may constitute part of the host’s response to infection. 
 
4.7.4 KSAPATGGVKKPHR peptide: 
 Following challenge with S. pneumoniae, there was a relative decrease in the 
abundance of H3K27me2 when compared to the PLY challenged cells.  
 H3K27me2 has been shown in embryonic stem cells to be one of the most 
abundant PTM, where it was found primarily in intergenic regions and appears to play a 
role in preventing aberrant acetylation of lysine 27 (Ferrari et al., 2014). This suggests 
that it is a primarily repressive mark. H3K27 is methylated by the polycomb repressive 
complex 2 (PCR2) to both dimethylated and trimethylated states (Conway et al., 2015; 
Juan et al., 2016). 
Furthermore, the authors showed that the two modifications were associated 
with functionally distinct regions of their embryonic stem cells (Juan et al., 2016). The 
different methylation states of lysine 27 are associated with distinct transcriptional 
profiles, the monomethylated form, in combination with H3K36me3, is seen in regions 
of active gene transcription, in contrast the dimethylated form is shown to play a role in 
gene repression (Ferrari et al., 2014), as is the trimethylated form (Barski et al., 2007). 
The H3K27me2 mark has been associated with repression of metabolic genes, and the 
H3K27me3 of developmental genes (Juan et al., 2016). In CD4+ T cells both the 
H3K27me2 and H3K27me3 mark were associated with gene repression (Wang et al., 
2008). Both the dimethylated and the trimethylated form of lysine 27 are demethylated 
by JMJD3 (Burchfield et al., 2015; Chen et al., 2012; De Santa et al., 2009a). Indeed, 
JMJD3 was shown to remove the H3K27me3 in macrophages stimulated with LPS (De 
Santa et al., 2009b). JMJD3 has been shown to be essential for the differentiation and 
polarisation of macrophages (Satoh et al., 2010). Highlighting the critical role played by 
this modification in the host response. 
 Given that this mark is decreased following challenge with S. pneumoniae 
compared to the challenge with PLY, it is possible that this predominantly repressive 
mark is being removed to allow the activation of genes related to metabolism as part of 
the cell’s response to infective challenge. 
 In the cells challenged with PLY, there was also an increase in the relative 
abundance of H3K27me2K36me2 and decrease in the H3K27me3K36me1 PTMs (see 
Figure 4.18). This highlights the advantages of mass spectrometry to identify 
combinatorial marks over antibody based approaches which would not have identified 
them. 
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 The literature is rather sparse when examining combinatorial modifications. 
Indeed, as they have primarily been identified by MS, functional studies describing the 
roles played by combinatorial modifications are lacking. The dimethylation of H3K27 
and H3K36 was found to be increased in diabetic rats (W. Wang et al., 2017). One of 
the early studies of histone PTMs across species has suggested that the combinatorial 
modifications have arisen by the co-evolution of two or more enzymes that maintain the 
different PTMs across eukaryotic species, the authors suggest that as the species 
become more complex (from eukaryotes to mammals), the complexity and 
combinatorial nature of PTMs becomes more prominent, indeed they demonstrate that 
several combinatorial modifications are lacking in yeast (Garcia et al., 2007). 
Furthermore, they suggest that the more complex an organism is, the more repressive 
marks it possesses. Another study suggests that lysine methylation can act as a buffer 
for the maintenance of epigenetic marks during cell division as the levels acquired by 
the daughter cell are not as abundant as the parental one (Xu et al., 2011).  
 H3K36 methylation has been shown to be associated with euchromatin and 
therefore with active gene transcription (Miao and Natarajan, 2005; Vakoc et al., 2006). 
H3K36me2 has been shown to antagonise PRC2 and therefore the methylation of lysine 
27 (Ballaré et al., 2012; Yuan et al., 2011). The authors suggest that this controls the 
progression of repressive chromatin. It has also been shown to be deposited after double 
stranded DNA breaks, as part of the repair mechanism (Fnu et al., 2011). Both H3K36 
mono and di-methylation are methylated by the absent, small, or homeotic-1 (ASH1)) 
subfamily of SET domain proteins (Tanaka et al., 2007).  
 Given that methylation of K27 is associated with gene repression and conversely 
the methylation of K36 is associated with active gene transcription the role of the 
combinatorial modifications is likely to be complex, and may be involved in the fine 
tuning of these events. 
 
4.7.5 KSAPSTGGVKKPHR peptide: 
 On the KSAPSTGGVKKPHR peptide of H3.3 there is an increase in 
H3.3K36me2 and in H3.3K27me2K36me1 with a reciprocal drop in 
H3.3K27me2K36me2 in response to challenge with S. pneumoniae and similar changes 
in H3.3K27me2K36me1 and H3.3K27me2K36me2 in response to challenge with PLY 
(see Figure 4.18). 
 Histone H3.3 is a variant of histone H3.1/2 that differs by 4 amino acids at 
positions 87, 89, 90 and 96 (Szenker et al., 2011). H3.3 has been found to be enriched at 
regions of active transcription in Hela cells (Xu et al., 2010) suggesting that it plays a 
key role in gene transcription control. Furthermore, H3.3 was found to be deposited in 
exchange for H3.1 at sites of active transcription (Schwartz and Ahmad, 2005). It has 
also been found to be associated with the enhancer regions of actively transcribed genes 
(Chen et al., 2013). H3.3 has been shown to accumulate with age in murine tissues and 
correlates with altered patterns of H3 PTMs (Tvardovskiy et al., 2017). The exact role 
of H3.3 is still to be more fully elucidated and the function of PTMs on H3.3 are likely 
to be similar to its counterparts on H3.1 but have yet to be extensively determined. 
 
4.7.6 H3K79 methylation: 
 Following challenge with the PLY there is an increase in the relative 
abundance of H3K79me2 on the EIAQDFKTDLR with a reciprocal drop in the 
unmodified form of the peptide (see Figure 4.18). 
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 The precise role played by H3K79me1 is yet to be fully understood. It has been 
found to localise at both promoter regions of active transcription sites and intergenic 
silent transcription (Steger et al., 2008). Indeed, the authors show that with successive 
levels of methylation (dimethylated and trimethylated) the marks were closer to the 
promoter regions and co-localised with H3K4me2/me3. They suggest therefore that the 
monomethylated form might act as a template for long range enhancers and a poised 
mark at promoters whereas the di- and trimethylated form act as an activator at the 
promoters. It has been proposed that H3K79me1 might play a role in the localisation of 
long range enhancers. Furthermore, it has been shown that H3K79 methylation is 
associated with H3K4me1 at promoter sites and correlates with H3K9ac suggesting an 
interplay between the two PTMs (Zhang et al., 2004). However, the observation that 
gene transcription is maintained at the same rate following depletion of H3K79 
methylation raises the possibility that its function may be distinct from transcription 
regulation and instead play a role in genome stability. This contrasts with other studies 
that have shown H3K79me1 level to be highly predictive of gene transcription (Karlić 
et al., 2010). H3K79me1 has been associated with active gene transcription whereas the 
trimethylated form, H3K79me3 is associated with repressed transcription (Barrand and 
Collas, 2010; Barski et al., 2007). The function of the dimethylated lysine 79 is yet to be 
fully elucidated, as H3K79me2 has been linked to active (Okada et al., 2005) 
transcription in some studies but not others (Barski et al., 2007). In cardiac myocytes 
H3K79me2 has been shown to control different transcriptional networks at different 
stages of the cells differentiation (Cattaneo et al., 2016). Moreover, H3K79me2 has 
been shown to play a role in the control of gene transcription during the haemopoetic 
differentiation of acute myeloid leukaemia by enhancing DNA accessibility (Ye et al., 
2015). Thus the exact role of the H3K79 methylation remains to be fully explained. 
 
4.7.7 Histone H4: 
 In response to the bacterial challenge with S. pneumoniae, there is a rise in the 
relative abundance of H4K16ac. In murine embryonic stem cells acetylation of histone 
H4K16 has been associated with active gene transcription as it was found not only in 
the transcription start site of genes but also in active enhancers accompanied by 
H3K4me1 (Taylor et al., 2013). However, in yeast cells H4K16ac was not associated 
with active transcription (Kurdistani et al., 2004). Moreover, in human embryonic 
kidney 293 cells H4K16ac only had a modest effect on transcriptional regulation, 
suggesting that as with many other PTMs the role of H4K16ac may vary from cell type 
to cell type (Horikoshi et al., 2013). The exact role for H4K16ac in human cells is 
therefore yet to be fully determined. It has been shown to be associated with double 
stranded DNA repair mechanisms by maintaining chromatin in an accessible open 
structure and thus enabling detection of DNA damage (Sharma et al., 2010; Zhong et 
al., 2017). In human CD4+ T cells the combination of H4K16ac and with other 
acetylated PTMs was associated with moderate to high rates of gene transcription 
(Wang et al., 2008). H4K16ac has been demonstrated to be removed by sirtuin 1 
(Sirt1)(Vaquero et al., 2004). Hypoacetylation of H4K16 was associated with the 
demethylation of H3K79me1 and with recruitment of Histone H1 leading to repression 
of gene transcription. 
 H4K20 methylation has been shown to be critical for embryonic 
development (Oda et al., 2009). The authors demonstrated that following depletion of 
PR-Set7/Set8/KMT5a, the lysine methyltransferase (KMT) responsible for the 
formation of H4K20me1 there was a loss of both H4K20me1 and H4K20me2/3 as well 
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as defects in the condensation of the chromatin highlighting its importance for normal 
embryogenesis. Indeed depletion of H4K20me1 was associated with mitotic defects 
(Julien and Herr, 2004). The authors suggest that the progression from 
monomethylation to the dimethylated form of H4K20 may cause irreversible changes in 
higher order chromatin structure. H4K20me1 has been shown to associate with regions 
of silent gene transcription and co-localises with H4K9me1 (Sims et al., 2006). 
H4K20me2 has also been associated with a role in double stranded DNA repair 
(Pellegrino et al., 2017). Mycobacterium tuberculosis has been shown to induce the 
Set8 methyltransferase via the induction of the microRNA 30e-3p, which causes H4K20 
methylation and this in turn leads to up-regulation of NAD(P)H dehydrogenase quinone 
1 (NQO1) and thioredoxin reductase (TRXR1) which are associated with the negative 
regulation of inflammation and apoptosis respectively, thus forming part of the 
pathogens immune evasion strategy (Singh et al., 2017). 
 
4.8 Conclusions: 
 In this chapter the effect of pneumolysin on MDMs has been examined at the 
transcriptional, proteomic and epigenome level. Following 3 hour exposure to S. 
pneumoniae or PLY, I demonstrated that MDMs have ingested either bacteria in 
similar numbers and started to release pro-inflammatory cytokines. Three hours 
following the infection of MDMs with either D39 or ∆PLY, mRNA was extracted and 
affymetrix Chip analysis performed to determine pneumolysin-dependent differentially 
expressed genes.  
 The microarray analysis showed that 503 probes are differentially expressed 
in pneumolysin-dependent manner. A number of probes relate to genes involved 
in the immune response such as TNF, and HMOX1. Pathway analysis of the 
differentially expressed probes highlighted the importance of metabolic pathways 
in response to infection, and in particular the role for oxidative stress responses. 
The oxidative stress response has been shown to be up-regulated following S 
pneumoniae infections in lung epithelial cells (Zahlten et al., 2015). As this 
response is also demonstrated in MDMs this provides further evidence for the 
important role played by oxidative stress responses following infections with S 
pneumoniae. Given the role played by NRF2 as a master regulator of oxidative 
stress responses in the lung this may provide a further therapeutic avenue by 
modulating NRF2 levels during infection. Furthermore, the KEGG pathway 
analysis for both of the infective challenges highlighted NFB, NOD-like receptor 
and TNF signalling as enriched pathways emphasising their importance in the 
host’s response to infective challenge.  
The label-free quantitative proteomic analysis revealed only small numbers of 
significantly differentially expressed proteins. 5 proteins were differentially expressed 
after 3 hours of infective challenge and 8 proteins were differentially expressed in a 
pneumolysin-dependent manner following a 6 hour challenge. This data set also showed 
an oxidative stress response protein being differentially expressed further reinforcing 
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the pivotal role played by oxidative stress responses in the context of infections. One of 
the reasons for the relatively small number of differentially expressed proteins may be 
the large differences between the biological replicates. Furthermore, several studies 
have shown only modest correlation between transcriptomic and proteomic datasets 
(Chen et al., 2002; Ghazalpour et al., 2011; Pascal et al., 2008; Stare et al., 2017), which 
might further explain the small number of differentially expressed proteins. Moreover, 
the translation from altered transcriptional response to altered proteome may be longer 
than the 6 hour time point studied, and it might be of benefit to extend the time point 
further. Indeed, in the study of proteomic response to M. tuberculosis and pathogenic 
porcine reproductive and respiratory syndrome virus both authors used a 24 hour time 
point (H. Li et al., 2017; Qu et al., 2017). It is possible that the differentially expressed 
proteins are of relatively low abundance and therefore not readily detected using a 
shotgun proteomics approach, as the more abundant structural proteins such as 
cytoskeletal proteins were readily identified but not differentially expressed.  
 
Finally, the global histone PTMs landscape study has shown that there are several 
changes in the relative abundance of histone PTMs in response to S pneumoniae. Using 
the data independent method optimised in Chapter 3, I was able to identify and quantify 
84 different peptide proteoforms. Of these, there were 5 whose relative abundance 
changed in a pneumolysin dependent manner. This is to my knowledge the first time 
that this approach has been used to study the changes in relative abundance of histone 
PTMs in primary MDMs in response to S. pneumoniae. The advantages of mass 
spectrometry were emphasised by the identification of combinatorial marks on both H3 
and H3.3 that would not have been possible using antibody based approaches. 
Interestingly several of these modifications are associated with gene transcription. The 
exact function of PTMs is yet to be fully described. It is likely to vary between cell 
types, furthermore individual PTMs won’t act in isolation but rather be part of a 
combinatorial code of fine tuning, in response environmental stressors, such as response 
to bacterial infection and at later time points to DNA damage. Nevertheless, in light of 
the changes observed in response to challenge with S. pneumoniae namely the rise in 
H3K4me1, H3K23ac, H4K16ac and given the decrease in H3K9me2, H3K79me2 it is 
possible that these changes represent the removal of repressive marks and the increase 
in marks associated with active gene transcription thereby allowing the host response to 
occur. This highlights the important role played by PTMs in the response to infection 
and therefore offer novel possible immunomodulating therapeutic avenues through the 
use of emerging classes of drugs that target the enzymes that regulate these histone 
PTMs. 
Chapter 5: The role of histone PTMs in the host’s response to infection.  
5.1 Introduction: 
 There are few studies of the impact of live bacteria on histone PTMs in primary 
cells and the functional consequences of these are not fully understood. Following 
infection of cell lines with L. monocytogenes and or L. pneumophilia changes in histone 
PTMs have been demonstrated and in the case of L. pneumophilia these were associated 
with changes in the immune responses (Eskandarian et al., 2013; Rolando et al., 2013; 
Rolando and Buchrieser, 2014). 
Following previous studies in Chapter 4 that identified a number of histone 
PTMs changing abundance upon challenge with S. pneumoniae, further studies were 
performed to provide additional mechanistic insight into the epigenomics associated 
with S. pneumoniae. In an attempt to infer a role for the changes observed in the relative 
abundance of histone PTMs during challenge with S. pneumoniae. Having established 
that histone PTMs were modulated during early infection, next I sought to establish if 
these could account for changes in the transcriptome. In order to establish this, I 
performed RNA-seq to establish the transcriptional activity of these cells at this early 
time point. Then I performed ChIP-seq for key histone PTMs to characterise the 
genomic location of these and their relationship to the differentially expressed genes. I 
obtained a further set of paired RNA, cross linked chromatin and histone samples from 
9 individuals. As there were only very few significant changes in the relative abundance 
of PTMs in response to challenge with PLY and in order to keep the number of 
samples to sequence and the amount of MS time down only the mock infected and the 
cells challenged with S. pneumoniae as described in Chapter 2 were taken forward for 
further analysis. Briefly, cells from nine different donors were either mock infected or 
challenged with S. pneumoniae, then at 3 hours following challenge cells were either 
taken for histone analysis, or RNA was collected in TriReagentTM or cross linked in 
formaldehyde for ChIP-seq. This resulted in paired samples for which RNA-seq, ChIP-
seq and histone PTM analysis was possible. 
 
 In this chapter I hypothesised that modifications in histone PTMs arising in 
response to bacterial challenge occur at specific genomic location and are in turn 
associated with changes in gene transcription. 
 
 
5.1 Analysis of the relative abundance of histone PTMs following challenge 
with S. pneumoniae: 
 Following mass spectrometry analysis of the relative abundance of histone 
PTMs following challenge with S. pneumoniae and PLY in monocyte derived 
macrophages (in Chapter 4), I identified a number of changes in the relative abundance 
of histone PTMs in a pneumolysin dependent manner. In this Chapter, I obtained paired 
samples of RNA, cross-linked chromatin and histones from 9 different individuals with 
and without in vitro challenge to S. pneumoniae. The sample preparations were as 
described in Chapter 3. 
 Figures 5.1, 5.2 and 5.3 illustrates the changes in relative abundance seen 
following 3 hour challenge with S. pneumoniae analysed using Orbitrap QExactive HF. 
This enabled the identification of several PTMs (as described in Chapter 4 and 
summarised in Appendix table 5.1). The changes in the relative abundance of histone 
 127 
PTMs in H3 are consistent with those seen in the comparison of challenge to both S. 
pneumoniae described in Chapter 4. 
The results show a number of histone PTMs are altered in abundance in response to 
challenge with S. pneumoniae including an increase in H3K4me1 and a decrease in 
H3K9me2 (which is maintained compared to MI) (Figure 5.1). In addition, the results 
show that there is also an increase in the level of H3K23ac, a decrease H3K27me2 and a 
reciprocal increase in the abundance of H3K27me3 in response to challenge with S. 
pneumoniae. However, despite increasing the number of samples analysed, although a 
similar trend was observed, the changes in the combinatorial modifications described in 
Chapter 4 (in response to challenge with PLY) did not reach statistical significance in 
this subset of samples. There was no significant change in the relative abundance of 
PTMs on the YQSTELLIR, EIAQFKTDLR and VTIMPKDIQLAR peptides of histone 
H3. 
 
Figure 5.1: Changes in relative abundance of histone PTMs on histone H3 
following 3 hour challenge with S. pneumoniae analysed on Orbitrap 
QExactive HF. 
This figure illustrates the changes in the relative abundance of the PTMs observed for the different peptides of Histone H3 in blue 
are the abundances of the mock infected samples and in red those of the samples challenged with S. pneumoniae. Panel a) represents 
the decrease in H3K4me of the TQTAR peptide (n=7, t tests, * p<0.05), Panel b) highlights the decrease in H3K9me2 and 
reciprocal increase in H3K9me1 and the unmodified form of the KSTGGKAPR peptide (n=8, t test * p<0.05), Panel c) illustrates 
the increase in H3K23ac of the KQLATKAR peptide (n=8, t tests, * p<0.05), Panel d) represents the increase in H3K27me3 and 
reciprocal fall in the abundance of H3K27me2 (n=8, t tests, * p<0.05). 
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Analysis of the PTMs on histone H3.3 revealed that on the identified 
KSAPSTGGVKKPHR peptide, the relative abundance of lysine 36 dimethylation 
(H3.3K36me2) was significantly increased (Figure 5.2). 
 
 
Figure 5.2: Changes in relative abundance of histone PTMs on histone H3.3 
following 3 hour challenge with S. pneumoniae analysed on Orbitrap 
QExactive HF. 
This figure illustrates the relative abundance of all of the PTMs observed for the KSAPSTGGVKKPHR peptide of Histone H3.3. 
n=8, t tests, *** p <0.001, q<0.001, in blue are the abundances of the mock infected samples and in red those of the samples 
challenged with S. pneumoniae. 
 
 On histone H4 (Figure 5.3) there was an increase in the monomethylation of 
lysine 20 (H4K20me1) and a reciprocal decrease in the dimethylated form 
(H4K20me2). There was also a trend towards increase in the abundance of H4K16ac, 
however this failed to reach significance in this subset of samples. 
 
Figure 5.3: Changes in relative abundance of histone PTMs on histone H4 
following 3 hour challenge with S. pneumoniae analysed on Orbitrap 
QExactive HF. 
This figure illustrates the relative abundance of all of the PTMs observed for the different peptides of Histone H3. n=8, t tests, *** p 
<0.001, in blue are the abundances of the mock infected samples and in red those of the samples challenged with S. pneumoniae. 
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 This data therefore confirms that the relative abundance of several different 
histone PTMs change in response to challenge with S. pneumoniae in two separate 
experiments. As discussed in Chapter IV, several of these marks have been associated 
with the control of gene expression and thus may play a role in host’s response to 
infection. 
 
5.2 Transcriptomic analysis of MDMs challenged with S pneumoniae: 
 Having established the changes occurring at a global histone PTMs level, next 
the changes in gene transcription were established in paired samples. RNA-seq was 
performed as described in Chapter 2. Briefly, following 3 hour challenge of MDMs with 
S. pneumoniae or mock infected, RNA was extracted from samples lysed in Tri Reagent 
using Direct-ZolTM extraction kits as per the manufacturer’s protocol. The extracted 
RNA was then transferred to the core facility who prepared the libraries and sequenced 
the samples on the HiScanTM SQ (as described in Chapter 2). 
 Quality control of the RNA-seq runs was performed by FASTQC (as described 
in chapeter 2). This demonstrated that overall the RNA-seq raw data was of good 
quality. Read depth was estimated based on number reads made as between 2-3X (read 
depth= (fragment length x number of reads ) / genome length). Overall this conforms 
with the number of reads required by ENCODE for an RNA-seq experiment to compare 
abundances of transcripts between two conditions. In addition, the mean coverage depth 
was measured using QualiMap and was found to be 22. This takes into account the 
number of reads per genomic region and therefore represents a better estimate of depth 
of sequencing as it isn’t influenced by the regions of the genome not identified.  
 Initially, the samples were analysed following the “new Tuxedo protocol” 
(Pertea et al., 2016), which uses HISAT2 (Kim et al., 2015) to align the samples to the 
reference HG38 genome, then Stringtie (Pertea et al., 2015) was used to generate the 
transcript count tables and finally differential expression was assessed using Ballgown 
in R. This identified 197,782 transcripts of which when performing differential 
expression only 199 had a p value of less than 0.001. Unfortunately, none of the 
transcripts identified were differentially regulated after multiple test correction is taken 
into consideration (FDR <0.05) (Appendix table 5.2 shows the top 10 transcripts). 
 Therefore, in order to assess differential expression at gene level rather than look 
for novel transcripts, I used the quasi-mapping to the reference transcriptome approach 
from Salmon (Patro et al., 2017) to generate transcript level count tables and assessed 
differential expression using EdgeR (Robinson et al., 2010). 
 This approach identified 155 010 transcripts (76% of the 203 903 known 
transcripts in Ensembl). Of these, when performing differential expression analysis, 347 
had a p value of less than 0.05, and 47  were considered to be differentially expressed, 
as the transcripts had a q value of less than 0.05 (FDR) (Table 5.1). 
 In order to establish the total number of genes identified at least once by the 
RNA-seq the Salmon transcript count data was converted to gene level count data using 
txtimport. This revealed 24 104 genes identified in at least one sample (61% of human 
genes of the 39 297 in the Ensmbl biomart database used to convert transcript to genes). 
 
 
Table 5.1: Differentially expressed transcripts. 
Transcripts identified following quasi-mapping to the RefSeq transcriptome and differential expression 
assessed in EdgeR, all upregulated following infective challenge (n=3): 
RefSeq ID Gene name q value 
Fold 
change Spn 
to MI 
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NR_033926.1 actin gamma 1 pseudogene 20 0.01961 -3.79 
NM_021006.5 C-C motif chemokine ligand 3 like 1 variant 1 0.00193 -9.16 
NR_111964.1 C-C motif chemokine ligand 3 like 1, variant 2 0.00232 -8.98 
NR_111969.1 C-C motif chemokine ligand 4 like 1 variant CCL4Ldelta2 0.03280 -7.51 
NM_001565.3 C-X-C motif chemokine ligand 10 0.00000 -15.59 
NM_001199880.1 early growth response 3, transcript variant 2 0.01521 -3.83 
NM_001199881.1 early growth response 3, transcript variant 3 0.01521 -3.83 
NM_004430.2 early growth response 3, transcript variant 1 0.01421 -3.77 
XM_005273425.3 early growth response 3 (EGR3), transcript variant X1 0.01521 -3.83 
XM_005273426.3 early growth response 3 (EGR3), transcript variant X3 0.01521 -3.84 
XM_011544429.2 early growth response 3 (EGR3), transcript variant X2 0.01557 -3.82 
NM_015675.3 growth arrest and DNA damage inducible beta 0.00011 -3.97 
XM_017026822.1 
Nuclear growth arrest and DNA damage inducible beta 
 (GADD45B), transcript variant X1 0.00010 -3.98 
NM_000619.2 Interferon gamma 0.00000 -207.52 
XR_937617.2 uncharacterized LOC105372754 0.00012 -6.65 
XR_001754988.1 uncharacterized LOC107985489 0.00732 -5.17 
XR_001756620.1 uncharacterized LOC107987437 0.01521 -7.26 
NR_001458.3 MIR155 host gene 0.00752 -3.51 
NM_001202233.1 
nuclear receptor subfamily 4 group A member 1, 
 transcript varint 3 0.00193 -2.99 
NM_001202234.1 
nuclear receptor subfamily 4 group A member 1,  
transcript varint 4 0.00247 -2.90 
NM_002135.4 
nuclear receptor subfamily 4 group A member 1,  
transcript varint 1 0.00193 -2.99 
NM_173157.2 
nuclear receptor subfamily 4 group A member 1,  
transcript variant 2 0.00171 -3.03 
XM_005268822.3 
nuclear receptor subfamily 4 group A member 1 (NR4A1),  
transcript variant X1 0.00230 -2.95 
XM_005268824.3 
nuclear receptor subfamily 4 group A member 1 (NR4A1),  
transcript variant X4 0.00211 -2.98 
XM_006719363.1 
nuclear receptor subfamily 4 group A member 1 (NR4A1), 
 transcript variant X3 0.00193 -2.98 
XM_006719364.3 
nuclear receptor subfamily 4 group A member 1 (NR4A1),  
transcript variant X5 0.00232 -2.96 
XM_017019247.1 
nuclear receptor subfamily 4 group A member 1 (NR4A1), 
 transcript variant X2 0.00193 -3.00 
NM_006186.3 nuclear receptor subfamily 4 group A member 2 0.00193 -2.81 
XM_005246621.3 
uclear receptor subfamily 4 group A member 2 (NR4A2),  
transcript variant X1 0.00211 -2.84 
XM_005246622.3 
Homo sapiens nuclear receptor subfamily 4 group A member 2 
 (NR4A2), transcript variant X6 0.00247 -2.91 
XM_006712553.3 
nuclear receptor subfamily 4 group A member 2 (NR4A2),  
transcript variant X3 0.00300 -2.76 
XM_011511246.1 
nuclear receptor subfamily 4 group A member 2 (NR4A2),  
transcript variant X5 0.00247 -2.76 
XM_017004219.1 
nuclear receptor subfamily 4 group A member 2 (NR4A2),  
transcript variant X2 0.00247 -2.83 
XM_017004220.1 
nuclear receptor subfamily 4 group A member 2 (NR4A2), 
 transcript variant X4 0.00353 -2.73 
XR_001738751.1 
nuclear receptor subfamily 4 group A member 2 (NR4A2),  
transcript variant X8 0.00294 -2.71 
XR_001738752.1 
nuclear receptor subfamily 4 group A member 2 (NR4A2), 
 transcript variant X9 0.00391 -2.79 
XR_427087.3 
nuclear receptor subfamily 4 group A member 2 (NR4A2),  
transcript variant X7 0.00284 -2.74 
NM_002852.3 Pentraxin 3 0.00353 -4.94 
NR_002716.3 U2 small nuclear 1 0.00006 -7.51 
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NR_004394.1 U6 small nuclear 1 0.00000 -13.62 
NR_125730.1 U6 small nuclear 2 0.02262 -3.11 
NR_104084.1 U6 small nuclear 7 0.00000 -12.20 
NR_104088.1 U6 small nuclear 8 0.00000 -12.20 
NR_104080.1 U6 small nuclear 9 0.02262 -3.11 
NM_000594.3 Tumour necrosis factor 0.00193 -13.23 
NM_001178096.1 Coagulation factor III, tissue factor (F3) transcript variant 2 0.01943 -2.56 
NM_001993.4 Coagulation factor III, tissue factor (F3) transcript variant 1 0.02060 -2.54 
 
 The RNA-seq analysis revealed 47 transcripts that were differentially expressed 
after challenge with S. pneumoniae (q<0.05). These relate to 18 different genomic 
locations. Given the low number of genes, pathway analysis was not performed. 
The C-C motif chemokine ligand 3 like 1(CCL3L1) gene encodes the 
chemotactic cytokine known as macrophage inflammatory protein (MIP-1/LD78 ). It 
attracts both lymphocytes and monocytes as part of the inflammatory response. It has 
been shown to potently bind to chemokine receptor 5 (CCR5 ) but also receptors 1 and 
3 (Struyf et al., 2001). It therefore plays a key role in the host response to the 
macrophage tropic Human immunodeficiency virus-1 infection (Proost et al., 2000). 
Importantly it is upregulated during pneumococcal infection and associated with 
macrophage recruitment (Fillion et al., 2001). 
 C-C motif chemokine ligand 4 like 1(CCL4L1) gene encodes the chemotactic 
cytokine know as MIP-1. It was first identified following endotoxin stimulation of 
macrophages (Wolpe et al., 1988). Like MIP-1, it binds to CCR5 cell surface receptor 
and acts as a chemoattractant and pro-inflammatory cytokine. Both CCL3L1 and 
CCL4L1 can competitively bind to CCR5 thereby impairing HIV-1 entry into cells 
(Shao et al., 2007). It is also upregulated by pneumococcal infection and is linked to 
macrophage recruitment (Fillion et al., 2001). 
 The C-X-C motif chemokine ligand 10 (CXCL10) is a C-X-C chemokine that is 
secreted in response to inflammatory stimuli, it acts as a chemoattractant promoting 
inflammation and binds to the CXCR3 receptor (Liu et al., 2011). It has been shown to 
play a crucial role in the pathogenesis of a number of different infections such as 
Legionella pneumophilia. In murine models CXCL10 has been shown to be one of the 
most highly up regulated genes following an intranasal S. pneumoniae infection, 
highlighting the importance of these chemokines in the host response to infection. More 
recently, it has been shown to regulate the production of pro-inflammatory cytokines in 
monocytes by binding to the CXCR3 receptor and initiating downstream p38 MAPK 
signalling (Q. Zhao et al., 2017).  
 Early growth response 3 (EGR3) is a member of the EGR transcription factor 
family whose members are involved in the regulation of growth and differentiation 
(Tourtellotte and Milbrandt, 1998). It was initially seen to be induced by growth factors 
(Patwardhan et al., 1991). EGR3 deficient mice were found to develop sensory ataxia as 
it was shown to be critical for muscle spindle development (Tourtellotte and Milbrandt, 
1998). More recently, it has been shown to play an important role in the regulation of 
transcription of inflammatory genes in T cell activation by interacting with NFB 
(Safford et al., 2005; Wieland et al., 2005). Furthermore, deficiency in EGR-2 and 
EGR-3 in B and T cells results in a lethal autoimmune syndrome (Li et al., 2012). 
Moreover, adhesion of S. pneumoniae to pharyngeal epithelial cells has been shown to 
induce the upregulation of EGR-3 amongst other transcription factors (Bootsma et al., 
 132 
2007). EGR-3 has been found to be up-regulated following infection of human 
monocytes with different gram positive bacteria such as Staphylococcus aureus, S. 
pneumoniae and L. monocytogenes (Tchatalbachev et al., 2010). This highlights the 
importance of EGR-3 in the regulation of the inflammatory response. 
 Growth arrest and DNA damage inducible beta (GADD45B) is involved in the 
response to DNA damage in particular in response to environmental stresses (Jiang et 
al., 2016) and mediates apoptosis via p38/JNK pathway (Takekawa and Saito, 1998). 
GADD45B has been shown to play an important role in the regulation of the 
inflammatory response in mice (Salerno et al., 2009). The authors showed that 
GADD45B deficient mice were more susceptible to septic shock from low dose LPS 
challenge. It has a role as a stress sensor in mice. Indeed, in an intraperitoneal sepsis 
model, GADD45B deficient mice recruited less macrophages to the peritoneum. 
Furthermore, the bone marrow derived macrophages from GADD45B deficient mice 
produced less ROS in response to LPS, highlighting its importance in the host’s innate 
immune response (Salerno et al., 2012). It has been shown to be suppressed in a number 
of cancers (Ou et al., 2015; Zerbini et al., 2004). 
 Interferon gamma (IFN-) is a key component of both the adaptive and innate 
immune responses (Schroder et al., 2004). It has been shown to be secreted by 
monocyte derived macrophages in response to IL-12 and IL-18 co-stimulation (Darwich 
et al., 2009). IFN- has been demonstrated to play a number of different 
immunomodulatory roles in particular activating macrophages and leading to T cell 
differentiation (Gessani and Belardelli, 1998) but also priming for the production of 
antimicrobial components such as NO or ROS; therefore demonstrating its pivotal role 
in the host-pathogen response. Furthermore, IFN- has been shown to be essential to 
NO production in response to pneumolysin stimulation in murine macrophages (Braun 
et al., 1999). 
 microRNA 155 host gene (miR155) is a small non protein coding RNA (Elton et 
al., 2013). It plays an important role in post translational control of gene expression by 
interacting directly with messenger RNA for example (Guo et al., 2010). Macrophages 
were found to up-regulate the production of miR155 in response to TLR, TNF- or 
IFN- stimulation (O’Connell et al., 2007). Additionally, the production of pro-
inflammatory cytokines was found to be reduced in miR155 deficient mice (Jablonski et 
al., 2016). It has also been shown to be critical for clearance of S. pneumoniae from the 
nasopharynx of mice (Verschoor et al., 2014). miR-155 has been implicated in a 
number of different cancers and it has been postulated that it may represent a link 
between aberrant inflammatory processes and pro-oncogenic state (Elton et al., 2013). 
 Nuclear receptor subfamily 4 group A member 1 (NR4A1, also known as 
Nur77) is a member of the steroid thyroid hormone receptor family (Ryseck et al., 
1989). It has been shown to play a number of metabolic roles in skeletal muscle cells 
and hepatocytes (Zhan et al., 2012). It has been demonstrated to bind to liver kinase B1 
and lead to attenuation of AMP-activated protein kinase (AMPK) thereby modulating 
glucose metabolism (Zhan et al., 2012). Moreover, in T cells NR4A1 has been shown to 
have a pro-apoptotic role by interacting with Bcl-2 (Lin et al., 2004). Furthermore, the 
regulation of activated T cells has been shown to play a role in bacterial clearance in the 
lung (Marriott et al., 2012). Nuclear receptor subfamily 4 group A member 2 (NR4A2) 
also known as Nurr1, along with NR4A1 have been demonstrated in macrophages to 
play important roles in the regulation of inflammation as they are induced by a number 
of different pro-inflammatory ligands such as LPS (Pei et al., 2005). More recently it 
has been demonstrated that NR4A1, and NR4A2 to a lesser extent, induce a number of 
inflammatory cytokines such TNF- via modulation of the NFB pathway (Pei et al., 
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2006), highlighting the important role played by these nuclear receptors in the host-
pathogen interaction. NR4A2 has also been implicated in the polarisation of 
macrophages towards an alternative or M2 phenotype (Mahajan et al., 2015, p. 2) 
suggesting that it may play a role in controlling inflammation and resolution of the 
inflammatory response. 
 Pentraxin 3 (PTX3) is a secreted protein that plays a critical role in the innate 
immune response (Bottazzi et al., 2010). It is involved in resistance to a number of 
different infections including bacterial (Soares et al., 2006), influenza A virus (Reading 
et al., 2008) and fungal infections (Garlanda et al., 2002). It modulates the production of 
NO and TNF- during the inflammatory response (Perea et al., 2017; Soares et al., 
2006) and therefore plays a key role in the resolution of inflammation in macrophages 
(Shiraki et al., 2016) and the response to S. pneumoniae (Cole et al., 2014; Kadioglu et 
al., 2008b). 
 The transcripts for both U2 and U6 components of the spliceosome were also 
upregulated by the bacterial challenge which would be expected given the increase in 
gene transcription and therefore the need for post-translational modification of pre-
mRNA (Will and Lührmann, 2011). It has been suggested that during infection of 
macrophage alternative splicing events can occur to confer increased survival for 
intracellular pathogens such as M. tuberculosis (Kalam et al., 2017). 
 Coagulation factor III, also known as tissue factor is a cell surface glycoprotein 
that playa a critical role in the coagulation cascade (Nemerson, 1988) and as such is an 
important component of the immune response. 
 Finally, it is reassuring to see that despite the low number of differentially 
expressed transcripts, the majority of them relate to the host’s immune response with 
upregulation of pre-dominantly pro-inflammatory cytokines such as TNF-, CCL4 and 
CCL3. The overall low numbers of differentially transcription may reflect the early time 
point, and as I would expect only a subset of cells will have ingested S. pneumoniae, it 
is possible that the overall effect is masked by non-reactive bystander cells. 
 Moreover, the overall overlap in the RNA-seq and microarray analyses shows 
that the 64% of the differentially expressed genes from the microarray analysis were 
also identified in the RNA-seq analysis.  
 
 
5.3 Chromatin precipitation and sequencing of key histone PTMs: 
 In order to gain further insight into the role played by the changes in global 
relative abundance of the histone PTMs observed by MS, ChIP-Seq was employed. 
Given the potential role played by H3K4me1, H3K27me3 and H3K9me2 as part of the 
regulation of gene transcription these marks were selected for further analysis. Despite 
the use of HFBA in the loading buffer the overall abundance of H3K4me3 and 
H3K27ac marks remains low and I was not able to distinguish any significant 
differences in their relative abundance after infective challenge. However, given the 
pivotal role played of both of these marks in the regulation of transcriptional responses 
(Creyghton et al., 2010; Jenuwein and Allis, 2001), and as they have been widely 
studied by ChIP-Seq and are difficult to quantitate by mass spectrometry, they too were 
taken forward for further analysis. 
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5.3.1 Optimisation of ChIP-Seq workflow: Sonication efficiency: 
 The success of ChIP-Seq relies on several factors; adequate fragmentation of the 
chromatin to be able to sequence it efficiently, and antibody specificity are two key 
components (Landt et al., 2012). 
Therefore, the efficiency of the sonication used to shear the crosslinked DNA 
fragments was first validated by assessing the effect of sonication prior to agarose gel 
electrophoresis analysis (after reversal of the crosslinking as described in Chapter 2 on 
an agarose gel (Figure 5.4). 
 
 
Figure 5.4: Validation of sonication efficiency. 
This 2% agarose gel demonstrates the efficiency of the chromatin sheering after 4 x 10min cycles, 30s on 
/ off on high output. 4 x 106 cells were lysed and the chromatin sheered 10% of the sample was ran on the 
2 % gel after having cross link reversal, RNAase A and Proteinase K treatment, then PCR clean up kit. 
 
 The results show that using 4 x 10 minute cycles of 30 seconds on / off on the 
high output setting, resulted in efficient shearing of the DNA to the correct size range of 
200bp. In order to further validate the sonication efficiency, prior to pull down each 
sample was also analysed on a Bioanalyser prior to sequencing (Figure 5.5). the results 
show that the majority of the sheared DNA was around 200bp in length. 
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Figure 5.5: Analysis of the DNA fragments after sonication using the 
Bioanalyser. 
This figure shows the bioanalyser analysis results and illustrates the length of the DNA fragments after 
sonication demonstrating that the majority of DNA fragments are around 221 bp. 
 
5.3.2 Antibody validation: 
 ChIP-Seq data is only as good as the antibody used to perform the pull downs 
(Landt et al., 2012). Therefore, only antibodies previously used by the Encode consortia 
were used (Table 2.17). Furthermore, western blots were carried out for each antibody 
to ensure only a single band was detected (Figure 5.6). 
 
 
Figure 5.6: Western blot validation of the ChIP grade antibodies used for 
the ChIP. 
5 L of MDMs lysed in Laemli buffer were run 12% SDS page gel. After semidry transfer, the 
membranes were incubated overnight with each antibody as described in Chapter 2. This shows a clear 
single band at the level expected for histone H3. 
 
5.4 ChIP-qPCR: 
 To confirm that the chromatin immunoprecipitations had worked and were able 
to enrich DNA compared to non-specific pull downs (beads only), I carried out a series 
of pull downs followed by qPCR. The primers chosen were either house keeping genes 
(GAPDH, Actin, OAZ1) or genes known to be targets of H3K9me2 for example Insulin 
(Mutskov et al., 2007), MYOD10, STAT1 and CCL3 (Yoshida et al., 2015). The initial 
pull downs were carried out comparing total H3 antibody to beads only and then 
looking for enrichment in the house keeping genes (Figure 5.7).  
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Figure 5.7: Validation of ChIP using qPCR.  
ChIP was performed using total H3 antibody to enrich DNA fragments in conjunction with qPCR to 
detect a number of house keeping genes. This figure demonstrates successful enrichment of the pulldown 
DNA compared to the non-specific binding seen in the beads only sample as the cycle threshold (CT) 
values are significantly lower in the total H3 pull down. This in turn corresponds to significant 
enrichment compared to non-specific binding.  
 
 Next, the individual antibodies were assessed to see if enrichment was 
detectable compared to non-specific binding (Figure 5.8). 
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Figure 5.8: ChIP-qPCR validation of the antibodies.  
This figure demonstrates that successful enrichment was possible for all of the antibodies. Unfortunately, 
there was some non-specific signal see in the water only qPCR for the GAPDH and MYOD10 primers 
although this had a greater CT value than the non-specific binding seen with beads only. As H3K27me3 
is thought to be predominantly associated with repressed gene expression the lack of enrichment with all 
but the primer for insulin maybe due to these genes being expressed in our cells. Furthermore, the primers 
were chosen to look for known targets of H3K9me2. 
 
 Finally, the samples taken forward for ChIP-Seq also had an aliquot run by 
qPCR to ensure that they had been successfully enriched (Figure 5.9). 
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Figure 5.9: ChIP-qPCR QC prior to NGS. 
These bar charts illustrate the CT values for the qPCR following the 6 different ChIP of 6 samples prior 
to library preparation and sequencing. In an effort to constrain costs only 2 “beads only” samples were 
run. The left hand panel shows the results of pull downs for H3K4me1, H3K4me3 and H3K27me3 and 
10% input samples (for the first two samples) using GAPDH primers. The right had panel shows those 
resulting from the H3K4me3, H3K9me2 pull downs and 10% input samples for the last four samples 
using primers for STAT1. With each qPCR pull down a “bead only” pull down was included to assess 
non-specific binding, and a negative control (water). 
 
5.4 ChIP-Seq analysis: 
 Following optimisation of the ChIP procedure, chromatin immunoprecipitations 
for H3K4me1, H3K4me3, H3K9me2, H3K27ac and H3K27me3 were performed for 3 
biological replicates of either mock infected or cells challenged with S. pneumoniae (as 
described in Chapter 2). The precipitated DNA was then indexed and library preparation 
performed by the core facility (SITraN, University of Sheffield). A selection of the pull 
downs were assessed after the libraries were prepared using the Bioanalyser to ensure 
appropriate size selection had occurred (Appendix figure 5.1) prior to high throughput 
DNA sequencing using a HiSeq 4000 (Illumina) performed by Edinburgh Genomics 
(University of Edinburgh). The samples were pooled and run as described in Chapter 2. 
The ChIP-Seq of histone PTMs has identified a number of PTMs to have distinct 
profiles, some are considered to form narrow peaks (such as H3K27ac), others form 
broader peaks (such as H3K9me2) (Landt et al., 2012). In order to achieve the required 
depth of sequencing suggested by Encyclopaedia of DNA elements (ENCODE), the 
broad marks (H3K9me2 and H3K27me3) were run across two lanes. The remaining 3 
narrow ones (H3K4me1, H3K4me3, H3K27ac) and the input controls were run on 
another two lanes. The raw data was then processed in collaboration with the Advanced 
Data Analysis Centre of the University of Nottingham. 
 
5.4.1 ChIP-Seq analysis and quality controls: 
 Briefly, the FASTQ files for each lane were assessed using FastQC (version 
0.11.7, https://www.bioinformatics.babraham.ac.uk/projects/download.html#fastqc). 
This showed that the median quality scores were greater than 25 (Appendix figure 5.2). 
The reads from both lanes were then concatenated, and trimmed using Trimomatic 
(Bolger et al., 2014), alignments were made using Burrows-Wheeler Alignment tool 
(BWA) (Li and Durbin, 2009), samples were deduplicated using Picard-tools 
(https://github.com/broadinstitute/picard). Peak calling was made using both narrow and 
broad peak modes of Model-based Analysis of ChIP-Seq (MACS2) (Zhang et al., 
2008), then the peaks were assessed using phantompeakqualtools 
(https://code.google.com/archive/p/phantompeakqualtools/source/default/source). This 
showed that the majority of normalised strand coefficients (NSC) were greater than 1.05 
and the relative strand correlation (RSC) was greater than 0.8 (Appendix figure 5.3) 
suggesting that the ChIP had been successful (Landt et al., 2012). Finally, ChipQC 
(Carroll et al., 2014) in R was used to characterise the peak picking (summarised in 
Appendix figure 5.4). 
 
5.4.2 ChIP-Seq analysis and genomic distribution of peaks: 
 To further characterise each pull down, I also used ChIPseeker (Yu et al., 2015) 
to annotate and visualise the peaks. This revealed that the H3K27ac and H3K4me3 pull 
downs had sequences that were predominantly located at or near the transcription start 
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site (TSS) as demonstrated in Figure 5.10 (and Appendix figures 5.5-6), whereas 
H3K27me3 and H3K9me2 had predominantly distal intergenic occupancy. 
 
 
Figure 5.10: Distribution of reads relative to TSS of genes. 
Using ChIPseeker, the reads were mapped to genomic locations. This figure illustrates that the majority 
of the peaks identified following H3K27ac (left side) ChIP-Seq were within 1kb of the TSS. On the other 
hand (right side) the results from the H3K27me3 ChIP-Seq illustrates that the majority of the peaks are 
distal intergenic. 
 
5.4.3 ChIP-Seq differential analysis and visualisation: 
Differential enrichment for both the peaks picked in narrow and in broad mode 
was performed using the R package Diffbind (Ross-Innes et al., 2012). This generated a 
number of BED files containing the differentially bound regions. In addition, using 
Bedtools (Quinlan and Hall, 2010) a consensus file for each of the pull downs for both 
the mock infected and the S. pneumoniae challenge samples were created. The data was 
visualised in Integrated Genomics Viewer (IGV) as illustrated in Figure 5.11 (Robinson 
et al., 2011). 
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5.4 ChIP-Seq results: Analysis of differentially enriched genomic locations  
 The analysis of the ChIP-Seq showed that overall the data was of good quality 
(Appendix figures 5.1-4). The differentially enriched peaks between the two conditions 
(mock infected and challenged with S. pneumoniae) however, only identified a few 
differentially enriched regions after multiple test correction (FDR<5%). 
 
 ChIP-seq suffers from a number of limitations in particular in relation to 
sensitivity. The overall ability to correctly identify changes in relative abundance of 
histone PTMs at a given genomic location is governed a number of different factors. 
Firstly, the quality of the antibody used and its ability to bind to the histone PTM, not 
be displaced by neighbouring PTMs such as is the case in epitope occlusion and or 
cross reactivity with other PTMs. It is also possible that the conformation of the 
chromatin may not allow binding of the antibody to a PTM. Furthermore, the ability to 
distinguish small changes occurring at a specific location may be below the detection 
limit of these novel next generation sequencing methods. Moreover, there is a lack of 
consensus on the interpretation of multiple replicates within the field. Additionally, a 
global decrease in a PTM occurring across the entire genome may not identify distinct 
sites of change by ChIP-seq. Finally, it is likely that several layers of redundancy exist 
within the histone PTM landscape and as a result it is probable that multiple PTMs act 
in consort to perform their role, leading to dangers of over interpretation if individual 
PTMs are studied in isolation. Taken together, these factors dictate that some caution be 
used in the interpretation of the ChIP-seq data and further validation studies using 
ChIP-qPCR for example are warranted before making firm conclusions. 
 
 
5.5 H3K27ac: 
 The ChIP-Seq analysis identified between 20 744 and 32 713 narrow peaks 
identified in 5 of the 6 samples with one outlier at 8 758.  
 There was one differentially enriched region for the narrow peak results for 
H3K27ac pull downs (Table 5.2 and Figure 5.12). This corresponded to chromosome 21 
position 8 219 749 to 8 220 258, this is within the intron for NR_038958, also known as 
LOC100507412 and is a long non-coding RNA. It also happens to occur within a CpG 
island. The analysis of broad peak enrichment identified a region 10kb upstream of the 
Gap junction protein alpha 3 (GJA3 gene). Defects in this gene are associated with 
congenital cataract formation (Yao et al., 2017). It also identified a region within the 
intron for Corf159, also known as D-Glutamate cyclase (DGLUCY). The enzyme 
encoded for by this gene is responsible for the metabolism of D-glutamate (Ariyoshi et 
al., 2017).  
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Figure 5.12: IGV visualisation of enriched region for H3K27ac pull downs. 
This IGV figure illustrates the region on chromosome 21 that is differentially populated following 
bacterial challenge with an increase in H3K27ac within a CpG island in a long non-coding RNA. The top 
track in blue is the transcriptome information, in orange is the consensus BED file for the mock infected 
and in green for the S. pneumoniae challenged. Finally, the bottom track shows the location of the CpG 
islands. This approach was used to characterise the relationship with coding regions of the genome for all 
of the statistically differentially enriched regions. 
 
 As one of the samples had very few peaks, it is possible that this biological 
replicate skewed the results, therefore the differential analysis was repeated excluding 
this biological replicate (Table 5.2 orange rows). This resulted in 5 differentially 
enriched regions being identified when looking at the broad peak picking results. The 
first region corresponds to an intron for the long non-coding RNA (LOC101929709 also 
known as NR_125822). This site is also situated within 10kb of the start site for 
Receptor-interacting Serine/threonine-protein kinase 2 (RIPK2). RIPK2 is a 
Serine/threonine/kinase that is essential in the regulation of the innate immune response 
due to its involvement in the NOD / NFB signalling pathway (Tigno-Aranjuez et al., 
2010; Zhao et al., 2012). The first intron for stabilin 1 (STAB1) was also found to be 
differentially enriched. This gene is encodes the receptor protein stabilin 1. High levels 
of stabilin 1 have been associated with down-regulation of pro-inflammatory genes 
(Palani et al., 2016). The ChIP-Seq analysis suggests that there is less H3K27ac, a mark 
commonly associated with active gene transcription found at the start of this gene. The 
transcriptomic analysis shows that there is slightly less transcript (-0.327 fold change) 
in the bacterial challenge samples than the mock infected although this does not reach 
statistical significance (p>0.05). Finally, the region 60kb downstream for the 
pseudogene Ankyrin domain 26 pseudogene 1 was also differentially enriched. Ankyrin 
domain 26 protein is found within the inner cellular membranes of multiple tissues and 
is thought cooperate with signalling proteins (Raciti et al., 2011). Mutations in Ankyrin 
domain 26 gene have been associated with acute myeloid leukaemia (Marconi et al., 
2017) and thrombocytopenia 2 (Bluteau et al., 2014).  
 
Table 5.2: List of differentially enriched regions for H3K27ac pull downs. 
PTM n Chr Start End Fold FDR Gene 
Gene 
body Distance 
H3K27ac 
Broad 2 chr8 89727950 89730853 3.57 5.32E-05 
NR_125822 / 
upstream of RIPK2 Intron   
H3K27ac 
Broad 2 chr3 52494678 52501213 -1.64 0.0199 STAB1 Intron   
H3K27ac 
Broad 2 chr13 20174031 20175733 3.47 0.000828 
Upstream GJA3 / 
dowstream GJB2 No 
10kb / 10 
kb 
H3K27ac 
Broad 2 chr16 46398609 46401505 7.96 0.0379 
Downstream from 
ANKRD26P1 no 60kb 
H3K27ac 
Broad 2 chr5 49601597 49602776 7.85 0.0414 centromere no   
H3K27ac 
narrow 2 chr16 46398519 46401602 8.03 0.0107 
Downstream from 
ANKRD26P1 no 60kb 
H3K27ac 
narrow 2 chr5 49601485 49602902 8.24 0.0101 centromere no   
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H3K27ac 
Broad 3 chr8 89727950 89730853 3.17 6.33E-05 
NR_125822 / 
upstream of RIPK2 Intron   
H3K27ac 
Broad 3 chr14 91220428 91223032 4.74 0.00985 C14orf159 Intron   
H3K27ac 
Broad 3 chr21 8219800 8220686 5.07 0.00985 NR_038958 Intron   
H3K27ac 
Broad 3 chr13 20174031 20175733 4.03 3.22E-05 
Upstream GJA3 / 
dowstream GJB2 No 
10kb / 10 
kb 
H3K27ac 
narrow 3 chr21 8219748 8220258 6.08 0.0019 NR_038958 Intron 
  
  
 
5.6 H3K9me2: 
 There were between 4 604 and 13 210 broad peaks identified in 5 of the 6 
samples with one outlier at 539. 
 Despite identifying 9 355 regions in both the mock infected and S. pneumoniae 
challenged samples following ChIP, none of these were differentially enriched after 
FDR correction. 
 
5.7 H3K27me3: 
 There were between 12 653 and 30 103 broad peaks identified in 5 of the 6 
samples with one outlier with only 1 851 peaks. There are 18 regions with differential 
H3K27me3 peaks following challenge with S. pneumoniae (Table 5.3). 
 There were two differentially enriched regions following analysis with all three 
samples; this is a region on chromosome 2 that is situated within 30kb of the start of the 
cytoskeleton regulator RNA gene (CYTOR) and another region on chromosome Y, 1mb 
away from the testis specific transcript Y linked 23 (TTTY23). 
 The differential analysis after excluding the outlying biological replicate (orange 
rows of Table 5.3) resulted in more regions of interest. One region was on chromosome 
22, involving one of the exons for RNA, 45S Pre-Ribosomal N1 gene (RNA45SN1). 
This region encodes the 45S ribosomal RNA, an important constituent of the ribosome 
(Yu and Lemos, 2016). On chromosome 2, the intron for the SLIT homolog 2 protein 
coding gene (SLIT2) was found to be differentially enriched. This protein is found to 
play a number of different roles and has recently been implicated in the control of 
inflammation caused by LPS in endothelial cells (Zhao et al., 2014) and has been found 
to regulate monocyte adhesion to endothelial walls, hence playing a part in the 
regulation of inflammation (Mukovozov et al., 2015). On chromosome 9 the intron for 
the glutamate ionotropic receptor N-methyl-D-aspartate type subunit 1 (GRIN1) was 
differentially enriched. This gene encodes a portion of the N-methyl-D-aspartate 
receptor which plays a role in memory and learning. Mutations in GRIN1 have been 
associated with encephalopathies (Zehavi et al., 2017). A further region was on 
chromosome 12, located at the non-coding RNA transcript NR_120467, a gene of 
unknown significance. 
On chromosome 14, the region upstream of neuronal Per-Arnt-Sim domain 3 
(NPAS3), which has been implicated in the development of schizophrenia, is also 
differentially enriched (Macintyre et al., 2010). The region 10kb upstream of uridine-
cytidine kinase 1 (UCK1) was also enriched. UCK1 phosphorylates uridine and cytidine 
(Meinsma and van Kuilenburg, 2016) and has been associated with neuroblastomas 
(van Kuilenburg and Meinsma, 2016). Finally, the region 6kb upstream of Human 
growth hormone 1 homolog (HGH1) gene was also found to be differentially enriched. 
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Table 5.3: Differentially enriched regions following H3K27me3 diffbind 
analysis. 
PTM n Chr Start End Fold FDR Gene 
Gene 
body 
distance 
H3K27m
e3 Broad 
3 chrY 11322543 11322787 3.22 0.0438 
downstream 
TTY23 /  
no 1mb 
H3K27m
e3 Broad 
3 chr2 87423893 87425699 2.47 0.0284 
Upstream 
CYTOR 
no 30kb 
H3K27
me3 
Broad 
2 
chr22_ 
KI270733v
1_random 
133811 135280 7.08 1.31E-05 RNA45SN1 intron   
H3K27m
e3 Broad 
2 
chr1_ 
KI270712v
1 
_random 
58428 59525 5.96 0.00116       
H3K27
me3 
Broad 
2 chr4 20254532 20255349 3.23 0.00557 SLIT2 exon   
H3K27
me3 
Broad 
2 chr9 137160768 137161470 3.91 0.0166 GRIN1 exon   
H3K27
me3 
Broad 
2 chr12 132330028 132330311 3.59 0.0244 NR_120467 exon   
H3K27m
e3 Broad 
2 
chrUn_ 
KI270467v
1 
2051 3828 -0.73 0.0252       
H3K27m
e3 Broad 
2 chr14 32932478 32934557 1.92 0.0152 
Upstream 
NPAS3 
no 10kb 
H3K27m
e3 Broad 
2 chr9 131545680 131546557 2.2 0.0336 
Upstream 
UCK1 
no 10kb 
H3K27m
e3 Broad 
2 chr2 89610914 89613026 2.71 0.0265 
Downstream 
NR_136329 
no 15kb 
H3K27m
e3 Broad 
2 chrY 11332961 11334300 1.91 1.31E-05 
Downstream 
GYG2P1 
no 1mb 
H3K27m
e3 Broad 
2 chr21 12965934 12966712 -2.25 0.0356 
Upstream 
ANKRD30B
P2 
no 1mb 
H3K27m
e3 Broad 
2 chr2 91477391 91479074 3.02 0.00557 
downstream 
LOC654342 
no 200kb 
H3K27m
e3 Broad 
2 chr2 87423893 87425699 2.81 0.000791 
Upstream 
CYTOR 
no 30kb 
H3K27m
e3 Broad 
2 chr2 87418396 87419860 3.45 0.0146 
Upstream 
CYTOR 
no 33kb 
H3K27m
e3 Broad 
2 chr20 26602470 26604119 -3.51 0.0366 
centromere / 
Upstream 
MIR663AHG 
no 400kb 
H3K27m
e3 Broad 
2 chr7 56370534 56373033 3.4 0.0326 
Downstream 
LOC650226 
no 40kb 
H3K27m
e3 Broad 
2 chr8 144125644 144126008 1.94 0.0487 
Upstream 
HGH1 
no 6kb 
H3K27m
e3 Broad 
2 chr20 29326303 29327076 2.63 0.0156 centromere No   
H3K27m
e3 
narrow 
2 
chr14_ 
GL000225v
1_ 
random 
59742 59886 3.84 0.0318       
 
5.7 H3K4me1: 
 The number of narrow peaks identified following the pull downs with H3K4me1 
ranged from 1 313 to 3 169 across the 6 samples. 
 The differential binding analysis for the narrow peaks following H3K4me1 pull 
down with the outlier excluded resulted in 75 significantly different regions (Table 5.4). 
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The analysis of the broad peaks resulted in 70 peaks (Appendix table 5.3) of which the 
only difference of note was the presence of enrichment in the exon / transcription start 
site of long non-protein coding RNA 1667 (LINC01667). 
 The results also identified enriched regions common to both analyses, including 
the second exon for mucin 3A (MUC3A) gene. MUC3A encodes a transmembrane 
mucin (Williams et al., 1999). It has been suggested that mucin in macrophages may 
play an anti-inflammatory role (Kato et al., 2016). Another is within the Rho associated 
coiled-coil containing protein kinase 1 pseudogene 1 (ROCK1P1) pseudogene body. A 
further region was within one of the introns for Double homeobox 4 (DUX4), which 
was also significantly different between the two conditions. Deficiencies in DUX4 are 
associated with Facioscapulohumeral muscular dystrophy (Dmitriev et al., 2013). 
Finally, the region coding for NR_038958, which is of unknown function, was also 
differentially enriched between the two conditions.  
 When comparing the differential analysis with the outlier included, the only 
significant addition was an enriched region of chromosome 20 situated 30kb upstream 
of the defensin beta 125 (DEFB125) gene, which can act as antimicrobial peptides. 
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Table 5.4: Differentially enriched regions following H3K4me1 diffbind 
analysis. 
Chromosome Start End Fold FDR Gene  distance  
chr18 110245 110763 7.43 2.29E-05 ROCK1P1 /MIR8078 exon   
chr18 109729 110029 5.89 0.00783 ROCK1P1 /MIR8078 exon   
chr18 107882 109395 2.24 0.0111 ROCK1P1 /MIR8078 exon   
chr7 100957785 100958930 6.1 0.00298 MUC3A exon   
chr21 8219768 8220288 5.7 0.014 NR_038958 intron   
chr4 190177603 190178966 3.98 0.035 DUX4 intron   
chr16 46389641 46391270 9.56 1.88E-11 Downstream ANKRD26P1 no 100kb 
chr16 46388615 46389363 7.91 3.74E-06 Downstream ANKRD26P1 no 100kb 
chr16 46394275 46395099 8.2 0.000344 Downstream ANKRD26P1 no 100kb 
chr21 10692370 10693086 4.39 0.048 Downstream TPTE no 100kb 
chr3 75668894 75669629 7.82 7.13E-06 
Downstream FRG2C / 
Upstream LINC00960 no 
10kb / 
12kb 
chr8 144125633 144126054 4.89 0.0398 
Downstream WDR97 / 
Upstream HGH1 no 
10kb / 
12kb 
chr20 28897867 28898808 4.72 0.0466 Upstream FRG1DP  no 180kb 
chrY 11332971 11334272 7.76 7.13E-06 Downstream GYG2P1 no 1mb 
chrY 11329704 11330373 5.7 0.00783 Downstream GYG2P1 no 1mb 
chrY 11322566 11322761 4.77 0.0243 Downstream GYG2P1 no 1mb 
chrY 11318613 11319054 5.12 0.0267 Downstream GYG2P1 no 1mb 
chrY 10775971 10776671 -4.63 0.0492 Downstream TTTY23 no 1mb  
chr1 143214220 143215408 6.54 0.00182 Downstream LOC645166 no 200kb 
chr1 143184638 143185470 6.19 0.0023 Downstream LOC645166 no 200kb 
chr1 143263376 143264803 7.12 0.0033 Downstream LOC645166 no 200kb 
chr10 42070441 42071049 -4.16 0.0318 Downstream LOC441666 no 200kb 
chr10 41903968 41904399 4.53 0.0413 Downstream LOC441666 no 200kb 
chr10 41896173 41896560 4.7 0.0467 Downstream LOC441666 no 200kb 
chr10 41879280 41879654 3.58 0.0492 Downstream LOC441666 no 200kb 
chr16 34582695 34583823 8.82 9.56E-10 Upstream LINC00273 no 200kb 
chr16 34594857 34595785 6.89 0.00125 Upstream LINC00273 no 200kb 
chr16 34586491 34587021 4.59 0.00222 Upstream LINC00273 no 200kb 
chr16 34571640 34572115 6.24 0.00278 Upstream LINC00273 no 200kb 
chr16 34592580 34593661 6.38 0.014 Upstream LINC00273 no 200kb 
chr16 34573906 34574451 6.05 0.0222 Upstream LINC00273 no 200kb 
chr16 34582134 34582473 5.79 0.0313 Upstream LINC00273 no 200kb 
chr16 46380706 46381059 5.62 0.0396 Upstream LINC00273 no 200kb 
chr2 89836279 89836822 6.95 0.000408 Upstream NR_136329 no 200kb 
chrY 56734619 56734919 5.93 0.00387 Upstream SPRY3 no 250kb 
chr10 41883097 41884055 4.75 0.00275 Downstream LOC441666 no 300kb 
chr4 49091787 49092425 6.43 0.00126 Downstream CWH43 no 30kb 
chr4 49110648 49110846 3.58 0.0493 Downstream CWH43 no 30kb 
chr22 12693437 12694023 6.01 0.00325 Downstream NR_110761 no 600kb 
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chr20 31185032 31187393 4.19 0.0225 Upstream DEFB115 no 70kb 
chr20 47894718 47895496 5.37 0.0484 Upstream LINC01522 no 80kb 
chr1_KI270709v1_r
andom 6596 7783 5.42 0.048       
chr14_GL000225v1
_random 131547 131970 7.16 0.000532       
chr14_GL000225v1
_random 6675 6980 6.86 0.000542       
chr14_GL000225v1
_random 81845 82339 6.17 0.0023       
chr14_GL000225v1
_random 125653 126052 5.81 0.0103       
chr14_GL000225v1
_random 25423 25829 5.46 0.0188       
chr14_GL000225v1
_random 45947 46206 5.28 0.0279       
chr14_GL000225v1
_random 90884 91265 5.01 0.0313       
chr14_GL000225v1
_random 40435 41042 4.93 0.0396       
chr14_GL000225v1
_random 85565 86015 3.33 0.0413       
chr14_GL000225v1
_random 17007 17269 4.86 0.0413       
chr14_KI270723v1
_random 35218 35437 5.03 0.0313       
chr15 17080543 17081024 5.45 0.014       
chr17_KI270729v1
_random 2325 3648 4.07 1.30E-05       
chr17_KI270729v1
_random 21051 21569 5.49 0.0162       
chr22_KI270733v1
_random 165118 165364 5.22 0.0222       
chr22_KI270736v1
_random 179479 181786 4.07 0.00126       
chrUn_GL000214v
1 125307 125518 4.68 0.0476       
chrUn_GL000216v
2 149357 149842 6.63 0.00125       
chrUn_GL000216v
2 160613 161004 6.52 0.00126       
chrUn_GL000216v
2 158635 159714 4.27 0.0275       
chrUn_GL000220v
1 144801 145571 -5.53 0.0132       
chrUn_GL000224v
1 3509 4577 6.88 2.78E-05       
chrUn_GL000224v
1 944 1901 6.1 0.00278       
chrUn_KI270438v1 103888 105259 4.21 1.65E-12       
chrUn_KI270438v1 111252 112440 2.25 0.000511       
chrUn_KI270438v1 109174 110591 2.04 0.0267       
chrUn_KI270465v1 802 1397 4.75 0.048       
chrUn_KI270519v1 137592 138002 4.13 0.0497       
chrUn_KI270589v1 41729 42716 5.27 0.0218       
chrUn_KI270744v1 119664 121040 7.05 0.0029       
chrUn_KI270744v1 109241 109721 4.45 0.0417       
chrUn_KI270751v1 149528 150682 5.87 0.0192       
chrUn_KI270754v1 18129 18342 5.68 0.00974       
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5.8 H3K4me3: 
 This identified over 19 000 peaks in each sample. However, the diffbind 
analysis did not discern any significantly differentially enriched regions directly relating 
to nearby protein coding regions (Appendix table 5.4). 
 
5.9 Integration of ChIP-Seq and RNA-Seq data: 
 In order to further investigate the relationship between histone PTMs and host 
transcriptional response, the results of the ChIP-Seq were used to assess the coding 
regions for the significantly differentially expressed transcripts identified in Table 5.1. 
 
Table 5.5: Analysis of histone motif surrounding differentially expressed 
genes. 
Gene name H3K27ac H3K4me3 H3K4me1 H3K27me3 H3K9me2 
actin gamma 1 pseudogene 20 TSS TSS       
C-C motif chemokine ligand 3 like 1 variant 1 
    
30kb 
down-
stream     
C-C motif chemokine ligand 3 like 1, variant 2 
TSS TSS       
C-C motif chemokine ligand 4 like 1 variant 
CCL4Ldelta2           
C-X-C motif chemokine ligand 10 
         
early growth response 3, transcript variant 2   TSS   Spn only   
growth arrest and DNA damage inducible beta TSS TSS       
Nuclear growth arrest and DNA damage  
inducible beta (GADD45B), transcript variant 
X1 TSS TSS       
Interferon gamma           
MIR155 host gene TSS TSS       
nuclear receptor subfamily 4 group A member 
1, TSS TSS       
nuclear receptor subfamily 4 group A member 2 TSS TSS   Spn only   
Pentraxin 3   TSS       
U2 small nuclear 1 TSS TSS       
U6 small nuclear            
Tumour necrosis factor           
Coagulation factor III, tissue factor (F3)  TSS TSS       
 
 Having found 17 genes whose expression was found to be significantly 
differentially expressed and were all up-regulated, I examined these genomic locations 
in the ChIP-Seq data sets (Table 5.5). This revealed that for the most part (8 out of 17) 
the transcription start sties (TSS) were predominantly associated with H3K27ac. 
Furthermore, H3K4me3 was found in the TSS of 11 out of the 17 genes. As both of 
these marks are associated with active gene transcription and that these genes were up-
regulated this was to be expected. Unfortunately, there was no discernible difference 
between the mock infected samples and those challenged with S. pneumoniae (as 
illustrated in Figure 5.13). In the case of EGR3 and NR4A2 there was also association 
of the genomic locations with H3K27me3. As this mark is predominantly associated 
with gene repression this may represent a negative feedback mechanism. 
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Figure 5.13: IGV view of the NR4A2 gene and the ChIP-Seq profiles for 
H3K27ac and H3K4me3 and H3K27me3. 
This figure illustrates the peaks identified following the ChIP-Seq for H3K27ac, H3K27me3 and 
H3K4me3 around the NR4A2 gene. The majority of the peaks are identified within 1kb of the start of the 
coding sequence for this gene. 
 
5.10 Conclusions: 
 The aim of this chapter was to characterise the changes occurring in MDMs 
following challenge with S. pneumoniae at an epigenomic (histone PTMs) and 
transcriptomic level and attempt to integrate the two data sets by using ChIP-Seq in 
order to infer a functional role for the changes observed. This chapter has further 
highlighted the ability of MS to assess global changes in histone PTMs. Three hours 
following the challenge of MDMs with S. pneumoniae there were a number of changes 
in the relative abundance of histone PTMs. These changes were similar to those seen 
following infective challenge in MDMs with S. pneumoniae or PLY (in Chapter 4), 
namely the increase in the relative abundance of H3K4me1, H3K23ac, H3K27me3 and 
H4K20me1, and a decrease in H3K9me2, H3K27me2 and H4K20me2. As a number of 
these marks have been associated with the regulation of gene transcription, it is likely 
that they play a critical role in the host’s response to infection. 
The RNA-Seq analysis showed that at this very early time point there are 47 
transcripts whose expression is significantly modified. Importantly, these include 
several genes involved in the innate immune response including TNF, INF-, CCL3L1, 
CCL4L1, CXCL10, and so on. This indicates that the although there are very few 
transcripts whose expression is significantly modified after challenge with S. 
pneumoniae, the vast majority of those that are, are involved in the immune response. 
Furthermore, I demonstrated significant changes in a number of histone PTMs at the 
global level after challenge with S. pneumoniae. These epigenetic modifications may 
potentially play a role in the regulation of the transcriptional response. 
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Finally, the ChIP-Seq experiments identified several thousand peaks in the majority 
of the pull downs across the genome. The data was overall good quality and it 
highlighted a number of different genomic regions that were differentially enriched 
following challenge with S. pneumoniae. This confirms that changes not only occur at a 
global level, as seen by MS, but also impact at the level of individual genes. 
Interestingly, the H3K27ac pull downs identified an increase in the abundance of 
H3K27ac upstream of the RIPK2. As this has been associated with the innate immune 
response this maybe illustrative of epigenetic control of the innate immune response. 
Unfortunately, the transcript for RIPK2 was not identified in the paired RNA-Seq, 
limiting the potential to draw any further conclusions. 
One of the limitations of this study has been the low number of differentially 
enriched genomic locations in the ChIP-Seq with the H3K9me2 broad mark. This may 
be due to technical limitations, as it has been demonstrated that detecting global 
decreases in marks can be difficult without the use of spike-in standards to normalise 
against (Orlando et al., 2014). Unfortunately, despite identifying a number of interesting 
genes related to immune responses, they were not associated with differentially bound 
histone PTMs in the ChIP-Seq analysis. Finally, it is possible that the early time point 
has restricted both the number of differentially expressed transcripts and the 
differentially enriched genomic locations following the ChIP-Seq and repeating the 
bacterial challenge with a longer duration may prove more fruitful. 
Chapter 6: Conclusions and future work 
 
6.1 Conclusions: 
S. pneumoniae is the principle cause of community acquired pneumonia and as 
such poses a significant public health burden (Ladhani et al., 2013). There are up to six 
thousand cases of invasive pneumococcal disease (IPD) in the UK per year 
(“GOV.UK,”2018.).As colonisation of the nasopharynx has been shown to precede 
invasive pneumococcal disease, it is therefore the interaction between the host’s innate 
immune system and the pathogen that will dictate whether IPD occurs. Once bacteria 
translocate to the lower airway one of the key components of the innate immune 
response is the alveolar macrophage, while once bacteria spread to the blood splenic 
macrophages are critical for clearance and therefore it is this interaction between the 
macrophage and S. pneumoniae that I chose to study (Dockrell, 2012). Histone PTMs 
have been shown to be modulated by pathogens to hijack the host’s epigenetic 
machinery to its own advantage. Thus, in this thesis I set out to study the changes in 
global histone PTM profiles following challenge with S. pneumoniae 
Previous studies have suggested that many histone PTM changes occur very 
rapidly upon exposure to other bacteria (Hamon et al., 2007). Therefore, I sought the 
earliest time point at which host response was modulated in an attempt to characterise 
the first changes seen. Following, analysis of cytokine release I established that in my 
model TNF and IL-6 were released and were detectable following a 3 hour challenge 
with S. pneumoniae. Although, analysis of this time point allowed the identification of 
several histone PTM changes, the transcriptomic and ChIP-Seq analysis may have been 
limited by the dynamic range of these early changes. 
Initial work focused on the optimisation of mass spectrometry based methods 
for identification and quantification of histone PTMs. Reductions in the amount of MS 
and data analysis time was achieved by adapting data independent methods. Using the 
optimised data independent acquisition methods, I was able to identify and quantify 83 
histone proteoforms across histones H3 and H4, and demonstrate significant changes in 
the abundance of 10 different histone PTMs between MDMs mock infected and those 
challenged with S. pneumoniae. I focussed on lysine methylation and acetylation on 
histones H3 and H4 as these are the most abundant modifications and have been 
implicated in the pathogenesis of many disease processes, including infection. Indeed, 
several pathogens have been found to hijack the host’s epigenome to promote its 
survival. One of the limitations of this approach is that it was restricted to acetylation 
and methylation modifications and did not examine other post-translational. However, 
as the data was acquired in a data independent manner it is possible to re-analyse the 
current data, targeting alternative histone PTMs if required. 
Many studies in vivo have demonstrated the importance of pneumolysin as a 
virulence factor (Benton et al., 1995). Initially, in Chapter 4, I focussed on the study of 
pneumolysin, a key virulence factor for S. pneumoniae (Kadioglu et al., 2008b). First, I 
aimed to establish the importance of pneumolysin on the host’s response by studying 
transcriptomic changes by microarray. Further studies were subsequently aimed at 
identifying potential proteins that play a critical role in the host’s response to 
pneumolysin. High throughput label-free quantitative proteomics in conjunction with 
microarray analysis was performed to identify differentially expressed proteins and 
genes following infection with S. pneumoniae or a pneumolysin deficient mutant. 
Finally, I established the changes in abundance of histone PTMs in a pneumolysin 
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dependent manner. To conclude I attempted to integrate these findings to demonstrate 
that there are specific changes in the host’s cell response to infection in a pneumolysin 
dependent manner. 
The transcriptomic analysis revealed 503 pneumolysin dependent differentially 
expressed probes. Further pathway analysis demonstrated that several of these were 
involved in inflammatory responses. In particular, oxidative stress responses were 
highlighted as being up regulated during infection.  
Quantitative proteomic analysis identified differentially expressed proteins at 3 
and 6 hours in a pneumolysin dependent manner following challenge with S. 
pneumoniae. Of note, one of these differentially abundant proteins includes oxidative 
stress response protein 1, suggesting that stress responses play a key role in the host 
pathogen interaction at both the transcriptome and proteome level. 
The study of pneumolysin dependent changes in relative abundance of histone 
PTMs revealed 5 statistically significant histone PTMs changes on histone H3. This 
suggests that the host’s response to challenge with S. pneumoniae includes modification 
of global abundance of histone PTMs, and extends on this by linking the changes to a 
specific virulence factor, supporting the hypothesis that pneumolysin may be 
responsible for alterations in gene transcription by modulating the epigenome. 
However, despite establishing pneumolysin specific changes in abundance of histone 
PTMs, the exact role for these remains unclear. Further work using alternative 
approaches including ChIP-Seq would potentially provide further insight proved too 
costly to undertake for both the mutant and the parent strain for all of the modifications. 
Moreover, a number interesting changes occurred in combinatorial modifications such 
as H3K27me2K36me2, highlighting the advantages of MS over antibody based 
approaches to study histone PTMs; it will prove challenging to illicit the role for these 
combinatorial marks by ChIP-Seq as this is likely to require sequential pull downs and 
therefore require large amounts of starting chromatin to perform ChIP-ChIP-Seq. 
To provide further insight into the effects of S. pneumoniae on the epigenome an 
integrated multi-omic approach was used. Initial work focussed on analysing changes in 
global histone PTMs using mass spectrometry. The results identified a number of 
histone PTMs that are altered in abundance following the challenge of MDMs with S. 
pneumoniae. These include increases in H3K4me1, H3K23ac, H3K27me3 and 
H4K20me1, and a decrease in H3K9me2, H3K27me2 and H4K20me2, similar to the 
effects seen with pneumolysin. Consistent with previous observations in response to 
other pathogens (Hamon et al., 2007; Rolando and Buchrieser, 2014), these results 
demonstrate alterations at the epigenetic level following infection with S. pneumonia, 
highlighting potential important novel histone PTMs associated with this host-pathogen 
interaction.  
Next, I sought to ascertain the role played by the changes seen in histone PTMs 
abundance following challenge with S. pneumonia. In order to achieve this, I used 
RNA-Seq to establish the transcriptomic changes occurring in response to infection. 
The RNA-Seq analysis identified several genes involved in the inflammatory response 
namely, TNF, INF-, CCL3L1, CCL4L1, CXCL10 that are differentially expressed and 
all of which were up-regulated, at this early time point, 3 hours following challenge 
with S. pneumoniae. Reassuringly, a number of these differentially expressed transcripts 
were also identified in the microarray analysis in Chapter 4 including TNF and NR4A2. 
These results are  consistent with previous studies that have highlighted the role of TNF 
in the host response to S. pneumoniae infections (Jeong et al., 2015; Kirby et al., 2005).  
Having demonstrated that upon challenge with S. pneumoniae alterations at both 
the epigenetic and gene level were observed, further analysis was performed using 
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ChIP-Seq in an effort to link alterations observed at the epigenetic level (histone PTMs) 
with perturbations observed at the transcriptional level. The analysis of the H3K9me2 
ChIP-Seq, a mark associated with gene repression and that of the H3K4me3 ChIP-Seq, 
a mark associated with active gene transcription when located in the promoter regions 
did not demonstrate any differentially enriched locations. For the other marks examined, 
H3K4me1, H3K27me3 and H3K27ac, the ChIP-Seq analysis revealed a number of 
differentially enriched regions suggesting that these are indeed modulated during the 
host pathogen interaction. 
H3K27ac has been associated with active gene transcription when located in the 
transcription start site. H3K4me1 has been associated with active or poised enhancer 
and promoter regions of genes and is associated with active gene transcription. The 
initial analysis revealed that H3K27ac was found in close proximity to transcription 
start sites. There were 5 differentially enriched genomic locations following pull down 
with H3K27ac, two of which involved the gene body of STAB1 and RIPK2. Both of 
which have been shown to play a role in the inflammatory response. The analysis of the 
H3K4me1 ChIP-Seq demonstrated 70 differentially enriched genomic locations. This 
included the MUC3A gene which has been associated with anti-inflammatory properties 
in macrophages. The analysis of H3K27me3, a mark associated with gene repression, 
revealed 18 differentially enriched genomic locations. This included the coding region 
for SLIT2 which has been associated with inflammatory processes. 
This confirms that changes not only occur at a global level, as seen by MS, but 
also impact at the level of individual genes. Interestingly, the H3K27ac pull downs 
identified an increase in the abundance of H3K27ac upstream of the RIPK2. As this has 
been associated with the innate immune response this potentially important finding is 
illustrative of epigenetic control of the innate immune response. Unfortunately, the 
transcript for RIPK2 was not identified in the paired RNA-seq.  
One possible explanation for the paucity of findings following ChIP-Seq is that 
the global effect demonstrated by MS is not distinguishable by this method due to the 
relative small changes in abundance occurring across large sections of the genome. 
Newer, approaches relying on spike-in methods to normalise the signal from each ChIP 
may be more sensitive to these global changes and represent a useful approach. Indeed, 
the ability to distinguish changes in the relative abundance of histone PTMs for broad 
marks has been demonstrated using Drosophilia chromatin spike in (Orlando et al., 
2014). Furthermore, the early time point studied (3 hours after exposure to bacteria) 
may also be contributing to the limited number of statistically significant findings. 
 
6.2 Future work: 
 In order to further characterise the role played by pneumolysin in the 
pathogenesis of pneumococcal infections a number of different approaches could be 
used. It would be of interest to use exogenous pneumolysin to establish if the same 
changes in histone PTMs occur as are seen following infection with S. pneumoniae. 
Furthermore, different pneumolysin mutants exist that either lack pore forming ability 
or have different degrees of haemolytic activity. These mutants have been implicated in 
the pathogenesis of pneumococcal diseases and therefore could be used to establish 
which aspect of pneumolysin’s function is essential for the formation of these histone 
PTMs. Moreover, having established that S. pneumoniae causes changes in histone post 
translational modifications, future work could be aimed at studying the different 
serotypes of S. pneumoniae. These studies would provide important insight and 
determine if changes in histone PTMs are specific to capsular serotype, or just governed 
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by the activity of pneumolysin, or related to other widely expressed virulence factors 
with more variable expression such as pili (Kadioglu et al., 2008b; Mitchell and 
Mitchell, 2010). In order to further establish the role of the pneumolysin dependent 
changes in the abundance of histone PTMs, further work should be performed using 
ChIP-qPCR to establish the changes in histone PTMs in the promoter regions of key 
genes involved in the response to infection (such as TNF). 
 The work presented in this thesis has been focused on the use of monocyte 
derived macrophages as a model for tissue resident macrophages. However, it is well 
established that alveolar macrophages arise from two distinct mechanisms. Firstly 
embryonic derived from a foetal liver linage and secondly from circulating peripheral 
monocytes (Gordon and Taylor, 2005). In order to further validate the importance of the 
role played by modulation of histone PTMs in the host’s response to infection, future 
work could include a murine challenge. Such studies could examine the global changes 
in histone PTMs from alveolar macrophages following intra-nasal challenge. This 
model mimics pneumonia more closely than in vitro models and therefore is a closer 
representation of the clinical pathology. It will allow the confirmation that the 
epigenetic changes are indeed observed in tissue resident macrophages as well as other 
distal sites such as bone marrow or spleen. Moreover, it has been suggested that 
epigenetic changes are potentially inheritable and therefore future work proposed would 
also include breeding these mice to examine subsequent generations’ histone PTM 
profile and carry out a phenotypic characterisation of the animals to look for 
susceptibility or resistance to pneumococcal challenge in the offspring. Furthermore, if 
the changes in the relative abundance of histone PTMs is also observed in the murine 
alveolar macrophages it would be important to establish a functional consequence of 
these changes by measuring cytokine responses, bacterial clearance and attempt to 
modify these modifications by using epigenetic modulators such as HDACi. 
 Initial work performed in Chapters 4 and 5 isolated all the MDMs following S. 
pneumoniae infection. However, a caveat associated with this approach is that only a 
subset of MDMs will have ingested the S. pneumoniae. This could have hampered the 
ability to identify differentially expressed genes and proteins and downstream ChIP 
analysis. Therefore, to overcome this caveat, it is proposed that future work could focus 
on using a fluorescent tagged bacteria and cell sorting the MDMs following challenge 
would guarantee that the cell had ingested at least one pathogen. This may reveal a 
greater number of differentially expressed proteins, transcripts and histone PTMs as the 
“noise” from the uninfected cells would be abrogated. However, the number of cells 
required would prove challenging to perform in primary monocyte derived 
macrophages and it may require a cell line such as THP-1 cells to obtain the necessary 
cells following infection. 
 Although changes in histones PTMs have been shown to occur very rapidly after 
bacterial challenge (Hamon et al., 2007), and I was able to demonstrate changes in the 
relative abundance of histone PTMs in MDMs and cytokine release following bacterial 
challenge at 3 hours, it is possible by studying a later time point that more pronounced 
changes might be apparent at the transcriptional and proteomic level, and possibly lead 
to better identification of differentially enriched regions by ChIP-Seq. 
 As alluded to in Chapter 1, histone PTMs are one of several different epigenetic 
mechanisms. It would therefore be interesting to ascertain the level of changes 
occurring in the DNA methylome, microRNA and histone PTMs and try to establish 
any of the interactions between the three as of these DNA methylation may represent a 
mechanism for the maintenance of longer term epigenetic “memory” as seen in trained 
immunity. 
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 Although there is conclusive evidence that the relative abundance of histone 
PTMs is modified during the bacterial challenge it remains unclear whether this is a 
pathogen specific phenomenon or a generic host response to stress. It would therefore 
be of value to repeat the profiling of histone PTMs looking at the interaction with other 
pathogens such as using Staphylococcus aureus another important Gram positive 
pathogen, Gram negative bacteria and stress induced responses to other microbial 
components such as LPS, lipopeptides and peptidoglycan challenge. 
Finally, in an attempt to further establish a role for these different histone PTMs 
one approach further work should focus on, is targeting the enzymes responsible for the 
histone PTMs that were perturbed during the challenge with S. pneumoniae. Two 
possible methods would be either the use of epigenetic inhibitors targeting key enzymes 
such as the G9a/GLP methyltransferase responsible for the methylation of H3K9me2, 
using BIX01294. Alternatively inhibiting the demethylases responsible for the decrease 
in H3K9me2 by using daminozide (a selective inhibitor of lysine demethylase 2/7), 
IOX-1 (histone demethylase JMJD inhibitor) or GSK Lysine Specific demethylase 1 
(LSD1) inhibitor. Similar approaches could be used for the other histone PTMs. The 
methyltransferases responsible for H3K4me1 are Set9, MLL3 and MLL4. However, 
specific methyltransferase inhibitors for these enzymes are not very well developed, 
demethylation of H3K4me1 is mediated by LSD1 and can be inhibited by GSK LSD1 
inhibitor. H3K23ac could be modulated by HDAC inhibitors however, one of the 
principle drawbacks of inhibitor based approaches is that they rarely are very specific 
and will therefore have a number of different off-target effects. An alternative method 
would be to use a CRISPR-Cas9 approach to either inhibit the enzymes responsible for 
the methylation / acetylation by cleaving the genes encoding them prior to infection, or 
using a CRISPR-Cas9 null construct coupled to an acetyltransferase (Hilton et al., 2015) 
or a methyltransferase (Xiong et al., 2017) to specifically acetylate the neighbouring 
histones or methylate the neighbouring DNA of a target gene and subsequently measure 
the response to infection. 
 
6.3 Concluding remarks: 
 In conclusion, this thesis describes the development and optimisation of a mass 
spectrometry based method for the study of histone PTMs. The mass spectrometry 
approach is a powerful approach for the identification and quantification of histone 
PTMs, demonstrating a number of advantages over antibody based approaches. I 
utilised the developed methods to analyse epigenetic changes in monocyte derived 
macrophages in response to challenge with S. pneumoniae. In addition, high throughput 
transcriptomic and proteomic methods were also used to study changes in 
transcriptional response and protein expression at an early time to challenge with S. 
pneumoniae. The results identified a number of histone PTMs were indeed modulated 
as part of the response to pneumococcal challenge, supporting the hypothesis that 
epigenetics (histone PTMs) play a role in the regulation of the innate immune response. 
Furthermore, the transcriptomic and ChIP-Seq analyses both showed a number of innate 
immune response genes to be differentially enriched following infection confirming that 
the epigenome is modified in response to infective challenge with S. pneumoniae and is 
associated with alterations in the host’s transcriptome and proteome. Together, these 
results, demonstrate the role of epigenetic regulation of gene expression associated with 
the innate immune response upon challenge with S. pneumoniae.
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Chapter 8: Appendices 
Appendix table 1.1: Data independent isolation list. 
 
Appendix table 2.1: Contaminants removed prior to analysis. 
Contaminant Sequence 
solexa-forward AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT 
truseq-forward-contam AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC 
truseq-reverse-contam AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA 
nextera-forward-read-contam CTGTCTCTTATACACATCTCCGAGCCCACGAGAC 
multiplexing-forward  GATCGGAAGAGCACACGTCT 
nextera-reverse-read-contam CTGTCTCTTATACACATCTGACGCTGCCGACGA 
solexa-reverse AGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 
 
DIA60/30 isolation list
310.390973 292 580 730
330.400068 359 585 735
350.409163 378 590 740
370.418258 397 595 745
390.427353 416 600 750
410.436448 432.5 605 755
430.445543 446.5 610 760
450.454638 458 615 765
470.463733 465 620 770
490.472828 470 625 775
510.481923 475 630 780
530.491018 480 635 785
550.500113 485 640 790
570.509208 490 645 795
590.518303 495 650 800
610.527398 500 655 805
630.536493 505 660 812
650.545588 510 665 823.5
670.554683 515 670 840
690.563778 522.5 675 859
710.572873 530 680 880.5
730.581968 535 685 904.5
750.591063 540 690 928.5
770.600158 545 695 965
790.609253 550 700 1014.5
810.618348 555 705
830.627443 560 710
850.636538 565 715
870.645633 570 720
890.654728 575 725
DIAvw isolation list
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Appendix figure 4.1.1: Microarray quality control: RNA degradation plot. 
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Appendix figure 4.1.2: Microarray quality control: Relative log expression 
(RLE). 
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Appendix figure 4.1.3: Microarray quality control: Cluster dendrogram 
before and after normalisation. 
 
Appendix table 4.1: Probes excluded from downstream analysis. 
Probe ID pt2...pt1 pt3...pt1 pt2...pt3 AveExpr P.Value adj.P.Val 
215492_x_at 1.03 0.00 1.03 3.52 1.6E-07 0.004 
220558_x_at 1.53 0.14 1.39 4.41 2.3E-07 0.004 
209728_at -3.71 0.12 -3.83 11.25 7.6E-07 0.010 
205001_s_at -5.10 0.63 -5.73 6.67 1.8E-06 0.017 
221291_at 2.57 -0.07 2.65 3.44 2.5E-06 0.020 
230846_at 2.70 0.63 2.06 5.68 3.9E-06 0.026 
219759_at 6.31 0.45 5.86 7.09 5.6E-06 0.032 
201909_at -7.77 0.22 -7.99 8.94 6.4E-06 0.032 
223062_s_at 4.21 0.80 3.42 7.95 8.0E-06 0.033 
1558199_at 3.64 -0.31 3.94 4.90 8.4E-06 0.033 
201069_at -4.77 0.36 -5.13 7.01 1.0E-05 0.034 
239824_s_at 0.70 -0.59 1.29 8.52 1.1E-05 0.034 
212532_s_at -0.81 -0.15 -0.67 7.95 1.2E-05 0.034 
201196_s_at -0.94 0.39 -1.33 9.09 1.2E-05 0.034 
230360_at 5.94 0.01 5.93 4.45 1.3E-05 0.034 
227462_at 5.03 0.47 4.56 8.48 1.7E-05 0.040 
203475_at 7.15 0.35 6.80 6.54 1.8E-05 0.040 
223423_at -3.29 -0.39 -2.90 6.70 1.9E-05 0.040 
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229862_x_at 0.41 -0.01 0.42 5.38 2.2E-05 0.040 
204916_at 2.63 0.01 2.62 6.78 2.4E-05 0.040 
226836_at 0.78 -0.12 0.90 3.91 2.5E-05 0.040 
1553551_s_at 0.91 -0.04 0.95 13.56 2.6E-05 0.040 
228160_at -2.73 -0.33 -2.39 5.60 2.6E-05 0.040 
223640_at 1.52 -0.33 1.85 11.31 2.9E-05 0.040 
209147_s_at 1.50 -0.11 1.61 5.87 2.9E-05 0.040 
202777_at -0.65 -0.12 -0.53 9.98 3.0E-05 0.040 
204531_s_at 1.31 0.03 1.28 5.48 3.0E-05 0.040 
214701_s_at 1.67 -0.02 1.70 3.04 3.0E-05 0.040 
212062_at 3.23 -0.24 3.47 5.83 3.0E-05 0.040 
203433_at 1.12 -0.16 1.28 7.83 3.0E-05 0.040 
204443_at -3.05 -0.18 -2.87 4.65 3.3E-05 0.042 
215333_x_at 0.78 0.00 0.78 2.48 3.4E-05 0.042 
228353_x_at 2.19 0.68 1.50 6.70 3.6E-05 0.042 
38487_at -6.00 -1.10 -4.90 8.35 4.2E-05 0.049 
 
Appendix table 4.2: Differentially expressed probes. 
Pneumolysin dependent (503) Common (506) Pneumolysin independent (234) 
226331_at 218502_s_at 236140_at 216248_s_at 205476_at 
222756_s_at 227354_at 1552553_a_at 243366_s_at 232797_at 
222805_at 206723_s_at 228188_at 204622_x_at 204470_at 
233255_s_at 229383_at 222173_s_at 1552315_at 237252_at 
221861_at 1554539_a_at 234979_at 204621_s_at 207850_at 
219349_s_at 235306_at 209340_at 225827_at 209098_s_at 
214228_x_at 227533_at 223446_s_at 220005_at 1553449_at 
212234_at 244519_at 207840_at 244804_at 240231_at 
204552_at 219574_at 235094_at 242329_at 239876_at 
227446_s_at 211676_s_at 218617_at 209959_at 223218_s_at 
211715_s_at 223620_at 212747_at 203665_at 228258_at 
226016_at 222146_s_at 202266_at 219210_s_at 221756_at 
201447_at 244008_at 219166_at 212086_x_at 204103_at 
222201_s_at 219581_at 220731_s_at 202284_s_at 204182_s_at 
224978_s_at 204669_s_at 207038_at 228825_at 219540_at 
206278_at 207978_s_at 202643_s_at 209684_at 226893_at 
203253_s_at 202727_s_at 204440_at 203297_s_at 212724_at 
32723_at 1557432_at 213524_s_at 209446_s_at 205114_s_at 
218862_at 223470_at 225539_at 1556385_at 227140_at 
242062_at 236802_at 214059_at 203810_at 210511_s_at 
224185_at 220987_s_at 201464_x_at 244341_at 210118_s_at 
212704_at 37170_at 1554334_a_at 228846_at 228496_s_at 
225632_s_at 230252_at 201881_s_at 217996_at 213327_s_at 
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AFFX-M27830_M_at 203765_at 205599_at 232744_x_at 230526_at 
227678_at 226479_at 203473_at 219239_s_at 203887_s_at 
242943_at 228075_x_at 203241_at 243179_at 243463_s_at 
228189_at 239901_at 202114_at 231199_at 39402_at 
226080_at 228702_at 201845_s_at 226650_at 223217_s_at 
219885_at 204861_s_at 1556744_a_at 1555847_a_at 243338_at 
208875_s_at 213056_at 226507_at 226041_at 208811_s_at 
236381_s_at 236782_at 203785_s_at 203811_s_at 243664_at 
227112_at 203554_x_at 230380_at 236583_at 213353_at 
203690_at 226529_at 203246_s_at 229367_s_at 240108_at 
225154_at 203980_at 208760_at 219243_at 211538_s_at 
222716_s_at 227062_at 217998_at 221213_s_at 226906_s_at 
224788_at 228922_at 202014_at 236404_at 203888_at 
213189_at 204015_s_at 219016_at 223394_at 227200_at 
225022_at 242125_at 241472_at 38290_at 226574_at 
223741_s_at 206074_s_at 202644_s_at 205193_at 209774_x_at 
225455_at 201964_at 1565544_at 225171_at 215743_at 
209705_at 210785_s_at 223013_at 232431_at 205067_at 
232436_at 204526_s_at 218472_s_at 230298_at 201369_s_at 
223493_at 207826_s_at 226541_at 203879_at 214056_at 
228594_at 242919_at 203344_s_at 1555860_x_at 219165_at 
226068_at 225767_at 224699_s_at 205990_s_at 223289_s_at 
228968_at 36920_at 243046_at 228964_at 226534_at 
235529_x_at 235385_at 224864_at 201844_s_at 221757_at 
228670_at 223961_s_at 219911_s_at 226423_at 208296_x_at 
226030_at 228220_at 226219_at 210786_s_at 226630_at 
229983_at 202983_at 227182_at 238738_at 212365_at 
239804_at 219317_at 202329_at 203298_s_at 206173_x_at 
222586_s_at 224622_at 229899_s_at 201846_s_at 235407_at 
229333_at 219925_at 206332_s_at 1554015_a_at 217371_s_at 
208708_x_at 1560145_at 229574_at 228066_at 219161_s_at 
230332_at 204112_s_at 225567_at 209457_at 229795_at 
1554057_at 205885_s_at 223412_at 1552316_a_at 202085_at 
218218_at 203753_at 204159_at 204236_at 202385_s_at 
222392_x_at 227749_at 232012_at 239331_at 1555841_at 
225497_at 214467_at 202113_s_at 243296_at 221688_s_at 
213271_s_at 244462_at 244840_x_at 208707_at 201782_s_at 
229560_at 229431_at 204181_s_at 235242_at 223553_s_at 
229317_at 230099_at 218696_at 204472_at 210044_s_at 
41329_at 205251_at 1555274_a_at 207630_s_at 215224_at 
202224_at 1552634_a_at 219677_at 208093_s_at 214100_x_at 
213218_at 230329_s_at 228799_at 236401_at 239001_at 
 190 
204014_at 242143_at 232369_at 201266_at 1553987_at 
220631_at 214157_at 213281_at 217999_s_at 207616_s_at 
212798_s_at 226659_at 225040_s_at 209200_at 1568954_s_at 
228284_at 222663_at 227991_x_at 202887_s_at 207533_at 
213352_at 244650_at 225283_at 204180_s_at 232543_x_at 
212665_at 201751_at 220934_s_at 209681_at 229355_at 
222762_x_at 203048_s_at 1556007_s_at 235765_at 226952_at 
224581_s_at 227344_at 205449_at 36711_at 225443_at 
225910_at 235470_at 201448_at 240154_at 203099_s_at 
213016_at 212723_at 201986_at 213700_s_at 213872_at 
223219_s_at 227220_at 41387_r_at 227402_s_at 212902_at 
230178_s_at 208860_s_at 202779_s_at 214061_at 225136_at 
213572_s_at 225290_at 230941_at 1562056_at 224250_s_at 
228190_at 227184_at 208686_s_at 243496_at 226853_at 
222849_s_at 218377_s_at 235423_at 204094_s_at 31845_at 
219861_at 206028_s_at 219966_x_at 226542_at 208648_at 
209004_s_at 229891_x_at 219008_at 205407_at 207438_s_at 
208290_s_at 228588_s_at 226820_at 217997_at 225702_at 
228817_at 227295_at 213425_at 242268_at 205126_at 
225840_at 225954_s_at 55872_at 221044_s_at 209239_at 
218179_s_at 1555910_at 203179_at 232311_at 206026_s_at 
219467_at 234295_at 1553693_s_at 229762_at 226189_at 
225246_at 235071_at 213923_at 228869_at 220346_at 
222369_at 225992_at 227313_at 223980_s_at 227066_at 
204912_at 223178_s_at 219458_s_at 215498_s_at 223485_at 
228041_at 208869_s_at 230748_at 226743_at 219397_at 
229018_at 228324_at 205992_s_at 203128_at 228328_at 
235206_at 241908_at 232330_at 214508_x_at 202460_s_at 
216202_s_at 210962_s_at 226762_at 242403_at 229398_at 
218352_at 203596_s_at 241824_at 230511_at 200733_s_at 
223243_s_at 218842_at 234986_at 215933_s_at 210190_at 
59644_at 226855_at 241769_at 219694_at 228590_at 
228837_at 222443_s_at 202147_s_at 219777_at 202622_s_at 
226031_at 201585_s_at 204178_s_at 213677_s_at 223288_at 
203411_s_at 202530_at 235716_at 231234_at 1552277_a_at 
1569003_at 209995_s_at 225955_at 216834_at 239835_at 
1552733_at 235890_at 205419_at 219315_s_at 244826_at 
211763_s_at 212905_at 244511_at 233952_s_at 222395_s_at 
1555950_a_at 1558511_s_at 209928_s_at 240859_at 221064_s_at 
226644_at 219169_s_at 213134_x_at 227385_at 237444_at 
218323_at 232014_at 208966_x_at 226275_at 202551_s_at 
202281_at 212387_at 202911_at 202859_x_at 202414_at 
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225435_at 218700_s_at 223206_s_at 242853_at 241371_at 
211458_s_at 226157_at 218300_at 219481_at 204512_at 
228772_at 1555920_at 204286_s_at 222450_at 207181_s_at 
212331_at 230091_at 232835_at 223275_at 225267_at 
225824_at 207571_x_at 201878_at 239486_at 206025_s_at 
228392_at 225163_at 218310_at 226180_at 205038_at 
238041_at 229670_at 202334_s_at 222605_at 203743_s_at 
203376_at 208644_at 225755_at 219625_s_at 225061_at 
230836_at 221965_at 201431_s_at 40255_at 227630_at 
235698_at 244397_at 219475_at 203925_at 223144_s_at 
218370_s_at 210719_s_at 225864_at 223028_s_at 214911_s_at 
212557_at 203404_at 212089_at 216061_x_at 232652_x_at 
204928_s_at 226221_at 209782_s_at 227626_at 217813_s_at 
218449_at 213294_at 205220_at 229373_at 205122_at 
228760_at 232134_at 231183_s_at 225120_at 217985_s_at 
204787_at 218432_at 242058_at 222449_at 219386_s_at 
219826_at 213891_s_at 228812_at 225842_at 201146_at 
238013_at 219174_at 227008_at 225432_s_at 206976_s_at 
210028_s_at 206861_s_at 209357_at 209967_s_at 211297_s_at 
229394_s_at 204957_at 232287_at 1554014_at 221058_s_at 
201453_x_at 220183_s_at 235670_at 232052_at 223451_s_at 
228454_at 229123_at 223059_s_at 242558_at 238337_s_at 
224973_at 225001_at 213797_at 244859_at 235338_s_at 
209115_at 213626_at 1554171_at 203482_at 218168_s_at 
212382_at 224793_s_at 239300_at 202988_s_at 221797_at 
212923_s_at 232210_at 225890_at 212799_at 226673_at 
202190_at 227418_at 214486_x_at 228700_at 228280_at 
238963_at 209434_s_at 218880_at 225262_at 229058_at 
211063_s_at 218131_s_at 212470_at 37028_at 236953_s_at 
225843_at 221677_s_at 225921_at 205053_at 225950_at 
235422_at 244312_at 209539_at 221428_s_at 203721_s_at 
209658_at 235159_at 218252_at 232024_at 1568680_s_at 
211786_at 221813_at 242688_at 212757_s_at 203490_at 
244788_at 206126_at 
AFFX-HUMRGE/ 
M10098_ 
M_at 204970_s_at 229870_at 
225528_at 230032_at 241418_at 201925_s_at 1561167_at 
223599_at 213480_at 229742_at 210029_at 222665_at 
209790_s_at 214290_s_at 1559584_a_at 211081_s_at 212991_at 
224492_s_at 225666_at 227255_at 222792_s_at 214368_at 
218431_at 228465_at 204720_s_at 222529_at 212644_s_at 
1566901_at 234989_at 203321_s_at 201195_s_at 224639_at 
221825_at 218927_s_at 223331_s_at 227395_at 223988_x_at 
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228095_at 201449_at 228077_at 225557_at 231897_at 
238812_at 217591_at 50374_at 206118_at 213229_at 
219947_at 213351_s_at 232356_at 223027_at 202693_s_at 
204646_at 226969_at 209099_x_at 207606_s_at 223157_at 
202439_s_at 218259_at 244087_at 209477_at 212018_s_at 
64418_at 223070_at 244415_at 200731_s_at 220935_s_at 
221073_s_at 202970_at 221652_s_at 219412_at 218543_s_at 
224900_at 208883_at 209269_s_at 203428_s_at 203839_s_at 
212659_s_at 229584_at 201368_at 212528_at 228961_at 
216243_s_at 228661_s_at 208706_s_at 217875_s_at 227878_s_at 
213015_at 230141_at 225350_s_at 232231_at 239891_x_at 
225484_at 221806_s_at 211704_s_at 242103_at 33148_at 
209199_s_at 225856_at 227570_at 208078_s_at 226017_at 
201034_at 210541_s_at 217922_at 224739_at 227178_at 
224130_s_at 212911_at 207980_s_at 204521_at 219774_at 
242439_s_at 1553957_at 1559249_at 215203_at 227580_s_at 
203263_s_at 212553_at 227621_at 219500_at 224461_s_at 
227450_at 208785_s_at 223528_s_at 229908_s_at 229632_s_at 
205192_at 229041_s_at 201020_at 1554638_at 1554173_at 
205504_at 236610_at 208912_s_at 242920_at 226089_at 
210826_x_at 235417_at 201489_at 231297_at 239154_at 
242990_at 221877_at 203073_at 215499_at 218859_s_at 
224175_s_at 228963_at 209447_at 201466_s_at 202301_s_at 
223405_at 1555833_a_at 39248_at 222613_at 241393_at 
212388_at 235926_at 216997_x_at 201465_s_at 210776_x_at 
209889_at 213237_at 236685_at 1554132_a_at 212625_at 
226609_at 213045_at 225212_at 224740_at 202386_s_at 
217792_at 222371_at 207540_s_at 231431_s_at 232413_at 
214435_x_at 227157_at 204157_s_at 202459_s_at 219322_s_at 
218315_s_at 230779_at 214755_at 209411_s_at 219340_s_at 
1558345_a_at 203319_s_at 205548_s_at 208392_x_at 220587_s_at 
211563_s_at 213227_at 213625_at 1554149_at 213286_at 
218570_at 227346_at 214684_at 218158_s_at 211105_s_at 
218113_at 211661_x_at 235864_at 204794_at 220326_s_at 
220329_s_at 226093_at 216268_s_at 1552318_at 226727_at 
218938_at 225338_at 201626_at 211506_s_at 221752_at 
202020_s_at 204817_at 204131_s_at 206036_s_at 214441_at 
225749_at 224467_s_at 212748_at 226034_at 224618_at 
227007_at 209761_s_at 203620_s_at 1559060_a_at 1562612_at 
223580_at 236288_at 242625_at 225095_at 204382_at 
226222_at 203420_at 1552846_s_at 212476_at 219684_at 
212407_at 221223_x_at 209567_at 218530_at 201858_s_at 
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229298_at 238558_at 221940_at 204285_s_at 210538_s_at 
212867_at 228630_at 218177_at 229566_at 208021_s_at 
228523_at 202417_at 243579_at 1555858_at 221492_s_at 
212527_at 226434_at 229821_at 225266_at 226874_at 
227897_at 212188_at 226831_at 238880_at 225623_at 
238057_at 205884_at 217886_at 212943_at 201279_s_at 
223335_at 218452_at 213593_s_at 239629_at 228549_at 
227210_at 212192_at 203542_s_at 1560071_a_at 242467_at 
204871_at 226683_at 1555167_s_at 227571_at 218679_s_at 
37577_at 222691_at 243303_at 204689_at 235692_at 
227252_at 227559_at 219378_at 217738_at 203723_at 
218152_at 226339_at 202365_at 214857_at 228385_at 
204146_at 235728_at 201080_at 209771_x_at 219417_s_at 
226867_at 213188_s_at 235005_at 212419_at 232405_at 
224730_at 230100_x_at 222148_s_at 240383_at 224670_at 
224558_s_at 225039_at 210793_s_at 229055_at 209433_s_at 
236375_at 1566557_at 203823_at 209882_at 1555960_at 
213598_at 212374_at 235339_at 226338_at 212429_s_at 
205642_at 212386_at 238624_at 225252_at 219910_at 
218230_at 218000_s_at 226949_at 208328_s_at 214946_x_at 
238004_at 223466_x_at 204752_x_at 214696_at 212041_at 
224643_at 203481_at 1569906_s_at 226875_at 202084_s_at 
221925_s_at 220992_s_at 203358_s_at 212672_at 202664_at 
224500_s_at 209431_s_at 225848_at 203741_s_at 223978_s_at 
241391_at 225558_at 242121_at 208944_at 218076_s_at 
228927_at 209721_s_at 228122_at 209378_s_at 235181_at 
228793_at 211913_s_at 216218_s_at 218491_s_at 215299_x_at 
206303_s_at 228084_at 229695_at 217739_s_at 218244_at 
224682_at 229393_at 205811_at 207655_s_at 206769_at 
228217_s_at 228544_s_at 219147_s_at 204683_at 220097_s_at 
213396_s_at 222130_s_at 1554251_at 202776_at 201563_at 
203348_s_at 203508_at 220035_at 210027_s_at 237104_at 
AFFX-M27830_5_at 212693_at 201753_s_at 207559_s_at 1554768_a_at 
223590_at 213064_at 218592_s_at 223797_at 1552618_at 
212740_at 225860_at 222989_s_at 224692_at 1569139_s_at 
211115_x_at 225918_at 1556064_at 210428_s_at 218833_at 
235739_at 39891_at 232148_at 218178_s_at 201349_at 
221666_s_at 218280_x_at 1554980_a_at 219734_at 204151_x_at 
211316_x_at 222538_s_at 207113_s_at 219582_at 201528_at 
228595_at 201280_s_at 212441_at 207667_s_at 213554_s_at 
242725_at 204226_at 231907_at 240013_at 225751_at 
230261_at 209704_at 238273_at 219448_at 224217_s_at 
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203089_s_at 227726_at 204032_at 226652_at 219131_at 
218396_at 219487_at 232406_at 213309_at 221081_s_at 
201384_s_at 229362_at 209694_at 236554_x_at  
218957_s_at 225769_at 222406_s_at 232504_at  
243993_at 227224_at 207030_s_at 223145_s_at  
218400_at 204788_s_at 212663_at 204923_at  
225076_s_at 222811_at 213670_x_at 223711_s_at  
222203_s_at 218827_s_at 218130_at 203846_at  
233656_s_at 205842_s_at 208998_at 242734_x_at  
243037_at 219081_at 240499_at 222955_s_at  
225313_at 203525_s_at 209770_at 36030_at  
219130_at 218797_s_at 1569362_at 223445_at  
203086_at 218870_at 203553_s_at 200815_s_at  
235464_at 211922_s_at 231548_at 218304_s_at  
212510_at 225762_x_at 204748_at 220560_at  
203351_s_at 219045_at 203640_at 204336_s_at  
224060_s_at 208925_at 226254_s_at 235222_x_at  
223320_s_at 210113_s_at 228940_at 203302_at  
209085_x_at 202951_at 225645_at 205771_s_at  
 
Appendix table 4.0: KEGG pathway enrichment analysis: 
  MI vs S 
pneumoniae 
  MI vs PLY 
Pathway p.val FDR 
q.val 
Pathway p.val FDR 
q.val 
hsa04668 TNF signaling pathway 3.0E-08 6.5E-06 hsa04668 TNF signaling 
pathway 
3.2E-12 5.9E-10 
hsa05202 Transcriptional 
misregulation in cancer 
3.0E-07 6.5E-05 hsa05202 Transcriptional 
misregulation in cancer 
5.5E-09 1.0E-06 
hsa04210 Apoptosis 4.3E-06 9.5E-04 hsa04064 NF-kappa B 
signaling pathway 
8.9E-09 1.6E-06 
hsa04064 NF-kappa B signaling 
pathway 
3.9E-05 8.6E-03 hsa05134 Legionellosis 6.6E-08 1.2E-05 
hsa04380 Osteoclast differentiation 4.6E-05 1.0E-02 hsa04210 Apoptosis 9.0E-08 1.7E-05 
hsa05210 Colorectal cancer 2.1E-04 4.6E-02 hsa04621 NOD-like 
receptor signaling 
pathway 
1.3E-07 2.4E-05 
hsa05142 Chagas disease (American 
trypanosomiasis) 
4.1E-04 9.0E-02 hsa04010 MAPK signaling 
pathway 
6.9E-07 1.3E-04 
hsa04010 MAPK signaling pathway 4.4E-04 9.7E-02 hsa05132 Salmonella 
infection 
3.3E-06 6.0E-04 
hsa04664 Fc epsilon RI signaling 
pathway 
4.8E-04 1.1E-01 hsa05323 Rheumatoid 
arthritis 
4.8E-06 8.8E-04 
hsa05166 HTLV-I infection 5.0E-04 1.1E-01 hsa04060 Cytokine-
cytokine receptor 
interaction 
5.5E-06 1.0E-03 
hsa04662 B cell receptor signaling 
pathway 
6.4E-04 1.4E-01 hsa05164 Influenza A 3.8E-05 7.0E-03 
hsa05164 Influenza A 7.5E-04 1.6E-01 hsa04932 Non-alcoholic 
fatty liver disease 
(NAFLD) 
5.5E-05 1.0E-02 
hsa04068 FoxO signaling pathway 8.3E-04 1.8E-01 hsa05166 HTLV-I infection 7.6E-05 1.4E-02 
hsa04120 Ubiquitin mediated proteolysis 9.9E-04 2.2E-01 hsa05133 Pertussis 9.4E-05 1.7E-02 
hsa05203 Viral carcinogenesis 1.1E-03 2.4E-01 hsa04380 Osteoclast 
differentiation 
1.0E-04 1.9E-02 
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hsa05145 Toxoplasmosis 1.1E-03 2.4E-01 hsa04620 Toll-like 
receptor signaling 
pathway 
1.2E-04 2.3E-02 
hsa04070 Phosphatidylinositol signaling 
system 
1.2E-03 2.6E-01 hsa05200 Pathways in 
cancer 
1.6E-04 3.1E-02 
hsa04015 Rap1 signaling pathway 1.5E-03 3.3E-01 hsa05321 Inflammatory 
bowel disease (IBD) 
2.9E-04 5.4E-02 
hsa03410 Base excision repair 1.6E-03 3.5E-01 hsa04062 Chemokine 
signaling pathway 
3.2E-04 5.9E-02 
hsa05161 Hepatitis B 1.7E-03 3.6E-01 hsa05120 Epithelial cell 
signaling in Helicobacter 
pylori infection 
3.8E-04 7.0E-02 
hsa04621 NOD-like receptor signaling 
pathway 
1.8E-03 4.0E-01 hsa04640 Hematopoietic 
cell lineage 
4.3E-04 7.9E-02 
hsa04620 Toll-like receptor signaling 
pathway 
1.9E-03 4.2E-01 hsa05140 Leishmaniasis 5.5E-04 1.0E-01 
hsa05014 Amyotrophic lateral sclerosis 
(ALS) 
2.1E-03 4.6E-01 hsa05203 Viral 
carcinogenesis 
6.5E-04 1.2E-01 
hsa00562 Inositol phosphate 
metabolism 
2.6E-03 5.6E-01 hsa05161 Hepatitis B 1.1E-03 2.0E-01 
hsa05160 Hepatitis C 2.7E-03 5.9E-01 hsa05143 African 
trypanosomiasis 
1.4E-03 2.6E-01 
hsa05169 Epstein-Barr virus infection 3.0E-03 6.5E-01 hsa05210 Colorectal cancer 1.7E-03 3.2E-01 
hsa04666 Fc gamma R-mediated 
phagocytosis 
3.1E-03 6.8E-01 hsa05169 Epstein-Barr 
virus infection 
2.4E-03 4.4E-01 
hsa04140 Regulation of autophagy 3.8E-03 8.2E-01 hsa05211 Renal cell 
carcinoma 
2.5E-03 4.6E-01 
hsa04144 Endocytosis 3.8E-03 8.3E-01 hsa05332 Graft-versus-host 
disease 
2.5E-03 4.7E-01 
hsa03018 RNA degradation 4.1E-03 8.9E-01 hsa05160 Hepatitis C 2.7E-03 5.0E-01 
hsa05200 Pathways in cancer 4.4E-03 9.6E-01 hsa04115 p53 signaling 
pathway 
2.8E-03 5.2E-01 
hsa00010 Glycolysis / Gluconeogenesis 5.3E-01 1.0E+0
0 
hsa05146 Amoebiasis 2.8E-03 5.2E-01 
hsa00030 Pentose phosphate pathway 1.9E-01 1.0E+0
0 
hsa04068 FoxO signaling 
pathway 
2.8E-03 5.2E-01 
hsa00040 Pentose and glucuronate 
interconversions 
2.2E-01 1.0E+0
0 
hsa04940 Type I diabetes 
mellitus 
3.0E-03 5.6E-01 
hsa00051 Fructose and mannose 
metabolism 
2.1E-01 1.0E+0
0 
hsa05162 Measles 3.1E-03 5.7E-01 
hsa00071 Fatty acid degradation 3.2E-01 1.0E+0
0 
hsa05142 Chagas disease 
(American trypanosomiasis) 
3.4E-03 6.4E-01 
hsa00072 Synthesis and degradation of 
ketone bodies 
2.7E-02 1.0E+0
0 
hsa04930 Type II diabetes 
mellitus 
4.5E-03 8.3E-01 
hsa00230 Purine metabolism 9.1E-02 1.0E+0
0 
hsa05168 Herpes simplex 
infection 
4.6E-03 8.6E-01 
hsa00240 Pyrimidine metabolism 2.1E-02 1.0E+0
0 
hsa05144 Malaria 4.8E-03 8.9E-01 
hsa00250 Alanine, aspartate and 
glutamate metabolism 
6.3E-02 1.0E+0
0 
hsa00010 Glycolysis / 
Gluconeogenesis 
2.4E-01 1.0E+0
0 
hsa00270 Cysteine and methionine 
metabolism 
6.3E-03 1.0E+0
0 
hsa00052 Galactose 
metabolism 
6.9E-02 1.0E+0
0 
hsa00280 Valine, leucine and isoleucine 
degradation 
3.6E-01 1.0E+0
0 
hsa00230 Purine 
metabolism 
3.7E-02 1.0E+0
0 
hsa00310 Lysine degradation 4.6E-01 1.0E+0
0 
hsa00240 Pyrimidine 
metabolism 
1.6E-02 1.0E+0
0 
hsa00340 Histidine metabolism 2.4E-02 1.0E+0
0 
hsa00270 Cysteine and 
methionine metabolism 
2.5E-02 1.0E+0
0 
hsa00380 Tryptophan metabolism 8.7E-02 1.0E+0
0 
hsa00310 Lysine 
degradation 
5.0E-02 1.0E+0
0 
hsa00410 beta-Alanine metabolism 1.9E-01 1.0E+0
0 
hsa00380 Tryptophan 
metabolism 
1.1E-01 1.0E+0
0 
hsa00450 Selenocompound metabolism 9.3E-03 1.0E+0
0 
hsa00450 Selenocompound 
metabolism 
2.3E-02 1.0E+0
0 
hsa00480 Glutathione metabolism 4.2E-01 1.0E+0
0 
hsa00480 Glutathione 
metabolism 
1.7E-01 1.0E+0
0 
hsa00510 N-Glycan biosynthesis 3.7E-01 1.0E+0
0 
hsa00520 Amino sugar and 
nucleotide sugar 
metabolism 
1.4E-01 1.0E+0
0 
hsa00512 Mucin type O-Glycan 
biosynthesis 
1.9E-01 1.0E+0
0 
hsa00561 Glycerolipid 
metabolism 
2.0E-01 1.0E+0
0 
 196 
hsa00520 Amino sugar and nucleotide 
sugar metabolism 
1.3E-01 1.0E+0
0 
hsa00562 Inositol 
phosphate metabolism 
2.6E-01 1.0E+0
0 
hsa00561 Glycerolipid metabolism 4.6E-01 1.0E+0
0 
hsa00564 
Glycerophospholipid 
metabolism 
1.5E-01 1.0E+0
0 
hsa00563 
Glycosylphosphatidylinositol(GPI)-
anchor biosynthesis 
1.4E-01 1.0E+0
0 
hsa00565 Ether lipid 
metabolism 
2.5E-02 1.0E+0
0 
hsa00564 Glycerophospholipid 
metabolism 
2.4E-01 1.0E+0
0 
hsa00590 Arachidonic acid 
metabolism 
2.1E-01 1.0E+0
0 
hsa00565 Ether lipid metabolism 1.1E-01 1.0E+0
0 
hsa00600 Sphingolipid 
metabolism 
1.4E-01 1.0E+0
0 
hsa00590 Arachidonic acid metabolism 4.9E-01 1.0E+0
0 
hsa00620 Pyruvate 
metabolism 
1.0E-01 1.0E+0
0 
hsa00591 Linoleic acid metabolism 1.8E-01 1.0E+0
0 
hsa00670 One carbon pool 
by folate 
3.1E-02 1.0E+0
0 
hsa00592 alpha-Linolenic acid 
metabolism 
1.4E-01 1.0E+0
0 
hsa00760 Nicotinate and 
nicotinamide metabolism 
6.2E-02 1.0E+0
0 
hsa00600 Sphingolipid metabolism 3.5E-01 1.0E+0
0 
hsa00860 Porphyrin and 
chlorophyll metabolism 
1.2E-01 1.0E+0
0 
hsa00604 Glycosphingolipid 
biosynthesis - ganglio series 
5.8E-02 1.0E+0
0 
hsa01100 Metabolic 
pathways 
5.8E-01 1.0E+0
0 
hsa00620 Pyruvate metabolism 2.7E-01 1.0E+0
0 
hsa01200 Carbon 
metabolism 
4.7E-01 1.0E+0
0 
hsa00630 Glyoxylate and dicarboxylate 
metabolism 
3.6E-02 1.0E+0
0 
hsa01230 Biosynthesis of 
amino acids 
2.8E-01 1.0E+0
0 
hsa00650 Butanoate metabolism 1.7E-01 1.0E+0
0 
hsa03008 Ribosome 
biogenesis in eukaryotes 
1.7E-02 1.0E+0
0 
hsa00670 One carbon pool by folate 9.6E-02 1.0E+0
0 
hsa03013 RNA transport 9.2E-02 1.0E+0
0 
hsa00760 Nicotinate and nicotinamide 
metabolism 
4.0E-02 1.0E+0
0 
hsa03015 mRNA 
surveillance pathway 
3.6E-01 1.0E+0
0 
hsa00770 Pantothenate and CoA 
biosynthesis 
8.0E-02 1.0E+0
0 
hsa03022 Basal 
transcription factors 
1.3E-01 1.0E+0
0 
hsa00860 Porphyrin and chlorophyll 
metabolism 
2.4E-02 1.0E+0
0 
hsa03030 DNA replication 1.4E-02 1.0E+0
0 
hsa00900 Terpenoid backbone 
biosynthesis 
1.1E-01 1.0E+0
0 
hsa03320 PPAR signaling 
pathway 
2.7E-01 1.0E+0
0 
hsa00910 Nitrogen metabolism 7.2E-02 1.0E+0
0 
hsa03410 Base excision 
repair 
1.1E-02 1.0E+0
0 
hsa00983 Drug metabolism - other 
enzymes 
1.2E-01 1.0E+0
0 
hsa03420 Nucleotide 
excision repair 
2.8E-02 1.0E+0
0 
hsa01100 Metabolic pathways 2.5E-01 1.0E+0
0 
hsa03430 Mismatch repair 4.1E-02 1.0E+0
0 
hsa01200 Carbon metabolism 3.5E-01 1.0E+0
0 
hsa03440 Homologous 
recombination 
1.1E-01 1.0E+0
0 
hsa01212 Fatty acid metabolism 3.6E-01 1.0E+0
0 
hsa04012 ErbB signaling 
pathway 
7.9E-03 1.0E+0
0 
hsa01230 Biosynthesis of amino acids 4.7E-02 1.0E+0
0 
hsa04014 Ras signaling 
pathway 
1.6E-02 1.0E+0
0 
hsa03008 Ribosome biogenesis in 
eukaryotes 
6.8E-03 1.0E+0
0 
hsa04015 Rap1 signaling 
pathway 
1.0E-02 1.0E+0
0 
hsa03013 RNA transport 2.9E-01 1.0E+0
0 
hsa04020 Calcium signaling 
pathway 
2.5E-01 1.0E+0
0 
hsa03015 mRNA surveillance pathway 2.2E-01 1.0E+0
0 
hsa04022 cGMP-PKG 
signaling pathway 
3.1E-02 1.0E+0
0 
hsa03030 DNA replication 1.4E-02 1.0E+0
0 
hsa04024 cAMP signaling 
pathway 
2.3E-02 1.0E+0
0 
hsa03040 Spliceosome 4.7E-01 1.0E+0
0 
hsa04066 HIF-1 signaling 
pathway 
5.7E-02 1.0E+0
0 
hsa03320 PPAR signaling pathway 2.9E-01 1.0E+0
0 
hsa04070 
Phosphatidylinositol 
signaling system 
1.6E-01 1.0E+0
0 
hsa03420 Nucleotide excision repair 3.4E-02 1.0E+0
0 
hsa04071 Sphingolipid 
signaling pathway 
2.7E-02 1.0E+0
0 
hsa03430 Mismatch repair 2.2E-02 1.0E+0
0 
hsa04080 Neuroactive 
ligand-receptor interaction 
5.5E-01 1.0E+0
0 
hsa03440 Homologous recombination 9.2E-02 1.0E+0
0 
hsa04110 Cell cycle 9.6E-02 1.0E+0
0 
hsa03460 Fanconi anemia pathway 5.6E-02 1.0E+0
0 
hsa04120 Ubiquitin 
mediated proteolysis 
1.3E-02 1.0E+0
0 
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hsa04012 ErbB signaling pathway 8.4E-03 1.0E+0
0 
hsa04130 SNARE 
interactions in vesicular 
transport 
8.2E-02 1.0E+0
0 
hsa04014 Ras signaling pathway 8.1E-02 1.0E+0
0 
hsa04140 Regulation of 
autophagy 
1.1E-01 1.0E+0
0 
hsa04020 Calcium signaling pathway 2.0E-01 1.0E+0
0 
hsa04141 Protein 
processing in endoplasmic 
reticulum 
8.4E-02 1.0E+0
0 
hsa04022 cGMP-PKG signaling 
pathway 
1.3E-02 1.0E+0
0 
hsa04142 Lysosome 5.1E-01 1.0E+0
0 
hsa04024 cAMP signaling pathway 6.8E-03 1.0E+0
0 
hsa04144 Endocytosis 1.6E-01 1.0E+0
0 
hsa04060 Cytokine-cytokine receptor 
interaction 
1.1E-02 1.0E+0
0 
hsa04150 mTOR signaling 
pathway 
6.0E-03 1.0E+0
0 
hsa04062 Chemokine signaling pathway 1.2E-01 1.0E+0
0 
hsa04151 PI3K-Akt 
signaling pathway 
5.1E-02 1.0E+0
0 
hsa04066 HIF-1 signaling pathway 1.9E-02 1.0E+0
0 
hsa04152 AMPK signaling 
pathway 
9.6E-02 1.0E+0
0 
hsa04071 Sphingolipid signaling 
pathway 
9.6E-02 1.0E+0
0 
hsa04261 Adrenergic 
signaling in cardiomyocytes 
1.6E-01 1.0E+0
0 
hsa04080 Neuroactive ligand-receptor 
interaction 
7.4E-01 1.0E+0
0 
hsa04310 Wnt signaling 
pathway 
5.1E-02 1.0E+0
0 
hsa04110 Cell cycle 5.5E-03 1.0E+0
0 
hsa04330 Notch signaling 
pathway 
1.4E-01 1.0E+0
0 
hsa04114 Oocyte meiosis 4.1E-01 1.0E+0
0 
hsa04350 TGF-beta 
signaling pathway 
3.0E-02 1.0E+0
0 
hsa04115 p53 signaling pathway 9.4E-03 1.0E+0
0 
hsa04360 Axon guidance 1.0E-01 1.0E+0
0 
hsa04130 SNARE interactions in 
vesicular transport 
5.9E-02 1.0E+0
0 
hsa04370 VEGF signaling 
pathway 
5.4E-02 1.0E+0
0 
hsa04141 Protein processing in 
endoplasmic reticulum 
7.2E-02 1.0E+0
0 
hsa04390 Hippo signaling 
pathway 
6.4E-01 1.0E+0
0 
hsa04142 Lysosome 6.3E-01 1.0E+0
0 
hsa04510 Focal adhesion 2.4E-02 1.0E+0
0 
hsa04145 Phagosome 5.8E-01 1.0E+0
0 
hsa04512 ECM-receptor 
interaction 
3.2E-01 1.0E+0
0 
hsa04146 Peroxisome 3.7E-01 1.0E+0
0 
hsa04514 Cell adhesion 
molecules (CAMs) 
6.0E-01 1.0E+0
0 
hsa04150 mTOR signaling pathway 5.1E-02 1.0E+0
0 
hsa04520 Adherens 
junction 
2.8E-01 1.0E+0
0 
hsa04151 PI3K-Akt signaling pathway 3.7E-02 1.0E+0
0 
hsa04540 Gap junction 3.5E-01 1.0E+0
0 
hsa04152 AMPK signaling pathway 2.3E-01 1.0E+0
0 
hsa04550 Signaling 
pathways regulating 
pluripotency of stem cells 
4.9E-02 1.0E+0
0 
hsa04261 Adrenergic signaling in 
cardiomyocytes 
1.7E-02 1.0E+0
0 
hsa04610 Complement and 
coagulation cascades 
9.9E-02 1.0E+0
0 
hsa04270 Vascular smooth muscle 
contraction 
6.2E-01 1.0E+0
0 
hsa04611 Platelet activation 2.4E-01 1.0E+0
0 
hsa04310 Wnt signaling pathway 8.3E-02 1.0E+0
0 
hsa04612 Antigen 
processing and presentation 
9.3E-02 1.0E+0
0 
hsa04330 Notch signaling pathway 3.6E-01 1.0E+0
0 
hsa04614 Renin-
angiotensin system 
4.1E-02 1.0E+0
0 
hsa04350 TGF-beta signaling pathway 7.0E-02 1.0E+0
0 
hsa04622 RIG-I-like 
receptor signaling pathway 
1.7E-02 1.0E+0
0 
hsa04360 Axon guidance 9.5E-02 1.0E+0
0 
hsa04623 Cytosolic DNA-
sensing pathway 
6.0E-02 1.0E+0
0 
hsa04370 VEGF signaling pathway 7.6E-02 1.0E+0
0 
hsa04630 Jak-STAT 
signaling pathway 
7.1E-02 1.0E+0
0 
hsa04390 Hippo signaling pathway 3.8E-01 1.0E+0
0 
hsa04650 Natural killer cell 
mediated cytotoxicity 
4.1E-02 1.0E+0
0 
hsa04510 Focal adhesion 1.7E-01 1.0E+0
0 
hsa04660 T cell receptor 
signaling pathway 
1.6E-02 1.0E+0
0 
hsa04512 ECM-receptor interaction 3.6E-01 1.0E+0
0 
hsa04662 B cell receptor 
signaling pathway 
1.9E-02 1.0E+0
0 
hsa04514 Cell adhesion molecules 
(CAMs) 
3.3E-01 1.0E+0
0 
hsa04664 Fc epsilon RI 
signaling pathway 
1.7E-02 1.0E+0
0 
hsa04520 Adherens junction 3.1E-01 1.0E+0
0 
hsa04666 Fc gamma R-
mediated phagocytosis 
1.4E-01 1.0E+0
0 
hsa04540 Gap junction 4.1E-01 1.0E+0
0 
hsa04670 Leukocyte 
transendothelial migration 
4.9E-01 1.0E+0
0 
hsa04550 Signaling pathways regulating 
pluripotency of stem cells 
1.3E-02 1.0E+0
0 
hsa04672 Intestinal immune 
network for IgA production 
1.5E-01 1.0E+0
0 
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hsa04610 Complement and coagulation 
cascades 
3.4E-01 1.0E+0
0 
hsa04710 Circadian rhythm 6.9E-02 1.0E+0
0 
hsa04611 Platelet activation 4.2E-02 1.0E+0
0 
hsa04713 Circadian 
entrainment 
3.9E-01 1.0E+0
0 
hsa04612 Antigen processing and 
presentation 
1.4E-01 1.0E+0
0 
hsa04722 Neurotrophin 
signaling pathway 
9.0E-02 1.0E+0
0 
hsa04614 Renin-angiotensin system 1.2E-01 1.0E+0
0 
hsa04723 Retrograde 
endocannabinoid signaling 
1.7E-01 1.0E+0
0 
hsa04622 RIG-I-like receptor signaling 
pathway 
1.1E-01 1.0E+0
0 
hsa04725 Cholinergic 
synapse 
2.0E-01 1.0E+0
0 
hsa04630 Jak-STAT signaling pathway 2.4E-02 1.0E+0
0 
hsa04726 Serotonergic 
synapse 
4.7E-01 1.0E+0
0 
hsa04640 Hematopoietic cell lineage 1.1E-01 1.0E+0
0 
hsa04727 GABAergic 
synapse 
3.5E-01 1.0E+0
0 
hsa04650 Natural killer cell mediated 
cytotoxicity 
9.4E-03 1.0E+0
0 
hsa04728 Dopaminergic 
synapse 
5.4E-01 1.0E+0
0 
hsa04660 T cell receptor signaling 
pathway 
6.4E-03 1.0E+0
0 
hsa04750 Inflammatory 
mediator regulation of TRP 
channels 
5.0E-02 1.0E+0
0 
hsa04670 Leukocyte transendothelial 
migration 
2.0E-01 1.0E+0
0 
hsa04810 Regulation of 
actin cytoskeleton 
8.3E-02 1.0E+0
0 
hsa04672 Intestinal immune network for 
IgA production 
1.4E-01 1.0E+0
0 
hsa04910 Insulin signaling 
pathway 
5.8E-01 1.0E+0
0 
hsa04710 Circadian rhythm 4.7E-02 1.0E+0
0 
hsa04911 Insulin secretion 3.3E-01 1.0E+0
0 
hsa04713 Circadian entrainment 1.1E-01 1.0E+0
0 
hsa04912 GnRH signaling 
pathway 
1.4E-01 1.0E+0
0 
hsa04720 Long-term potentiation 5.3E-01 1.0E+0
0 
hsa04913 Ovarian 
steroidogenesis 
1.5E-01 1.0E+0
0 
hsa04722 Neurotrophin signaling 
pathway 
9.9E-02 1.0E+0
0 
hsa04914 Progesterone-
mediated oocyte maturation 
4.0E-01 1.0E+0
0 
hsa04723 Retrograde endocannabinoid 
signaling 
2.7E-01 1.0E+0
0 
hsa04915 Estrogen 
signaling pathway 
5.2E-02 1.0E+0
0 
hsa04724 Glutamatergic synapse 3.5E-01 1.0E+0
0 
hsa04916 Melanogenesis 1.7E-01 1.0E+0
0 
hsa04725 Cholinergic synapse 2.7E-02 1.0E+0
0 
hsa04917 Prolactin 
signaling pathway 
1.8E-02 1.0E+0
0 
hsa04727 GABAergic synapse 2.0E-01 1.0E+0
0 
hsa04918 Thyroid hormone 
synthesis 
2.8E-01 1.0E+0
0 
hsa04728 Dopaminergic synapse 2.6E-01 1.0E+0
0 
hsa04919 Thyroid hormone 
signaling pathway 
2.3E-01 1.0E+0
0 
hsa04740 Olfactory transduction 1.0E+0
0 
1.0E+0
0 
hsa04920 Adipocytokine 
signaling pathway 
7.5E-02 1.0E+0
0 
hsa04750 Inflammatory mediator 
regulation of TRP channels 
1.5E-02 1.0E+0
0 
hsa04921 Oxytocin 
signaling pathway 
2.5E-02 1.0E+0
0 
hsa04810 Regulation of actin 
cytoskeleton 
1.2E-01 1.0E+0
0 
hsa04922 Glucagon 
signaling pathway 
1.5E-02 1.0E+0
0 
hsa04910 Insulin signaling pathway 5.0E-01 1.0E+0
0 
hsa04950 Maturity onset 
diabetes of the young 
5.1E-02 1.0E+0
0 
hsa04911 Insulin secretion 7.3E-02 1.0E+0
0 
hsa04960 Aldosterone-
regulated sodium 
reabsorption 
1.0E-01 1.0E+0
0 
hsa04912 GnRH signaling pathway 3.4E-02 1.0E+0
0 
hsa04962 Vasopressin-
regulated water 
reabsorption 
2.3E-02 1.0E+0
0 
hsa04913 Ovarian steroidogenesis 3.8E-01 1.0E+0
0 
hsa04971 Gastric acid 
secretion 
2.8E-01 1.0E+0
0 
hsa04914 Progesterone-mediated 
oocyte maturation 
4.4E-02 1.0E+0
0 
hsa04973 Carbohydrate 
digestion and absorption 
1.4E-01 1.0E+0
0 
hsa04915 Estrogen signaling pathway 1.6E-02 1.0E+0
0 
hsa04977 Vitamin digestion 
and absorption 
4.4E-02 1.0E+0
0 
hsa04916 Melanogenesis 1.3E-01 1.0E+0
0 
hsa04978 Mineral 
absorption 
1.6E-01 1.0E+0
0 
hsa04917 Prolactin signaling pathway 4.1E-02 1.0E+0
0 
hsa05010 Alzheimer's 
disease 
9.2E-02 1.0E+0
0 
hsa04918 Thyroid hormone synthesis 1.3E-01 1.0E+0
0 
hsa05012 Parkinson's 
disease 
5.9E-01 1.0E+0
0 
hsa04919 Thyroid hormone signaling 
pathway 
2.0E-01 1.0E+0
0 
hsa05014 Amyotrophic 
lateral sclerosis (ALS) 
3.4E-02 1.0E+0
0 
hsa04920 Adipocytokine signaling 
pathway 
1.1E-01 1.0E+0
0 
hsa05016 Huntington's 
disease 
5.1E-01 1.0E+0
0 
hsa04921 Oxytocin signaling pathway 2.5E-02 1.0E+0
0 
hsa05020 Prion diseases 1.3E-02 1.0E+0
0 
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hsa04922 Glucagon signaling pathway 5.8E-03 1.0E+0
0 
hsa05030 Cocaine 
addiction 
3.1E-02 1.0E+0
0 
hsa04930 Type II diabetes mellitus 8.3E-03 1.0E+0
0 
hsa05031 Amphetamine 
addiction 
7.0E-02 1.0E+0
0 
hsa04932 Non-alcoholic fatty liver 
disease (NAFLD) 
1.8E-02 1.0E+0
0 
hsa05034 Alcoholism 7.2E-01 1.0E+0
0 
hsa04940 Type I diabetes mellitus 1.0E-01 1.0E+0
0 
hsa05100 Bacterial invasion 
of epithelial cells 
3.0E-01 1.0E+0
0 
hsa04950 Maturity onset diabetes of the 
young 
1.5E-01 1.0E+0
0 
hsa05131 Shigellosis 2.3E-01 1.0E+0
0 
hsa04960 Aldosterone-regulated sodium 
reabsorption 
8.2E-02 1.0E+0
0 
hsa05145 Toxoplasmosis 6.3E-03 1.0E+0
0 
hsa04962 Vasopressin-regulated water 
reabsorption 
2.8E-02 1.0E+0
0 
hsa05150 Staphylococcus 
aureus infection 
1.8E-01 1.0E+0
0 
hsa04970 Salivary secretion 6.9E-01 1.0E+0
0 
hsa05152 Tuberculosis 2.4E-01 1.0E+0
0 
hsa04971 Gastric acid secretion 1.3E-01 1.0E+0
0 
hsa05204 Chemical 
carcinogenesis 
3.2E-01 1.0E+0
0 
hsa04972 Pancreatic secretion 2.4E-01 1.0E+0
0 
hsa05205 Proteoglycans in 
cancer 
6.9E-02 1.0E+0
0 
hsa04973 Carbohydrate digestion and 
absorption 
3.2E-02 1.0E+0
0 
hsa05206 MicroRNAs in 
cancer 
2.5E-02 1.0E+0
0 
hsa04975 Fat digestion and absorption 2.9E-01 1.0E+0
0 
hsa05212 Pancreatic 
cancer 
1.4E-02 1.0E+0
0 
hsa04976 Bile secretion 5.6E-01 1.0E+0
0 
hsa05213 Endometrial 
cancer 
3.6E-02 1.0E+0
0 
hsa04977 Vitamin digestion and 
absorption 
1.3E-01 1.0E+0
0 
hsa05214 Glioma 1.4E-02 1.0E+0
0 
hsa04978 Mineral absorption 4.0E-01 1.0E+0
0 
hsa05215 Prostate cancer 8.2E-03 1.0E+0
0 
hsa05010 Alzheimer's disease 6.6E-01 1.0E+0
0 
hsa05217 Basal cell 
carcinoma 
1.8E-01 1.0E+0
0 
hsa05012 Parkinson's disease 7.2E-01 1.0E+0
0 
hsa05218 Melanoma 1.7E-02 1.0E+0
0 
hsa05016 Huntington's disease 7.5E-01 1.0E+0
0 
hsa05219 Bladder cancer 1.9E-02 1.0E+0
0 
hsa05030 Cocaine addiction 9.0E-03 1.0E+0
0 
hsa05220 Chronic myeloid 
leukemia 
8.2E-02 1.0E+0
0 
hsa05031 Amphetamine addiction 8.8E-03 1.0E+0
0 
hsa05221 Acute myeloid 
leukemia 
1.9E-01 1.0E+0
0 
hsa05032 Morphine addiction 6.9E-01 1.0E+0
0 
hsa05222 Small cell lung 
cancer 
7.2E-03 1.0E+0
0 
hsa05033 Nicotine addiction 2.8E-01 1.0E+0
0 
hsa05223 Non-small cell 
lung cancer 
4.4E-02 1.0E+0
0 
hsa05034 Alcoholism 3.3E-01 1.0E+0
0 
hsa05230 Central carbon 
metabolism in cancer 
1.4E-02 1.0E+0
0 
hsa05100 Bacterial invasion of epithelial 
cells 
3.4E-01 1.0E+0
0 
hsa05231 Choline 
metabolism in cancer 
5.3E-02 1.0E+0
0 
hsa05120 Epithelial cell signaling in 
Helicobacter pylori infection 
8.8E-03 1.0E+0
0 
hsa05310 Asthma 6.9E-02 1.0E+0
0 
hsa05131 Shigellosis 2.4E-01 1.0E+0
0 
hsa05322 Systemic lupus 
erythematosus 
5.6E-01 1.0E+0
0 
hsa05132 Salmonella infection 2.6E-02 1.0E+0
0 
hsa05330 Allograft rejection 9.9E-02 1.0E+0
0 
hsa05133 Pertussis 4.9E-02 1.0E+0
0 
hsa05410 Hypertrophic 
cardiomyopathy (HCM) 
6.2E-03 1.0E+0
0 
hsa05134 Legionellosis 1.4E-02 1.0E+0
0 
hsa05412 Arrhythmogenic 
right ventricular 
cardiomyopathy (ARVC) 
2.0E-02 1.0E+0
0 
hsa05140 Leishmaniasis 1.2E-02 1.0E+0
0 
hsa05414 Dilated 
cardiomyopathy 
8.6E-03 1.0E+0
0 
hsa05143 African trypanosomiasis 1.3E-02 1.0E+0
0 
hsa05416 Viral myocarditis 2.0E-01 1.0E+0
0 
hsa05144 Malaria 1.4E-01 1.0E+0
0 
   
hsa05146 Amoebiasis 4.8E-02 1.0E+0
0 
   
hsa05150 Staphylococcus aureus 
infection 
1.8E-01 1.0E+0
0 
   
hsa05152 Tuberculosis 2.0E-02 1.0E+0
0 
   
hsa05162 Measles 2.7E-02 1.0E+0
0 
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hsa05168 Herpes simplex infection 2.5E-02 1.0E+0
0 
   
hsa05205 Proteoglycans in cancer 4.5E-02 1.0E+0
0 
   
hsa05206 MicroRNAs in cancer 2.6E-01 1.0E+0
0 
   
hsa05211 Renal cell carcinoma 8.2E-03 1.0E+0
0 
   
hsa05212 Pancreatic cancer 7.6E-03 1.0E+0
0 
   
hsa05213 Endometrial cancer 4.7E-02 1.0E+0
0 
   
hsa05214 Glioma 7.6E-03 1.0E+0
0 
   
hsa05215 Prostate cancer 8.9E-03 1.0E+0
0 
   
hsa05217 Basal cell carcinoma 1.7E-01 1.0E+0
0 
   
hsa05218 Melanoma 3.9E-02 1.0E+0
0 
   
hsa05219 Bladder cancer 9.2E-02 1.0E+0
0 
   
hsa05220 Chronic myeloid leukemia 4.3E-02 1.0E+0
0 
   
hsa05221 Acute myeloid leukemia 1.9E-01 1.0E+0
0 
   
hsa05222 Small cell lung cancer 7.6E-02 1.0E+0
0 
   
hsa05223 Non-small cell lung cancer 1.8E-01 1.0E+0
0 
   
hsa05230 Central carbon metabolism in 
cancer 
3.1E-02 1.0E+0
0 
   
hsa05231 Choline metabolism in cancer 1.3E-01 1.0E+0
0 
   
hsa05310 Asthma 1.9E-01 1.0E+0
0 
   
hsa05320 Autoimmune thyroid disease 4.1E-01 1.0E+0
0 
   
hsa05321 Inflammatory bowel disease 
(IBD) 
2.8E-02 1.0E+0
0 
   
hsa05322 Systemic lupus 
erythematosus 
4.7E-01 1.0E+0
0 
   
hsa05323 Rheumatoid arthritis 8.8E-02 1.0E+0
0 
   
hsa05330 Allograft rejection 7.7E-02 1.0E+0
0 
   
hsa05332 Graft-versus-host disease 9.2E-02 1.0E+0
0 
   
hsa05340 Primary immunodeficiency 7.2E-02 1.0E+0
0 
   
hsa05410 Hypertrophic cardiomyopathy 
(HCM) 
6.7E-02 1.0E+0
0 
   
hsa05412 Arrhythmogenic right 
ventricular cardiomyopathy (ARVC) 
1.3E-01 1.0E+0
0 
   
hsa05414 Dilated cardiomyopathy 3.1E-02 1.0E+0
0 
   
hsa05416 Viral myocarditis 4.6E-01 1.0E+0
0 
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Appendix table 4.3: 6hr LFQ data filtering. 
 
 
Appendix figure 4.2: Boxplots of six hour LFQ intensity before and after 
median correction. 
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Appendix figure 4.3: Relative abundance of the histone PTMs on 
YQSTELLIR and VTIMPKDIQLAR peptide.  
This figure illustrates the relative abundance in the histone PTMs identified on both peptides. There was 
no significant change observed between the infective challenges and the MI samples. n=3, on way 
ANOVA.  
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Appendix table 5.1 Summary of the histone PTMs for H3 and H4 identified: 
 
maXis QE	0.1%	TFA QE	0.05%	HFBA
H3_3_8 unmod
H3_3_8 K4me1
H3_3_8 K4me2
H3_3_8 K4me3
H3_9_17 unmod
H3_9_17 K9me1
H3_9_17 K9me2
H3_9_17 K9me3
H3_9_17 K9ac
H3_9_17 K14ac
H3_9_17 K9me1K14ac
H3_9_17 K9me2K14ac
H3_9_17 K9me3K14ac
H3_9_17 K9acK14ac
H3_18_26 unmod
H3_18_26 K23me1
H3_18_26 K18me1
H3_18_26 K18me1K23me1
H3_18_26 K18ac
H3_18_26 K23ac
H3_18_26 K18acK23ac
H3K27ac1K36me0
H3K27me0K36me0
H3K27me0K36me1
H3K27me0K36me2
H3K27me0K36me3
H3K27me1K36me0
H3K27me1K36me1
H3K27me1K36me2
H3K27me1K36me3
H3K27me2K36me0
H3K27me2K36me1
H3K27me2K36me2
H3K27me3K36me0
H3K27me3K36me1
H3K27me3K36me2
H3.3K27ac
H3.3K27me0K36me0
H3.3K27me1
H3.3K27me1K36me1
H3.3K27me1K36me2
H3.3K27me1K36me3
H3.3K27me2
H3.3K27me2K36me1
H3.3K27me2K36me2
H3.3K27me3
H3.3K27me3K36me1
H3.3K27me3K36me2
H3.3K36me1
H3.3K36me2
H3.3K36me3
H3_54_63 unmod
H3_54_63 K56me1
H3_54_63 K56me2
H3_54_63 K56ac
H3_73_83 unmod
H3_73_83 K79me1
H3_73_83 K79me2
H3_73_83 K79me3
H3_73_83 K79ac
H3_117_128 unmod
H3_117_128 K122ac
H4_4_17 unmod
H4_4_17 K5ac
H4_4_17 K8ac
H4_4_17 K12ac
H4_4_17 K16ac
H4_4_17 K5acK8ac
H4_4_17 K5acK12ac
H4_4_17 K5acK16ac
H4_4_17 K8acK12ac
H4_4_17 K8acK16ac
H4_4_17 K12acK16ac
H4_4_17 K5acK8acK12ac
H4_4_17 K5acK8acK16ac
H4_4_17 K5acK12acK16ac
H4_4_17 K8acK12acK16ac
H4_4_17 K5acK8acK12acK16ac
H4_20_23 unmod
H4_20_23 K20me1
H4_20_23 K20me2
H4_20_23 K20me3
H4_20_23 K20ac
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Appendix table 5.2: Top ten transcripts identified using “new Tuxedo 
protocol”. 
Transcript_Name Log_FC p value q value chr 
uc059mdu.1 0.553223688 2.65E-06 0.1838 chr15 
uc062xni.1 0.549128506 4.49E-06 0.1838 chr4 
uc021yro.2 0.302302898 5.56E-06 0.1838 chr6 
uc058tfo.1 2.887789605 6.20E-06 0.1838 chr12 
uc001isy.4 -1.57550692 7.63E-06 0.1838 chr10 
uc061zwi.1 -0.73943678 9.66E-06 0.1939 chr21 
uc062jir.1 -0.31967312 1.64E-05 0.2328 chr3 
uc058nws.1 0.28993914 1.78E-05 0.2328 chr12 
uc011lhj.3 -0.80503139 1.85E-05 0.2328 chr8 
uc060moz.1 -0.72478913 2.06E-05 0.2328 chr17_KI270862v1_alt 
 
 
Appendix figure 5.1: Bioanalyser trace of ChIP following library preparation 
and size selection. 
This figure illustrates the post library preparation and magnetic bead size selection and PCR clean up 
prior to sequencing for a selection of the pull downs. 
 
 206 
 
Appendix figure 5.2: FASTQC assessment of ChIP-Seq raw data. 
This figure illustrates the results from the FASTQC analysis of the raw sequencing data obtained 
following ChIP-Seq. The mean Phred scores are greater than 25 and therefore of good quality. 
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Appendix figure 5.3: Phantom peak tools assessment of the peak picking. 
This figure illustrates the assessment of the peaks found after running MACS2 for the H3K27ac pull 
down in sample D3. Both the NSC and the RSC show good results. 
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Appendix figure 5.4: ChIPQC assessment of the peak picking. 
This figure illustrates the abundance of reads found to be inside peaks after running MACS2 in narrow 
mode for each of the different ChIPs.  
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Appendix figure 5.5: Average profile of ChIP peaks binding to TSS regions. 
This figure summarises the average profile of the ChIP peaks to the TSS regions for each pull down 
picked with MACS2 in either narrow mode (H3K4me1, H3K4me3 and H3K27ac) or broad mode 
(H3K9me2 and H3K27me3). 
 
 
 210 
 
Appendix figure 5.6: Genomic annotation barplot of ChIP peaks. 
This figure summarises the genomic annotations derived from ChIPseeker for each pull down picked with 
MACS2 in either narrow mode (H3K4me1, H3K4me3 and H3K27ac) or broad mode (H3K9me2 and 
H3K27me3). 
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Appendix table 5.3: Broad peak diffbind analysis for H3K4me1 pull downs. 
Chr Start End 
Fol
d FDR Gene  distance 
chr18 107169 110747 
3.6
3 
0.0002
22 ROCK1P1 /MIR8078 exon   
chr7 
1009577
88 
1009589
05 
6.1
1 
0.0012
9 MUC3A exon   
chr21 9820916 9821846 
4.1
6 0.0459 LINC01667 
exon / 
TSS   
chr21 8219787 8220666 
5.7
1 
0.0057
5 NR_038958 intron   
chr16 
4638964
6 
4639126
5 
9.5
6 
3.59E-
08 Downstream ANKRD26P1 no 100kb 
chr16 
4639429
7 
4639508
2 
8.1
7 
0.0002
22 Downstream ANKRD26P1 no 100kb 
chr16 
4638636
0 
4638934
3 
8.8
8 
0.0002
36 Downstream ANKRD26P1 no 100kb 
chr21 
1069237
0 
1069308
6 
4.3
9 0.028 Downstream TPTE no 100kb 
chr21 8420049 8420586 
5.0
4 0.0461 
Downstream NR_038958 / Upstream 
MIR6724-4 no 
10kb / 
12kb 
chr3 
7566889
4 
7566962
8 
7.8
2 
1.70E-
06 
Downstream FRG2C / Upstream 
LINC00960 no 
10kb / 
12kb 
chr20 
3106297
8 
3106414
3 
5.8
5 0.0025 Upstream DEFB115 no 120kb 
chr20 
2889788
3 
2889880
6 
4.7
4 0.0237 Upstream FRG1DP  no 180kb 
chrY 
1133297
1 
1133427
2 
7.7
6 
1.70E-
06 Downstream GYG2P1 no 1mb 
chrY 
1131813
4 
1131904
5 
5.4
8 
0.0069
1 Downstream GYG2P1 no 1mb 
chrY 
2667040
2 
2667189
9 
2.3
3 0.0483 Downstream TTTY3B no 1mb  
chr1 
1432142
20 
1432158
39 
6.9
1 
0.0001
01 Downstream LOC645166 no 200kb 
chr1 
1432516
11 
1432568
73 
7.0
9 
0.0001
46 Downstream LOC645166 no 200kb 
chr1 
1432636
26 
1432647
95 
7.0
1 
0.0016
7 Downstream LOC645166 no 200kb 
chr1 
1431846
42 
1431862
36 
4.2
4 
0.0073
5 Downstream LOC645166 no 200kb 
chr16 
3458139
6 
3458381
5 
8.9
5 
0.0002
36 Upstream LINC00273 no 200kb 
chr16 
3459485
7 
3459584
8 
6.9
4 
0.0002
69 Upstream LINC00273 no 200kb 
chr16 
3458650
5 
3458700
5 
4.5
9 
0.0007
24 Upstream LINC00273 no 200kb 
chr16 
3459259
0 
3459364
6 
6.3
6 
0.0064
5 Upstream LINC00273 no 200kb 
chr16 
3457391
0 
3457445
1 
6.0
5 0.0109 Upstream LINC00273 no 200kb 
chr16 
3457563
8 
3457669
6 
3.2
9 0.0412 Upstream LINC00273 no 200kb 
chr2 
8983628
3 
8983720
1 
6.8
1 
0.0002
05 Upstream NR_136329 no 200kb 
chrY 
5673406
5 
5673491
0 
5.9
6 
0.0016
7 Upstream SPRY3 no 250kb 
chr10 
4188310
3 
4188405
5 
4.7
5 
0.0006
57 Downstream LOC441666 no 300kb 
chr10 
4187928
0 
4187963
6 
3.5
2 0.0239 Downstream LOC441666 no 300kb 
chr15 
1708054
3 
1708167
0 
4.1
6 0.011 Updtream CHEK2P2 no 3mb 
chr4 
4963266
9 
4963561
1 
6.4
3 
0.0057
5 Downstream CWH43 no 400kb 
chr22 
1269343
7 
1269402
3 
6.0
1 
0.0014
8 Downstream NR_110761 no 600kb 
chr20 
3118534
6 
3118738
1 
6.6
3 
0.0002
89 Upstream DEFB115 no 70kb 
chrUn_KI270438v1 103891 105254 
4.1
8 
1.41E-
11       
chr1_KI270709v1_ran
dom 6608 7767 5.4 0.0322       
chr14_GL000225v1_r
andom 5434 6978 
7.6
1 
4.53E-
06       
chr14_GL000225v1_r
andom 64968 66357 
7.3
2 
8.40E-
06       
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chr14_GL000225v1_r
andom 130222 131970 
7.3
8 
1.45E-
05       
chr14_GL000225v1_r
andom 67256 68342 
5.0
4 
0.0003
63       
chr14_GL000225v1_r
andom 24991 25825 
6.2
9 
0.0007
15       
chr14_GL000225v1_r
andom 125125 126036 
6.3
1 
0.0017
7       
chr14_GL000225v1_r
andom 44328 44605 
5.4
3 
0.0073
5       
chr14_GL000225v1_r
andom 45973 46204 5.3 0.0146       
chr14_GL000225v1_r
andom 90884 91263 
5.0
3 0.0163       
chr14_GL000225v1_r
andom 136994 138232 
5.0
5 0.0171       
chr14_GL000225v1_r
andom 85568 86617 
3.7
1 0.0184       
chr14_GL000225v1_r
andom 17000 17268 
4.8
4 0.0237       
chr14_GL000225v1_r
andom 56981 57477 
4.7
9 0.0239       
chr14_GL000225v1_r
andom 49794 51004 
2.5
8 0.0438       
chr14_KI270723v1_ra
ndom 35218 37122 
6.4
1 
0.0003
76       
chr14_KI270724v1_ra
ndom 481 1334 5 0.0171       
chr17_KI270729v1_ra
ndom 2325 3633 4 
0.0057
5       
chr17_KI270729v1_ra
ndom 21060 21556 
5.5
3 
0.0073
5       
chr22_KI270733v1_ra
ndom 165119 166362 
5.4
7 
0.0073
5       
chr22_KI270733v1_ra
ndom 162219 163702 
5.1
2 0.0438       
chr22_KI270736v1_ra
ndom 179486 181786 
4.1
3 
0.0002
22       
chrUn_GL000214v1 117073 118932 
6.1
8 
0.0008
8       
chrUn_GL000216v2 160603 161004 
6.5
3 
0.0002
97       
chrUn_GL000216v2 149357 149840 
6.6
3 
0.0002
97       
chrUn_GL000216v2 14889 16143 5.4 
0.0080
1       
chrUn_GL000216v2 158642 159698 
4.2
6 0.0101       
chrUn_GL000220v1 143882 145560 
-
5.6
1 
0.0057
5       
chrUn_GL000224v1 3520 5750 
7.8
9 
1.50E-
06       
chrUn_GL000224v1 505 2748 
5.1
9 
0.0002
22       
chrUn_GL000224v1 16760 19239 
5.8
3 0.0025       
chrUn_KI270438v1 109177 112425 
2.1
4 
0.0077
8       
chrUn_KI270442v1 92121 92712 
2.5
6 0.0327       
chrUn_KI270589v1 41617 42623 
5.7
3 
0.0035
4       
chrUn_KI270744v1 119601 121462 
7.0
8 
0.0014
4       
chrUn_KI270744v1 108139 109571 
5.1
2 
0.0015
5       
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Appendix table 5.4: Diffbind analysis for H3K4me3 peaks. 
ab n Chr Start End Fold FDR Gene 
Gene 
body distance  
H3K4me3 
Broad 2 
chrUn_KI270
744v1 119089 121463 7.24 3.20E-05       
H3K4me3 
Broad 2 
chrUn_GL000
214v1 116810 118662 6.13 0.0159       
H3K4me3 
Broad 2 chr20 31064959 31065244 6.1 0.0332 
Upstream 
DEFB115 no 200bp 
H3K4me3 
Broad 2 chr4 49140532 49140889 3.34 0.0432 
centromere / 
downstream 
CWH43 no 60kb 
H3K4me3 
Broad 3 
chrUn_KI270
744v1 119089 121463 6.45 0.00218       
H3K4me3 
Broad 3 
chrUn_GL000
214v1 131146 131864 5.2 0.00691       
H3K4me3 
Broad 3 chr20 31064959 31065244 5.07 0.00594 
Upstream 
DEFB115 no 200bp 
H3K4me3 
narrow 2 
chrUn_KI270
744v1 119598 120332 6.41 0.00223       
H3K4me3 
narrow 2 
chrUn_GL000
216v2 166609 166932 6.3 0.00366       
H3K4me3 
narrow 2 
chr14_GL000
225v1_rando
m 74454 74902 -4.58 0.0355       
H3K4me3 
narrow 2 chr2 89836279 89836820 7.39 1.42E-05 
Upstream 
NR_136329 no 200bp 
H3K4me3 
narrow 2 chr20 31060276 31060908 7.14 0.00223 
Upstream 
DEFB115 no 200bp 
H3K4me3 
narrow 2 chr20 31064954 31065293 5.14 0.0174 
Upstream 
DEFB115 no 200bp 
H3K4me3 
narrow 2 chr1 143184636 143185468 2.08 0.0331 
Downstream 
LOC1645166 no 200bp 
H3K4me3 
narrow 2 chrY 56706930 56708146 6.37 0.00284 
Upstream 
SPRY3 no 250kb 
H3K4me3 
narrow 2 chr3 93470363 93470799 12.68 0.00642 
centromere / 
downstream 
PROS1 no 400kb 
H3K4me3 
narrow 2 chr4 49120883 49121208 3.33 0.0475 
centromere / 
downstream 
CWH43 no 60kb 
H3K4me3 
narrow 3 
chrUn_KI270
744v1 119598 120332 5.64 0.0444       
H3K4me3 
narrow 3 chr20 31064954 31065293 4.62 0.0131 
Upstream 
DEFB115 no 200bp 
H3K4me3 
narrow 3 chrY 56706930 56708146 5.91 0.000446 
Upstream 
SPRY3 no 250kb 
 
